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i 
Abstract 
Kocuria SM1 and Rhodococcus SM2 were administered to juvenile rainbow trout as 
dietary supplements dosed at ~107–108 cells g−1 of feed for two weeks, and conferred 
protection against Vibrio infections. Thus, use of SM1 and SM2 led to a significant 
(P < 0.05) reduction in mortalities, i.e. 12–15% (relative percent survival, RPS = 81–
85%) and 15–20% (RPS = 73–80%) after challenge with V. anguillarum and V. ordalii, 
respectively, compared to the 80% and 74% mortalities among the respective controls. 
A two-week feeding regime, compared with 1–4 weeks, for SM1 led to the maximum 
reduction in mortalities after challenge with V. anguillarum. The use of an equi-mixture 
of SM1 and SM2 led to significantly enhanced survival against vibriosis, but the result 
was not better than the use of single cultures. Moreover, use of SM1 for two weeks led 
to protection for up to 4 weeks. Fish inoculated with cell wall proteins (CWPs) and 
whole cell proteins (WCPs) of SM1 and SM2 demonstrated better protection against 
challenge with V. anguillarum, although extracellular proteins (ECPs) fared less well. 
The mode of action reflected competitive exclusion (= antibiosis), nutrition (= positive 
effects on growth), and stimulation of cellular and humoral innate immunity, notably 
greater head kidney macrophage phagocytic, respiratory burst, peroxidase and bacterial 
killing activities, and elevation of leucocytes, globulin, protein, complement and 
lysozyme levels. These results demonstrate the efficacy of dietary bacteria as probiotics 
for the control of vibriosis in rainbow trout. 
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CHAPTER 1 – INTRODUCTION 
 
Chapter 1 – Introduction 
 
1 
1.1 General introduction 
Aquaculture (= the production of aquatic plants and animals in controlled conditions), 
which has been commercially practiced in China since 500 BC (see Pillay and Kutty 
2005), continues to increase globally and accounts for about half (47%) of all food fish 
supplied in 2006 (Figure 1.1). It is viewed increasingly to have the greatest potential to 
meet the growing demand for aquatic food stimulated by the static or depleting nature of 
capture fisheries and the concomitant market forces of increased demand (FAO 2009). 
For example, production of rainbow trout (Oncorhynchus mykiss) in Scotland stood at 
7,414 tonnes in 2007 from a production of 4,263 tonnes in 1994 (FRS 2008). Scottish 
aquaculture is estimated to have had a farm gate value of £346 million in 2007, which 
includes £324 million for farmed Atlantic salmon, approximately £14 million for 
rainbow trout, and around £5 million for shellfish. The industry also makes a significant 
contribution to the Scottish rural economy, especially among the communities of the 
western and northern isles, where it directly generated ~1,500 jobs and through linked 
activities a further 4,700 indirect employment such as through processing and packaging 
activities (source: The Scottish Government; http://www.scotland.gov.uk).  
 
 
Figure 1.1 World fish production (source: Jiang 2009). 
 
Farming of rainbow trout was introduced to the U.K. in the 1950’s by a Danish 
entrepreneur, and since that time the activity has shown a steady increase in total 
production and has become an important industry, particularly in England. There are 
almost 360 trout farms in the U.K. producing ~16,000 tonnes per annum. Figure 1.2 
shows the active rainbow trout farms in Scotland. Among the trout species, rainbow 
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trout is the most popular one to farm due to its better tolerance to warm water, faster 
growth, larger size and fitness with farming systems (source: British Trout Association; 
http://www.britishtrout.co.uk). Other popular species include brown trout/sea trout 
(Salmo trutta), golden trout (Oncorhynchus mykiss aguabonita) and blue trout, though 
in smaller amounts (Figure 1.3). Most of the trout is farmed in freshwater, usually using 
tanks, ponds, cages or raceways, with a small quantity farmed in sea cages.  
 
 
Figure 1.2 Active rainbow trout sites (black dots 
on map) in Scotland, 2007 (source: FRS 2008). 
 
 
     
Figure 1.3 Various trout species farmed in Scotland: (A) rainbow trout (highly-spotted 
tail/fin often with a wide band of red, pink or mauve along the side/flank), (B) brown 
trout (highly-spotted skin, with brown background colouration varying to yellow, and 
with black, orange, or red spots) and (C) blue trout (bright silver underside and striking 
blue topside). With acknowledgements to http://www.coastalthings.com; 
http://www.bewl.co.uk; http://www.timberwolfoutfitters.com. 
 
Largely two types of farming systems are employed in aquaculture, either open or 
closed systems (Tacon and Forster 2003). The open system, also known as semi-culture, 
is the easiest and least technology demanding way to grow fish where farming takes 
place under relatively natural conditions with little manipulation, and the stocking 
A B C
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densities do not exceed those found in nature, for example, mollusks grown on racks or 
hanging rafts in favourable sites. Closed systems employ intensive management of a 
production system where the farming is optimized by totally controlling the organisms 
and their environment, thus ensuring maximal growth. This type of aquaculture is 
commonly regarded as intensive aquaculture, for example involving recirculating 
systems (Castro and Huber 1997). The stocking densities of such systems greatly 
exceeds those of open systems, i.e. more weight (Kg) of fish than the total volume (L) 
of water, consequently the yields are very high. However, the overall cost and 
management increases, as does the potential for catastrophic loss.  
 
Table 1.1 Some major pathogens of farmed fish and shellfish species (after Owens 
2003; Leong 2008). 
Group 
 
Genera, etc. 
 
Viruses DNA genomes: families include Iridoviridae, Adenoviridae, 
Herpesviridae 
 
RNA genomes: families include Picornaviridae, Birnaviridae, 
Reoviridae, Rhabdoviridae, Orthomyxoviridae, Paramyxoviridae, 
Caliciviridae, Togaviridae, Nodaviridae, Nidovirales, Retroviridae, 
Coronaviridae 
 
Bacteria Rickettsiales, Aeromonas, Enterococcus, Flavobacterium, Flexibacter, 
Pseudoalteromonas, Pseudomonas, Streptococcus, Vibrio 
 
Fungi Aphanomyces, Branchiomyces, Lagenidium, Saprolegnia, Sirolipidium 
 
Protozoa Amoebae: Neoparamoeba 
Flagellates: Hexamita, Ichthyobodo 
Ciliates: Ichthyophthirius, Trichodina 
Sporozoans: Bonamia, Loma, Marteilia, Perkinsus 
 
Helminths Dactylogyrus 
 
Nematodes Eustrongylides 
 
Annelids Polydora 
 
Crustaceans Fish ‘lice’: Isopods 
Fish ‘lice’: Branchiura: Argulus 
Copepods: Lernaea, Ergasilus, Mytilicola 
Crabs: Pinnotherids 
 
Gastropods Pyramidellids 
 
Although aquaculture is regarded to be the fastest growing animal food-production 
system in the world, disease outbreaks are often the key limitation to the expansion of 
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this sector in many parts of the world (Subasinghe 2005). In fact, all forms of 
aquaculture are susceptible to outbreaks of diseases as many pathogens are normal 
inhabitants of the aquatic environment (Pillay 2004). Taxonomically, the pathogens are 
ranged from single stranded RNA viruses, e.g. infectious salmon anaemia (ISA) to 
complex parasitic crustaceans, e.g. sea lice (Murray and Peeler 2005), and broadly 
classified as viruses, bacteria, fungi, parasites, protozoa and metazoans – Table 1.1 
(Owens 2003; Austin 2005; Bondad-Reantaso et al. 2005; Austin and Austin 2007). 
Particularly, the problems of Vibrio anguillarum, V. ordalii, V. salmonicida, V. 
vulnificus biotype 2 and V. harveyi with several important aquaculture species, such as 
salmonids, turbot (Scophthalmus maximus), sea bass (Dicentrarchus labrax), striped 
bass (Morone saxatilis), European eel (Anguilla anguilla), ayu (Plecoglossus altivelis), 
cod (Gadus morhua), sea bream (Sparus aurata), and shrimp may lead to huge 
economic loss (Karunasagar et al. 2005; Toranzo et al. 2005; Austin and Austin 2007). 
Certainly, the epidemiology of bacterial diseases in Norway between 1991 and 2000 
detected vibriosis as a major obstacle to the future growth of rainbow trout, halibut 
(Hippoglossus hippoglossus), turbot, cod and European eel farming (Lillehaug et al. 
2003). Consequently, control of fish diseases is of utmost importance. This thesis 
addresses control strategy of vibriosis in rainbow trout caused by infections due to V. 
anguillarum and V. ordalii through application of probiotics as a modern approach to 
disease control.    
 
1.2 Diseases of farmed fish 
The term ‘disease’ denotes a certain negative deviation from the normal state (health) of 
a living organism, where ‘negative’ means an impairment that is measurable in terms of 
a reduction in the ecological potential (for example survival, growth, reproduction, 
stress endurance) (Kinne 1980). Thus, disease can be defined as “any process that limits 
the productivity of a system” (Owens 2003). The great majority of diseases depend on 
particular interactions between the host, the disease agent or pathogen, and 
environmental stressors (Austin and Austin 2007); these interactions can be represented 
in the ‘epidemiological triad’ of Snieszko (Figure 1.4).  
 
Diseases may be divided into infectious and non-infectious. Infectious disease is caused 
by micro-organisms, including bacteria and fungi. Usually all the components in the 
‘epidemiological triad’, i.e. host characteristics (such as fish age, nutritional status, 
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stocking density), pathogen characteristics (such as its ability to infect, cause disease in 
and kill the host) and environmental factors (such as poor hygiene, water temperature or 
salinity) must have to come into play to trigger an outbreak of infectious disease 
(Owens 2003; Austin and Austin 2007). However, obligate pathogens are independent 
of other causal factors related to the host and the environment to cause clinical disease, 
and are regarded as the most hostile agents for disease outbreaks. “Epizootic 
haematopoietic necrosis virus in red fin perch and crayfish plague (Aphanomyces 
astaci) in signal crayfish are two such examples of obligate pathogens producing 
disease in the most pristine conditions” (Owens 2003). Moreover, some infectious 
diseases, e.g. bacterial coldwater disease and infectious haematopoietic necrosis (IHN) 
in salmon and rainbow trout, cause permanent skeletal deformities or stunting to 
surviving fish that may account for an indirect production loss (Georgiadis et al. 2001). 
Conversely, non-infectious disease caused by the environment, genetic abnormalities, 
stress and husbandry practices do not have the ability to spread between separate stocks. 
Nevertheless, an individual fish may differ in susceptibility to diseases, and also 
different strains of the same pathogens may vary significantly in their ability to cause a 
disease (Austin and Austin 2007).   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 The epidemiological triad of Snieszko, indicating the factors of a fish-culture 
system that can lead to disease (after Owens 2003). 
 
Over the past three decades, aquaculture has expanded, intensified and diversified, and 
thus numerous aquatic animal diseases and pathogens have emerged and become 
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widespread especially as a result of global movements of live animals and animal 
products such as brood stock, seed, and feed (Subasinghe 2005). Certainly, an intensive 
aquaculture creates the perfect environment to encourage disease because the higher the 
density the smaller the distance between infected and uninfected fish leading to an 
increased probability of pathogens reaching new hosts (Owens 2003). Estimates from 
various organizations have indicated that 30–50% of all fish and shrimp put into cages 
and ponds are lost due to diseases before they reach market (Tan et al. 2006). Thus, the 
economic losses in the aquaculture industry worldwide are estimated to be about US$8 
billion per year, which is roughly 15% of the world’s farmed fish and shellfish value 
(Xie et al. 2005). In particular, the outbreaks of viral and bacterial diseases caused 
losses of about US$750 million in 1993 in China, and US$210 million during 1995–
1996 in India (see Kautsky et al. 2000) to the penaeid shrimp aquaculture industry, and 
over US$120 million to the aquaculture industry in China between 1990 and 1992 (Wei 
2002).   
 
1.2.1 Bacterial fish diseases 
Among the casual agents of infectious diseases, bacteria remain a serious challenge for 
the growth of global fish and shellfish farming, because major pathogens, such as those 
causing motile aeromonad septicaemia, vibriosis, columnaris, enteric redmouth disease, 
edwardsiellosis and furunculosis are prevalent in nature (see Austin and Austin 2007). 
In northern China, fin rot due to V. anguillarum infection in juvenile turbot led to 
mortalities of 90–100% (Lei et al. 2006). Recently, high mortalities have been reported 
in populations of Atlantic salmon, Pacific salmon and rainbow trout farmed in the South 
of Chile due to vibriosis (Colquhoun et al. 2004; Silva-Rubio et al. 2008a,b). Table 1.2 
shows the wide variety of bacterial pathogens that have been associated with salmonid 
fish diseases.  
 
Table 1.2 Bacterial pathogens identified as the most problematic to the salmonids 
aquaculture (after Austin and Austin 2007). 
Pathogens Disease Host range Geographical 
distribution 
ANAEROBES 
Clostridiaceae representative  
Clostridium botulinum botulism salmonids Denmark, 
England, 
U.S.A.                
 
Chapter 1 – Introduction 
 
7 
GRAM-POSITIVE BACTERIA – THE ‘LACTIC ACID’ BACTERIA 
Carnobacteriaceae representative 
Carnobacterium piscicola  lactobacillosis, 
pseudokidney disease   
salmonids North America, 
U.K. 
 
Enterococcaceae representatives 
Enterococcus 
(Streptococcus) faecalis 
subsp. liquefaciens 
 
– 
 
 
rainbow trout  Italy 
 
 
Vogococcus 
salmoninarum  
lactobacillosis, 
pseudokidney                
disease, peritonitis, 
septicaemia 
 
Atlantic salmon (Salmo 
salar), brown trout (S. 
trutta), rainbow trout 
 
Australia, 
France, North 
America 
Lactobacillaceae representative  
Lactobacillus spp. lactobacillosis, 
pseudokidney disease 
salmonids 
 
North America, 
U.K. 
 
Streptococcaceae representatives 
Lactococcus garvieae  
(= Enterococcus 
seriolicida)  
streptococcicosis/         
streptococcosis 
many fish species 
 
 
 
 
Japan, Europe, 
Israel, Saudi 
Arabia, Red 
sea, Australia, 
Taiwan, South 
Africa, U.S.A.   
                                                   
Lactococcus piscium  lactobacillosis, 
pseudokidney disease 
 
rainbow trout  North America 
Streptococcus difficilis  
(= Str. agalactiae) 
meningo-encephalitis rainbow trout  Israel, Kuwait, 
U.S.A. 
 
Streptococcus iniae  
(= Str. shiloi) 
meningo-
encephalitis,                  
streptococcicosis/ 
streptococcosis 
various freshwater and 
coastal fish species 
Australia, 
Saudi Arabia, 
Israel, Europe, 
Bahrain, Japan, 
South Africa, 
U.S.A. 
 
AEROBIC GRAM-POSITIVE RODS AND COCCI                                             
Renibacterium 
salmoninarum   
bacterial  kidney 
disease (BKD; Dee 
disease; 
corynebacterial 
kidney disease) 
 
salmonids Japan, North 
and South 
America, 
Europe 
Bacillaceae representative 
Bacillus spp.                        septicaemia, bacillary 
necrosis  
various freshwater fish 
species 
Nigeria, 
Vietnam 
 
Coryneform bacteria ‘corynebacteriosis’  salmonids England 
 
Micrococcaceae representative 
Micrococcus luteus  micrococcosis  rainbow trout England 
 
Mycobacteriaceae representatives 
Mycobacterium spp.  mycobacteriosis (fish 
tuberculosis)  
 
most fish species worldwide 
Nocardiaceae representatives 
Nocardia spp. (Noc. 
asteroides, Noc. seriolae, 
Noc. salmonicida) 
nocardiosis   most fish species worldwide 
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Rhodococcus sp.   ocular oedema chinook salmon                
(O. tshawytscha) 
 
Canada 
Rhodococcus erythropolis ? Atlantic salmon Norway, 
Scotland 
 
Planococcaceae representative 
Planococcus sp.                  – salmonids England 
 
Staphylococcaceae representative 
Staphylococcus warneri ulcerations rainbow trout Spain 
 
GRAM-NEGATIVE BACTERIA 
Aeromonadaceae representatives 
Aeromonas caviae  septicaemia Atlantic salmon  Turkey 
 
Aeromonas hydrophila  
(= Aer. liquefaciens, Aer.   
punctata  
 
haemorrhagic 
septicaemia, motile 
aeromonas 
septicaemia, redsore 
disease, fin rot  
 
many fresh water fish 
species 
worldwide 
Aeromonas salmonicida 
(subspecies 
achromogenes, 
masoucida, and smithia) 
{= Haemophilus 
piscium} 
 
furunculosis, carp 
erythrodermatitis, 
ulcer disease 
salmonids, cyprinids, 
dab (Limanda 
limanda), cod  
worldwide 
Campylobacteriaceae representative 
Arcobacter cryaerophilus – rainbow trout Turkey 
 
Enterobacteriaceae representatives 
Citrobacter freundii   – salmonids, sunfish 
(Mola mola), carp 
(Cyprinus carpio)  
 
Europe, India, 
U.S.A. 
Edwardsiella tarda             
(Paracolobactrum               
anguillimortiferum,            
Edw. anguillimortifera) 
redpest, 
edwardsiellosis, 
emphysematous 
putrefactive disease 
of catfish 
  
various freshwater  fish 
species 
Japan, Spain, 
U.S.A.    
Escherichia vulneris   septicaemia various freshwater  fish 
species  
 
Turkey 
Hafnia alvei haemorrhagic 
septicaemia  
cherry salmon (O. 
masou), rainbow trout  
Bulgaria, 
Japan, England  
                                                                            
Klebsiella pneumoniae fin and tail disease  rainbow trout Scotland  
 
Plesiomonas shigelloides – rainbow trout, eel, 
sturgeon (Acipenser 
sturio), gourami 
(Osphyronemus 
gourami) 
 
Germany, 
Portugal, Spain 
Serratia liquefaciens   septicaemia   Atlantic salmon, 
Atlantic charr 
(Salvelinus alpinus), 
turbot 
 
France, 
Scotland, 
U.S.A. 
Serratia plymuthica  – rainbow trout Poland, Spain, 
Scotland 
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Yersinia intermedia   – Atlantic salmon  Australia 
 
Yersinia ruckeri     enteric redmouth 
(ERM), salmonid 
blood spot 
 
salmonids    Australia, 
Europe, North 
and South 
America   
Flavobacteriaceae representatives  
Flavobacterium 
branchiophilum 
gill disease salmonids Europe, Korea     
Japan, U.S.A. 
 
Flavobacterium 
columnare                   
(=Flexibacter/Cytophaga 
columnaris) 
 
columnaris, 
saddleback disease  
many freshwater  fish 
species   
worldwide 
Flavobacterium hydatis  
(= Cytophaga aquatilis) 
 
gill disease salmonids Europe, U.S.A. 
 
Flavobacterium 
psychrophilum  
(= Cytophaga 
psychrophila) 
 
coldwater disease, 
rainbow trout fry 
syndrome, necrotic 
myositis 
salmonids, sea lamprey 
(Petromyzon marinus) 
Australia, 
Europe, Japan, 
North America 
“Cytophaga rosea”             gill disease  salmonids Europe, U.S.A. 
 
Sporocytophaga sp.   saltwater columnaris salmonids Scotland, 
U.S.A. 
 
Moraxellaceae representative 
Acinetobacter sp. acinetobacter disease  
 
Atlantic salmon                
channel catfish 
(Ictalurus punctatus)  
 
Norway, 
U.S.A.   
 
Moritellaceae representatives 
Moritella marina 
(= V. marinus) 
 
skin lesions   Atlantic salmon    Iceland   
Moritella viscosa winter ulcer 
disease/syndrome   
Atlantic salmon    Iceland, 
Norway, 
Scotland 
 
Oxalobacteraceae representative 
Janthinobacterium 
lividum 
 
anaemia rainbow trout  Scotland 
Pasteurellaceae representative 
Pasteurella skyensis ? Atlantic salmon    Scotland 
 
Piscirickettsiaceae representative 
Piscirickettsia salmonis   coho salmon 
syndrome, salmonid 
rickettsial 
septicaemia   
salmon, sea bass 
(Atractoscion noblis) 
Canada, Chile,  
U.S.A., Greece, 
Norway, 
Scotland  
 
Pseudomonaceae representatives 
Pseudomonas 
anguilliseptica    
red spot (= Sekiten-
byo), winter disease  
rainbow trout, 
marine fish species, 
eels (Anguilla anguilla, 
A. japonica), black spot 
sea bream (Pagellus 
bogaraveo), gilthead 
sea bream (S. aurata), 
cod 
 
Finland, Japan  
France, Spain, 
Scotland, 
Portugal   
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Pseudomonas 
chlororaphis  
– amago trout (O. 
rhodurus)  
 
Japan 
Pseudomonas flourescens generalised 
septicaemia 
 
most fish species  worldwide 
Pseudomonas 
pseudoalcaligenes 
 
skin ulceration rainbow trout   Scotland 
Pseudomonas putida Haemorrhagic 
ascites, ulceration  
 
rainbow trout, ayu  
 
Japan, Turkey 
Vibrionaceae representatives 
Vibrio anguillarum vibriosis   most marine fish 
species 
 
worldwide 
V. ordalii   vibriosis most marine fish 
species 
 
worldwide 
V. logei   skin lesions   Atlantic salmon     Iceland 
 
V. salmonicida coldwater vibriosis, 
hitra disease 
Atlantic salmon   Canada, 
Norway,              
Scotland 
 
V. wodanis  winter ulcer 
disease/syndrome   
 
Atlantic salmon    Iceland, 
Norway, 
Scotland  
 
Miscellaneous pathogens 
‘Candidatus Arthromitus’ summer enteritic 
syndrome  
 
rainbow trout                  France, Spain 
Streptobacillus – Atlantic salmon    Ireland 
 
 Varracalbmi Atlantic salmon    Norway 
 
 ulceration rainbow trout Scotland 
 
(–) not associated with a named disease; (?) not associated with specific disease signs 
 
1.3 Vibrio infections 
Vibriosis due to Gram-negative pathogens of the family Vibrionaceae is one of the most 
serious bacterial diseases, causing septicaemia and death in a wide range of cold- and 
warm-water fish species of marine and freshwater origin, and often results in 
considerable economic losses in fish farming, worldwide (Rodkhum et al. 2005; 
Toranzo et al. 2005; Austin and Austin 2007). Generally vibrios are part of the normal 
marine microflora, and are found in gastrointestinal tract of marine animals or other 
organisms, and are also associated with live feed organisms, such as rotifers and 
Artemia (Verdonck et al. 1997; Eddy and Jones 2002; Mizuki et al. 2006; Austin and 
Austin 2007; Engelsen et al. 2008). The genus Vibrio has over 85 species 
(http://www.bacterio.cict.fr), and thus far fifteen types are known to be fish pathogens, 
namely V. anguillarum (= Listonella anguillarum), V. ordalii, V. cholerae (non-01), V. 
fischeri, V. furnissii, V. harveyi (= V. carchariae and V. trachuri), V. ichthyoenteri, V. 
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logei, V. pelagius, V. salmonicida, V. splendidus, V. tapetis, V. vulnificus, V. wodanis 
(Austin and Austin 2007). In the present study, V. anguillarum and V. ordalii were 
selected as model pathogens because of their well established virulence to salmonids, 
cod, turbot and halibut (Egidius 1987; Bergh et al. 2001; Lillehaug et al. 2003; 
Colquhoun et al. 2004; Austin and Austin 2007; Silva-Rubio et al. 2008a,b).  
 
1.3.1 Vibrio anguillarum – the classical cause of vibriosis 
V. anguillarum possesses a wide geographical distribution and causes a fatal 
haemorrhagic septicaemia affecting more than 80 different marine and estuarine fish, 
including species of aquacultural interest, i.e. Pacific and Atlantic salmon 
(Oncorhynchus spp. and S. salar), rainbow trout, turbot, sea bass, sea bream, striped 
bass, cod, Japanese eel (Anguilla japonica) and European eel, ayu, saithe (Pollachius 
virens) and Japanese flounder (Paralichthys olivaceus) (Actis et al. 1999; Kent and 
Poppe 2003; Colquhoun et al. 2004; Chrstiane et al. 2006; Austin and Austin 2007; 
Xiao et al. 2009). The pathogen was first described by Bergman in 1909 as the 
aetiological agent of ‘red-pest of eel’ during 1907 in Sweden. However, there was a 
description of red-pest probably dating back to the early 1700s in diseased eel from 
Italy. Despite the commonly used name of ‘vibriosis’, the disease has been referred to as 
‘salt-water furunculosis’, ‘boil-disease’, and ‘ulcer-disease’ (see Austin and Austin 
2007). It should be noted that V. anguillarum was suggested to be reclassified as 
Listonella anguillarum in the mid-1980s based on analysis of the 5S rRNA sequence 
(Macdonell and Colwell 1985), and thus Listonella has been on the ‘List of Prokaryotic 
Standing in Nomenclature’ since 1986 (http://www.bacterio.cict.fr/l/listonella.html). 
However, there is still debate regarding this change in nomenclature; consequently both 
names are used in recent published work (e.g. Gonzalez et al. 2003; Mizuki et al. 2006; 
Fjellheim et al. 2007; Caipang et al. 2008; Sugita et al. 2008).         
 
1.3.1.1 Characteristics 
V. anguillarum is a halophilic (grows in 0.3–3.0% NaCl) Gram-negative rod-shaped 
bacterium (0.5–0.8 μm in diameter and 1.4–2.6 μm in length) that is facultatively 
anaerobic, fermentative, catalase and oxidase positive, and motile by means of a 
sheathed polar flagellum, with growth between 15–37°C. A positive result is usually 
recorded for the Voges-Proskauer reaction, but not for the methyl red test. Also, nitrates 
are reduced. The G+C molar percentage (mol %) of the DNA is 45.6–46.3 (Austin and 
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Austin 2007). The pathogen can survive in seawater for over 50 months (Crosa et al. 
2006). Genetically, V. anguillarum is a heterogeneous species and so far 23 serotypes 
are known to occur based on antigen ‘O’ (Pedersen et al. 1999). However, only 
serotypes O1 and O2, and to some extent serotype O3 are regarded as serious pathogens 
because most vibriosis outbreaks are related to one of these serotypes (Toranzo and 
Barja 1990; Knappskog et al. 1993; Larsen et al. 1994; Larsen et al. 2001; Pedersen et 
al. 1999; Silva-Rubio et al. 2008b). The remaining serotypes (O4–O23) are considered 
as environmental strains. However, few of them were described as pathogenic to fish 
(serotype O4; Pazos et al. 1993) or in combination in the mortality of cultured cod (O4, 
O6 and O8; Larsen et al. 1994). 
 
        
     
Figure 1.5 Clinical signs of vibriosis: (A, B) surface haemorrhage (source: Austin and 
Austin 2007), (C) exophthalmia, (D) haemorrhaging ulcers (http://aqua.intervet.com), 
(E) skin lesions/ulcer (source: http://www.peteducation.com) and (F) muscle necrosis 
(source: Prof. Lone Gram). 
 
1.3.1.2 Pathology 
Infection with V. anguillarum is normally characterized by generalized septicaemia with 
clinical signs identical to other bacterial septicaemias (Figure 1.5). The disease ranges 
from peracute, i.e. mortalities without gross lesions, to acute, which typically involves 
skin discoloration, the presence of red necrotic lesions in the abdominal muscle, 
erythema at different body organs (i.e. bloody blotches at the base of the fins, around 
the vent and within the mouth), with possibly exophthalmia and fin rot. Internal 
symptoms include pale liver, accumulation of reddish ascitic fluid in the peritoneal 
A B C
D E F
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cavity (= sign of severe infection), swollen spleen, and distended gut and rectum filled 
with clear viscous fluid. Also, the bacteria’s strong affinity for iron may result in 
anaemia in chronically infected fish (Diggles et al. 2000; Austin and Austin 2007). For 
example, sea bream (Acanthopagrus cuvieri) infected by V. anguillarum demonstrates 
necrosis and atrophy of hepatocytes, necrosis of sheathed arteries in the spleen, and 
necrosis of renal tubules and glomeruli in the kidney (Rasheed 1989). Similarly, 
infected Pacific salmon fingerlings show pathological signs in the blood, connective 
tissue, gills, kidney, posterior gastro-intestinal tract, anaemia in the liver, and swelling 
in the spleen.  Generally areas of affected tissues are found with an even distribution of 
the pathogen, although the greatest cell concentration is in the blood. Infected fish 
become inactive, cease feeding and suffer mass mortalities (see Austin and Austin 
2007). In addition, the extracellular products (ECPs) secreted by the pathogen are toxic 
and cause comparable pathological changes to those elicited after inoculation of live V. 
anguillarum cells, albeit with the development of lesser acute lesions. It may be that the 
live pathogen can multiply spontaneously in the kidney and spleen causing more acute 
lesions to the host (Lamas et al. 1994). Typically, clinical signs attributable to a 
pathogen are dependent on the species and age of fish, and phase of the disease, i.e. 
acute, chronic, or subclinical carrier (Toranzo et al. 2005). 
 
1.3.1.3 Transmission routes 
It is widely recognized that pathogens can gain entry to fish through several portals of 
entry, including skin, gill and the gastro-intestinal tract (= horizontal transmission), and 
the parental route through eggs (= vertical transmission) (Tortora et al. 1995). However, 
the exact mode of infection of V. anguillarum has been debatable, but undoubtedly 
involves colonization of and attachment to the posterior gastro-intestinal tract and 
rectum, and then the direct penetration of the tissues (Austin and Austin 2007). For 
example, the recovery of >50% V. anguillarum from the spleen after anal and 
intragastric intubations (Olsson et al. 1996), and colonization of fluorescent-labelled 
cells in the gastro-intestinal tract with the subsequent development of septicaemia in 
zebrafish via immersion challenge (O’Toole et al. 2004) clearly support the argument of 
the gastro-intestinal tract as a point of entry. Also, orally administered V. anguillarum 
survived in the stomach of juvenile turbot for several hours, and persisted in the 
intestine and proliferated in faeces (Olsson et al. 1998). Similarly, V. anguillarum has 
been reported to occur in the intestinal epithelium of orally challenged turbot larvae, 
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where the pathogen was transported to different organs by the blood, leading to death 
(Grisez et al. 1996). These observations evidently demonstrated endocytosis of bacterial 
cells in the gastrointestinal tract of fish, and indicate that the whole gastrointestinal tract 
of fish is possibly exposed to infection (Ringø et al. 2001). Certainly, adhesion of V. 
anguillarum to rainbow trout by immersion appears to be fastest in the intestinal 
regions, with maximum attachment occurring within 100 min (Horne and Baxendale 
1983). However, using bath immersion as the route of infection, the skin was seen to be 
colonized at 12 h post infection, followed by the invasion of the liver, spleen, muscle, 
gills and intestine (see Austin and Austin 2007). Although the gills are mentioned as 
possible points of entry of V. anguillarum (Laurencin and Germon 1987), a few studies 
revealed poor or unsuccessful transmission (Kanno et al. 1989; Olsson et al. 1996). In 
addition, the presence of heavy metals mainly copper (30–60 μg mL−1) and iron (10 μm 
mL−1) could trigger vibriosis, although susceptibility is dependent on metal 
concentration and time of exposure (see Austin and Austin 2007).         
 
1.3.1.4 Virulence factors 
V. anguillarum is capable of producing many virulence factors that allow colonization 
and maintenance in the host. High affinity iron uptake mechanisms are recognized as 
important virulence factors. Indeed, iron is one of the growth limiting factors for all 
microorganisms, except lactobacilli (see Raaska and Mattila-Sandholm 1995). 
Additionally, pathogenic bacteria require iron to establish an infection, and thus they 
have developed siderophores, which is an efficient mechanism for iron acquisition from 
the host (Ratledge and Dover 2000). Serogroup O1 contains a 67 kbp virulence plasmid 
pJM1 (Pedersen and Larsen 1995; Di Lorenzo et al. 2003), which codes for iron 
transportation proteins and siderophores (Actis et al. 1986) enabling the bacterial cells 
to acquire available iron in the fish tissues. Thus, invading bacteria may multiply in the 
host by scavenging for the iron from free heme or heme-containing proteins, such as 
transferrin, lactoferrin and ferritin, which are present in the serum, secretions and tissues 
of the fish, respectively (see Austin and Austin 2007). Moreover, acquisition of iron 
from heme may be assisted by the production of haemolysins or cytotoxins, which have 
the ability to lyse host cells and release intracellular heme (García et al. 1997). 
Nevertheless, several haemolysin genes are reported in V. anguillarum strains 
(Rodkhum et al. 2005; Rock and Nelson 2006). However, serogroups without the pJM1 
Chapter 1 – Introduction 
 
15 
plasmid are also pathogenic, and are believed to have chromosome-mediated virulence 
characteristics (Wiik et al. 1989).  
 
Other essential virulence mechanisms are attributed to flagella (McGee et al. 1996; 
Milton et al. 1996; Ormonde et al. 2000), chemotaxis (O’Toole et al. 1996; Larsen et al. 
2004), and ECPs or secreted toxins, e.g. haemolysins, proteases, metalloprotease, 
dermatotoxin, haemagglutinin and cytotoxin (see Rodkhum et al. 2005, Austin and 
Austin 2007). O’Toole et al. (1996) observed that the loss of flagella by transposon 
mutagenesis led to a 500-fold reduction in virulence following an immersion challenge, 
which in turn suggests that flagella play a key role in pathogenicity. Besides, 
chemotactic motility is essential for virulence (Larsen et al. 2004), principally by 
enabling invasion of the host. According to O’Toole et al. (1999), the pathogen is 
attracted to amino acids and carbohydrates predominantly in intestinal mucus and to a 
lesser degree to skin mucus (see Austin and Austin 2007). Furthermore, chemotaxis was 
noted when the bacterial cells were starved for 2 and 8 days (Larsen et al. 2004). Cells 
of V. anguillarum were more chemotactic to serine (= a mucus component of fish) at 
25°C than at 5 or 15°C, and in the salinity range 0.8–2.7% NaCl (Larsen et al. 2004). 
Certainly, V. anguillarum is chemotactically motile towards fish skin and intestinal 
mucus (O’Toole et al. 1999), and uses intestinal mucus as a nutrient source (García et 
al. 1997). Moreover, crude ECPs led to the development of an inflammatory response, 
including leucopenia, in rainbow trout (Lamas et al. 1994).   
 
More recently, proteases of 36 kDa molecular weight have been implicated with 
virulence (Inamura et al. 1984; Kanemori et al. 1987). In particular, a zinc metallo-
protease was found to be associated with invasion (Norqvist et al. 1990). In addition, V. 
anguillarum is known to produce ‘haemolytic toxins’ (see Austin and Austin 2007), 
which are thermolabile enzymes of 191 kDa and might be responsible for the tissue 
damage and necrosis, and anaemic response in infected fish. Pathogenicity of V. 
anguillarum may well by attributable to Acylated Homoserine Lactone (AHL) signal 
molecules, i.e. the quorum sensing. For example, N-(2-oxodecanoyl)-L-homoserine 
lactone and N-(3-hydroxy-hexanoyl)-L-homoserine lactone with smaller amounts of 
other molecules have been recognized in V. anguillarum, perhaps having a role in the 
expression of virulence factors, e.g. biofilm formation and protease production 
(Buchholtz et al. 2006).  
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Resistance to the potentially debilitating effect of fish serum of this pathogen (Trust et 
al. 1981) can play an important role in pathogenesis, which may accelerate the invasion 
processes (see Austin and Austin 2007). Also environmental parameters such as the rise 
in (or rapidly changing) temperatures (above 10°C, i.e. during early to mid summer) and 
prolonged exposure to low estuarine salinities have been reported as a possible trigger 
of disease outbreaks (Rodgers and Burke 1981; Austin and Austin 2007). Nevertheless, 
the virulence mechanism of V. anguillarum involves uptake and penetration of the host 
tissues, scavenging for iron as a result of plasmid/chromosomal-mediated traits, and 
damage to the fish by means of haemolysins and proteases (Austin and Austin 2007). 
 
Table 1.3 Methods of isolation for V. anguillarum and V. ordalii (after Crosa et al. 
2006; Austin and Austin 2007). 
Medium Pathogen 
Nutrient agar  
TSA (tryptone soya agar)  
BHIA (brain heart infusion agar)  
 +
supplemented 
with 0.5–3.5% 
NaCl (w/v) 
V. anguillarum 
VAM (V. anguillarum medium; Alsina et al. 1994) V. anguillarum 
Seawater agar (marine 2216E agar, Difco)  V. anguillarum, V. ordalii 
TCBS (thiosulphate citrate bile salt sucrose agar)  V. anguillarum, V. ordalii 
 
1.3.1.5 Isolation/detection 
No single technique is suitable for the recovery of all known bacterial fish pathogens, 
thus researchers need to use a combination of methods and incubation conditions to 
achieve pure cultures. However, V. anguillarum isolation is readily done from infected 
fish tissue using a range of bacteriological media (Table 1.3), with incubation at 15–
25°C for up to 7 days. On solid medium, such as marine 221E agar, the colonies appear 
glistening cream-colored, circular, raised, entire and shiny (Austin and Austin 2007). 
The presumptive identification is effectively done by means of V. anguillarum medium 
(VAM) containing bile salts with a high sodium chloride concentration, ampicillin, 
sorbitol and a high pH (Alsina et al. 1994). V. anguillarum produces bright-yellow 
colonies with yellow haloes on VAM, which is identical for the majority, i.e. 197/227 = 
87%, of V. anguillarum isolates (Austin and Austin 2007). However, growth on VAM is 
not definitive evidence because some other vibrios (3/66 = 4%) are also mistaken for V. 
anguillarum (Alsina et al. 1994; Austin and Austin 2007). Nowadays, the API 20E 
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system (BioMérieux, France) is used extensively for identification. However, 
identification of V. anguillarum based purely on the results of the API 20E system is not 
recommended (Grisez et al. 1991). There are commercial kits for the specific 
identification of V. anguillarum, such as the Bionor® latex agglutination kit (Romalde et 
al. 1995), AquaRapid-Va® and Aqua-Eia-Va® kits (Gonzalez et al. 2004), but they are 
not recommended for discrimination between serotypes. In addition, molecular 
techniques including polymerase chain reaction (PCR; Gonzalez et al. 2003), pulse field 
gel electrophoresis (PFGE; Skov et al. 1995) amplified fragment length polymorphism 
(AFLP), multilocus sequence typing (MLST), repetitive extragenic palindrome PCR 
(rep-PCR), and ribotyping have been used successfully to identify vibrios, both at the 
species and strain level (see Thompson et al. 2004, 2005).   
 
1.3.2 V ibrio ordalii  
V. ordalii is the former biotype 2 of V. anguillarum, which was proposed as a separate 
species in view of cultural and biochemical characteristics as well as DNA homology 
(Crosa et al. 2006). The organism is also recognized as the aetiological agent of 
vibriosis with gross pathological symptoms comparable to those resulting from 
infection with V. anguillarum (Toranzo and Barja 1993). Disease caused by V. ordalii 
has been documented in Japan and the Pacific Northwest of the U.S.A. (Austin and 
Austin 2007).  
 
1.3.2.1 Characteristics 
V. ordalii comprises Gram-negative, curved rods of 2.5–3.0 × 1.0 μm in size, motile by 
means of single polar flagellum with fermentative and respiratory metabolism. The 
bacterium can be separated from V. anguillarum by the negative production/results of 
arginine dihydrolase, β-galactosidase and the Voges-Proskauer reaction, and by growth 
temperature which is between 15 and 22°C, but not at 37°C. Also the plasmid profile of 
V. ordalii is different from V. anguillarum (Austin and Austin 2007). The G+C ratio of 
the DNA of V. ordalii is 43–44 mol %. Characteristically, isolates of V. ordalii are 
homogeneous by plasmid type (pMJ101) with a molecular weight of 20 MDa (= ~32 
kbp), ribotyping and serogrouping, accommodated two lipopolysaccharide (LPS) 
groups, and are heterogeneous by BIOLOG-GN fingerprints and API 20E profiles 
(Austin et al. 1997; Austin and Austin 2007).  
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1.3.2.2 Pathology 
The disease is characterized as a haemorrhagic septicaemia, but there are slight 
variations in the pathologies compared to that caused by V. anguillarum. In the case of 
V. ordalii infection in Pacific salmon, there is a tendency for the formation of micro-
colonies in the skeletal and heart muscle, gill tissue, and in both the anterior and 
posterior regions of the gastro-intestinal tract. Moreover, bacteraemia develops much 
later in the disease cycle compared to V. anguillarum, which may be attributed to the 
lower bacterial cell numbers in the blood. A different distinguishable feature is the 
marked reduction of numbers of leucocytes in the blood, i.e. leucopenia (Austin and 
Austin 2007).            
 
1.3.2.3 Transmission routes 
V. ordalii may be prevalent in the environment. So, water-borne infection seems the 
most likely mode of transmission for V. ordalii infestation on fish. Typically, infection 
(colonization) begins in the rectum and posterior gastro-intestinal tract. Alternatively, its 
presence on skin suggests that entry may proceed by direct invasion of the integument 
(Austin and Austin 2007). 
 
1.3.2.4 Virulence factors 
The virulence plasmid pJM1, has not been detected in V. ordalii (see Austin and Austin 
2007). However, a 30 kbp extrachromosomal element (= cryptic plasmid), which was 
named pMJ101, which replicates in the absence of DNA polymerase I without 
generating single-stranded intermediates, has been found in all isolates of V. ordalii 
(Bidinost et al. 1999; Austin and Austin 2007). Haemolysins and proteases have not 
been found (Kodma et al. 1984). V. ordalii induces a pathogenesis not particularly 
different from that of V. anguillarum, but is generally less severe and with sporadic 
peracute cases. Infection may be via ascending infection from the posterior gut, or 
through the skin – a phenomenon rarely true outside salmonids (see Hjeltnes and 
Roberts 1993). The ability of V. ordalii to agglutinate trout and human erythrocytes, and 
yeast cells suggests that it could attach to and interact with the host cells, although this 
observation was inconsistent in some studies (Crosa et al. 2006).    
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1.3.2.5 Isolation/detection 
As with V. anguillarum, isolation and identification involves the use of seawater agar 
and TCBS (Table 1.3) with incubation at 15–25°C for up to 7 days (Austin and Austin 
2007). Cultures on marine 2216E agar appear as off-white, circular and convex colonies 
of 1–2 mm in diameter with slow growth rate (i.e. colony formation takes place between 
4–6 days of incubation at 22°C). The biochemical tests frequently used to distinguish 
between V. ordalii and V. anguillarum are listed in Table 1.4. 
 
Table 1.4 Phenotypic properties used to differentiate V. anguillarum from V. ordalii 
(after Crosa et al. 2006). 
Result for: 
Biochemical tests and growth temperature 
V. anguillarum V. ordalii 
Arginine-alkaline reaction + – 
Citrate, Christensen + – 
Citrate, Simmons + – 
Lipase + – 
1ONPG hydrolysis + – 
Starch hydrolysis + – 
Voges-Proskauer reaction + – 
Acid production from:   
   Cellobiose + – 
   Glycerol + – 
   Sorbitol + – 
   Trehalose + – 
Growth at 37°C  + – 
1o-Nitrophenyl-β-D-galactopyranoside 
 
1.4 Disease control measures 
Sanitary measures (= water quality), better nutrition, lower stocking densities and good 
farm husbandry practices may successfully prevent the introduction of pathogens in the 
fish farm environment, including problems attributed to vibriosis (Vendrell et al. 2006; 
Austin and Austin 2007). However, the search for effective disease control/prevention 
strategies in the last decades has led to some modern approaches, for example, the use 
of non-specific immunostimulants (e.g. β-1,3 glucan), dietary supplements (e.g. vitamin 
C), probiotics, the development of genetically disease-resistant stock, and restriction on 
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the movement of infected stock other than the traditional use of vaccines and antibiotics 
(Austin 2002; Austin and Austin 2007).       
 
1.4.1 Chemotherapy 
Antibiotic/chemotherapeutic agents are probably the most popular methods to treat 
infectious bacterial diseases, and are applied either as feed additives, by injection, or are 
added directly to the water (Crosa et al. 2006, Austin and Austin 2007). Generally 
flumequine and oxolinic acid (both quinolones), florfenicol, ampicillin, furanace, 
furazolidone, nitrofurantoin, oxytetracycline (= terramycin), chloramphenicol (= 
chloromycetin), nalidixic acid and derivatives, nitrofuran derivatives, kanamycin, 
sulphonamides and trimethoprim have been used to treat vibriosis with good results 
(Colquhoun et al. 2004, Crosa et al. 2006; Austin and Austin 2007). However, 
differences in sensitivity between serotypes and indeed between cultures of V. 
anguillarum to antibiotics are observed (Table 1.5), and strains have emerged that are 
resistant towards oxolinic acid (Colquhoun et al. 2007) and other antimicrobial 
compounds (see Crosa et al. 2006; Austin and Austin 2007) – a phenomenon well 
known in V. anguillarum (Aoki et al. 1985; Pedersen et al. 1995). It should be 
emphasized that antibiotic use in aquaculture may be detrimental to the environment 
and human health, and involves the development and transfer of resistance to other 
aquatic bacteria (Petersen et al. 2002; Alcaide et al. 2005), fish pathogens (Schmidt et 
al. 2000) and human pathogens (WHO 1999; Huys et al. 2007), the accumulation of 
residual antibiotics in aquaculture products (Cabello 2006; WHO 2006), and an effect 
on the microbial biodiversity (Zhou et al. 2009).  
 
Table 1.5 Sensitivity of V. anguillarum serotypes O1 and O2 to selected antibiotics 
used in aquaculture (after Gratacap 2008). 
Antibiotic Serotype O1 Serotype O2 
Colistin Resistant Sensitive 
Ampicillin Sensitive Resistant 
Cephalothin Sensitive Resistant 
   
1.4.2 Vaccines 
Prophylaxis measures may not be always effective in controlling diseases. Moreover, 
once fish are infected they tend to cease daily food intake, which may hinder 
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chemotherapy applied via feed (Austin and Austin 2007). Thus, vaccination should 
provoke a protective immune response without causing adverse side effects (Ellis 1989), 
and ideally should be the best method of disease control. However, only a 
comparatively few vaccines are available for use in aquaculture (Thorarinsson and 
Powell 2006). Vaccination of salmonids against vibriosis has proven to be successful 
(reviewed by Sommerset et al. 2005). As a result, the use of antibiotics in the treatment 
of Vibrio infections has been reduced dramatically (Håstein et al. 2005; Sommerset et 
al. 2005). Currently, most of the commercial vaccines are derived from simple 
empirically developed inactivated/killed cultures of bacterial pathogens, namely, V. 
anguillarum, V. ordalii, V. salmonicida and Yersinia ruckeri, being marketed as 
formalin inactivated vaccines (Gudding et al. 1999) either in monovalent (= a single 
antigen/microorganism) or multivalent/polyvalent (= multiple organisms) forms (see 
Gudmundsdóttir and Björnsdóttir 2007). Live attenuated vaccines, which are produced 
from pathogens following the deletion of specific genes known for virulence, cause 
essentially a controlled infection in the host. A few recombinant subunit vaccines, 
which are immunogenic protein units, i.e. whole, segments or regions of protein of 
disease agents or equally active synthetic peptides, are also available and regarded as 
second generation vaccines. Third generation vaccines are DNA vaccines, which use 
antigen-encoding plasmid DNA to express an encoded protein and stimulate the host’s 
immune system, are effective against viral fish diseases, such as infectious 
haematopoietic necrosis virus (IHNV) and viral haemorrhagic septicaemia virus 
(VHSV) in rainbow trout, and ictalurid herpes virus 1 (IHV-1) in channel catfish 
(Ictalurus punctatus) (see Verri et al. 2003). Currently commercial DNA vaccines are 
available against infectious pancreatic necrosis virus (IPNV) and IHNV in Norway and 
Canada (Adams and Thompson 2006).  
 
The majority of commercial vaccines contain adjuvants, substances used to improve the 
immune response and generally considered to (i) augment the consumption of antigens 
and the presentation of cells, (ii) induce a ‘signal of danger’ via pattern recognition 
receptor signaling, (iii) give a secondary signal (co-stimulatory) in the activation of 
lymphocytes (Secombes 2008), and (iv) allow an extended delivery of antigens 
(Evensen et al. 2005). Adjuvants used in fish vaccines include oil (which often produce 
the best results), glucans and aluminium salts (Midtlyng 1996). Vaccines are 
administered to fish in three different ways: injection (usually intraperitoneally), 
Chapter 1 – Introduction 
 
22 
immersion and orally; each of these methods has inherent advantages and disadvantages 
(for details see Gudmundsdóttir and Björnsdóttir 2007). However, vaccination regimes 
in fish farming do not always offer consistent protection; thus new outbreaks of 
classical vibriosis in vaccinated fish still occur (Bricknell et al. 2006; Samuelsen et al. 
2006), and occasionally the causative agents appear to be other/new variants of V. 
anguillarum (Mikkelsen et al. 2007).  
 
1.4.3 Immunostimulants 
An immunostimulant is defined as “a naturally occurring compound that modulates the 
immune system by increasing the host’s resistance against diseases that in most 
circumstances are caused by pathogens” (Bricknell and Dalmo 2005). The approach has 
been shown to be effective against a range of bacteria and viruses, and is suitable for 
many species of fish.  Moreover, efficacy is often better than that of vaccination (Sakai 
1999). A wide range of immunostimulants, over 20 different compounds, has been used 
in aquaculture (Anderson 1992) and include, substances of microbial origin such as 
glucan polymers and lipopolysaccharides, extracts from animals and herbal/medicinal 
plants, nutritional factors (= vitamins), or synthetic compounds namely levamisole and 
hydroxy-methyl-butyrate, and hormones. Most immunostimulants augment the innate 
defence mechanisms, but may also enable adaptive immune responses, and may have 
positive effects on antibody synthesis. Immunostimulants are easy to apply as they can 
be administered either orally via feeds, by immersion or by injection, and can be readily 
used with small fish. Potentially, immunostimulants can make cost effective dietary 
supplements due to the relatively low cost of their source ingredients (Anderson 1992; 
Sakai 1999; Bricknell and Dalmo 2005; Kunttu et al. 2009). Overall, the use of 
immunostimulants as feed supplements may improve the innate defence of animals 
providing resistance to pathogenic agents during periods of stress, for example during 
grading, reproduction, marine transfer and vaccination (Bricknell and Dalmo 2005). 
 
1.4.4 Administration of beneficial bacteria – the probiotics 
Nowadays, antibiotic-resistant pathogens and new pathogens are emerging in 
aquaculture, and the value of prevention of infection is acknowledged (Sanders 2003). 
Consequently, the use of probiotics, which was initiated during the late 1980s (Kozasa 
1986; Dopazo et al. 1988; Kamei et al. 1988), has garnered attention for disease 
prevention (Nikoskelainen et al. 2001; Aly et al. 2008; Pan et al. 2008; Vendrell et al. 
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2008). Also, probiotics have been attributed with improved nutrition (Balcázar et al. 
2006a) and food safety in a more environmentally friendly way (Macey and Coyne 
2005). Certainly, FAO has now highlighted the value of probiotics as a means of 
improving the quality of the aquatic environment (Subasinghe et al. 2003). 
 
1.4.4.1 Definition 
The concept of probiotic was used by Lilley and Stillwell in 1965 to describe 
“substances secreted by one microorganism which stimulate the growth of another”, 
thus ‘probiotic’, which is a Greek word meaning ‘for life’, is the opposite of the name 
antibiotic. It was Parker (1974), who probably first introduced the term and definition of 
‘probiotic’ as “organisms and substances which contribute to intestinal microbial 
balance”. Since then the description of probiotics has evolved throughout the years and 
is commonly used to name bacteria associated with beneficial effects on humans and 
animals. Fuller (1989) revised probiotics as a “live microbial feed supplement which 
beneficially affects the host animal by improving its intestinal microbial balance” – 
where the idea of substances were omitted as probiotics, but highlighted only the use of 
live microorganisms. To accommodate the immunostimulation aspect of probiotics, 
Naidu et al. (1999) modified the concept of probiotic as “a microbial dietary adjuvant 
that beneficially affects the host physiology by modulating mucosal and systemic 
immunity, as well as improving nutritional and microbial balance in the intestinal tract”. 
In the field of aquaculture, Moriarty (1998) widened the definition of probiotics to 
microbial ‘water additives’. Moreover, Verschuere et al. (2000) proposed a broader 
application of the term probiotic as “a live microbial adjunct which has a beneficial 
effect on the host by modifying the host-associated or ambient microbial community, by 
ensuring improved use of the feed or enhancing its nutritional value, by enhancing the 
host response towards disease, or by improving the quality of its ambient environment”. 
Furthermore, Salminen et al. (1999) proposed that a probiotic is “any microbial cell 
preparation or components of microbial cells that have a beneficial effect on the health 
and well-being of the host” – where dead cells or components of microorganisms are 
also included as probiotics if beneficial to the host. So, there is a bewildering array of 
definitions and the ‘probiotic concept’ remains controversial, because there were 
relatively few well controlled studies on the mode of action of probiotics in vivo (Atlas 
1999). Nevertheless, FAO/WHO (2001) simplified and integrated all theses definitions 
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and stated that probiotics are “live microorganisms which when administered in 
adequate amounts, confer a health benefit on the host”.    
 
1.4.4.2 Probiotics for use in aquaculture 
Many microorganisms have been evaluated as probiotics to improve growth or survival 
of farmed aquatic species, with candidate probionts often isolated from healthy adult 
fish (Gildberg et al. 1997; Gram et al. 1999), rearing water (Lauzon et al. 2009) and 
larvae (Gatesoupe 1999; Ringø and Vadstein 1998). It is interesting to note that human 
probiotics, i.e. L. rhamnosus (Nikoskelainen et al. 2003) and L. plantarum (Picchietti et 
al. 2007) and beneficial bacteria from terrestrial animals, i.e. Clostridium butyricum 
from the intestine of healthy chicken (Pan et al. 2008) offer promise for use in 
aquaculture. However, the search for new microorganisms continues. To date, a number 
of probiotic bacteria have been used in aquaculture, and these are mainly derived from 
two bacterial divisions, (i) Gammaproteobacteria, such as Aeromonas, Pseudomonas, 
Shewanella and Vibrio, and (ii) Firmicutes including lactic acid bacteria (= 
Carnobacterium,  Enterococcus, Lactobacillus, Leuconostoc, Pediococcus, 
Streptococcus, Weissella), Bacillus and Clostridium. The other phylogenetic lineages 
are Actinobacteria (= Arthrobacter, Micrococcus) and Alphaproteobacteria (= 
Roseobacter) – Table 1.6.   
 
Table 1.6 Probiotics used in aquaculture of fishes.  
Probiotics Source Host species References 
    
GRAM-POSITIVE BACTERIA 
Arthrobacter sp. cod larval rearing 
water 
Atlantic cod Lauzon et al. (2009) 
    
Bacillus sp. common snook common snook 
(Centropomus 
undecimalis) 
 
see Irianto and Austin (2002b) 
B. subtilis digestive tract of 
rainbow trout 
 
rainbow trout Newaj-Fyzul et al. (2007) 
 
B. megaterium, B. 
subtilis, B. 
polymyxa, B. 
licheniformis   
 
commercial  
product 
channel catfish Queiroz and Boyd (1998) 
B. circulans intestines of rohu  rohu (Labeo 
rohita)  
see Balcázar et al. (2006a) 
    
Carnobacterium sp. intestine of rainbow 
trout, Atlantic 
salmon, rotifers 
 
rainbow trout/fry, 
Atlantic salmon, 
turbot larvae 
 
Irianto and Austin (2002a); 
Robertson et al. (2000) 
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C. divergens intestine of Atlantic 
salmon 
cod Gildberg et al. (1997); 
Gildberg and Mikkelsen 
(1998); Kim and Austin 
(2006a) 
 
C. inhibens intestine of Atlantic 
salmon 
 
salmonids see Irianto and Austin (2002b) 
C. maltaromaticum rainbow trout rainbow trout Kim and Austin (2006a) 
    
Clostridium 
butyricum 
intestine of chicken Chinese drum 
(Miichthys miiuy) 
Pan et al. (2008) 
    
Enterococcus sp. algal supplement Atlantic cod Lauzon et al. (2009) 
 
E. faecium  commercial 
product, piglet  
eel, tilapia 
(Oreochromis 
niloticus) 
Chang and Liu (2002); Wang 
et al. (2008) 
    
Lactobacillus sp. rotifers, tilapia 
intestine 
turbot larvae, 
tilapia 
Gatesoupe (1994); see Irianto 
and Austin (2002b) 
 
L. fructivorans Sea bream gut Sea bream Carnevali et al. (2004) 
 
L. plantarum human faeces, 
turbot larvae 
Sea bream, turbot Carnevali et al. (2004); see 
Irianto and Austin (2002b) 
 
L. bulgaricus ? turbot larvae see Balcázar et al. (2006a) 
 
L. rhamnosus  culture  collection rainbow trout Nikoskelainen et  al. (2001); 
Panigrahi et al. (2004) 
 
L. helveticus turbot larvae turbot see Irianto and Austin (2002b) 
    
Leuconostoc 
mesenteroides 
salmonids rainbow trout Vendrell et al. (2008) 
    
Micrococcus luteus digestive tract of 
rainbow trout, Nile 
tilapia 
rainbow trout, 
Nile tilapia 
Irianto and Austin (2002a); El-
Rhman et al. (2009) 
    
Pediococcus 
acidilactici 
commercial 
product 
pollack larvae 
(Pollachius 
pollachius) 
Gatesoupe (2002) 
    
Streptococcus 
lactis 
 
? 
 
turbot larvae  see Balcázar et al. (2006a) 
S. thermophilus turbot larvae turbot  see Irianto and Austin (2002b) 
    
Weissella helenica flounder intestine flounder 
(Paralichthys 
olivaceus) 
see Irianto and Austin (2002b) 
    
GRAM-NEGATIVE BACTERIA 
Aeromonas 
hydrophila 
digestive tract of 
rainbow trout 
 
rainbow trout Irianto and Austin (2002a) 
 
Aer. caviae turbot larvae turbot larvae Ringø and Vadstein (1998) 
 
    
Pseudomonas sp. rainbow trout, Nile 
tilapia 
rainbow trout, 
Nile tilapia 
Spanggaard et al. (2001); El-
Rhman et al. (2009) 
 
P. fluorescens iced freshwater 
fish, brown trout, 
rainbow trout 
rainbow trout, 
Atlantic salmon 
Gram et al. (1999); see Irianto 
and Austin (2002b); Gram et 
al. (2001) 
 
P. chlororaphis  intestine of perch  juvenile perch 
(Perca fluviatilis) 
 
Gobeli et al. (2009) 
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Roseobacter sp. turbot larvae 
rearing farm 
turbot larvae Hjelm et al. (2004) 
 
    
Shewanella sp. seabream skin Sea bream Salinas et al. (2006) 
    
Vibrio sp. turbot larvae turbot  Gatesoupe (1997) 
 
V. fluvialis   digestive tract of 
rainbow trout 
 
rainbow trout Irianto and Austin 2002a    
 
V. pelagius    turbot larvae  turbot Ringø and Vadstein (1998) 
 
V. alginolyticus beach sand Atlantic salmon Austin et al. (1995) 
 
 
       
Figure 1.6 Evaluation of the inhibitory activity of putative probiont against undesirable 
microbes – (A) cross-streak method (Decamp et al. 2008), (B) double-layer method 
(Hjelm et al. 2004), (C) disc-diffusion method (http://mason.gmu.edu) and (D) agar 
well-diffusion method (http://www.ispub.com).   
 
1.4.4.3 Development of novel probiotics  
The range of potential probiotics is diverse (Verschuere et al. 2000; Hong et al. 2005), 
and includes bacteria (Verschuere et al. 2000; Gram and Ringø 2005), bacteriophages 
(Nakai and Park 2002), yeasts (Tovar et al. 2002) and microalgae (Austin et al. 1992). 
A reasonable approach to isolate candidate probionts could be to search among the 
intestinal microbiota of healthy animals on the assumption that this is the natural 
location of “good” micro-organisms (Gullian et al. 2004). These micro-organisms 
should be (i) non-pathogenic to the host, (ii) compete with or inhibit the growth of fish 
pathogens, (iii) adhere to and grow inside the host, and (iv) be indigenous to the 
environment to which they will be subjected (Gatesoupe 1999; Verschuere et al. 2000). 
The focus of this thesis has been to develop bacteria as probiotic organisms, thus 
putative probionts were isolated from the host intestine before examining for 
antibacterial activity against pathogens. Studies have demonstrated that naturally 
occurring bacteria, i.e. the indigenous microbiota of fish or the rearing environment may 
produce a range of antagonistic compounds and inhibit the growth of pathogens 
(Robertson et al. 2000, Spanggaard et al. 2001, Vine et al. 2004a; Fjellheim et al. 
2007). Such organisms may be invaluable as probiotics (see Hai et al. 2009). Several 
A B C D 
Chapter 1 – Introduction 
 
27 
inhibitory assays have been used, such as the cross-streak, double-layer, spot-on-lawn, 
disc-diffusion, well-diffusion and co-culture methods – Figure 1.6 (Irianto and Austin 
2002a; Brunt and Austin 2005; Hai et al. 2007). The cross-streaking method (= 
bacteriocin-like inhibitory substance) is regarded to be suitable and allows a comparison 
of inhibitory activity for different putative probionts (Hai et al. 2007). This process may 
involve examination of possible harmful effects of the selected bacterial isolates on the 
host, preferably by intramuscular/intraperitoneal injection. If non-pathogenic, the 
organism is evaluated in vivo against the selected pathogen choosing a delivery method 
(see Section 1.4.4.4 for details). Finally, the beneficial strain is identified as probiotic 
(Irianto and Austin 2002a; Brunt and Austin 2005).      
 
1.4.4.4 Delivery methods 
In aquaculture, probiotic cultures have been applied either as food supplements or as 
additives to water (Moriarty 1998), and include (i) bathing the host in bacterial 
suspensions, (ii) addition to culture water, or (iii) supplemented with diets, i.e. simply 
mixed with inert diet or enrichment of live food (artemia/rotifers). Most studies have 
administered the probiotics to fish or shellfish (larvi)culture by adding them to the diet 
or directly into the rearing media; the former being more practical than the latter in 
reality (Hai et al. 2009). A feed supplement of Leuconostoc mesenteroides and L. 
plantarum dosed at 107 colony forming units (cfu) g−1 for 30 days (Vendrell et al. 
2008), and a mixture of B. subtilis and B. licheniformis dosed at 4 × 104 spores g−1 for 
42 days (Raida et al. 2003) controlled infections caused by Lactococcus garvieae and Y. 
ruckeri in rainbow trout. Similarly, the application of probiotics via rearing water has 
been successful (Queiroz and Boyd 1998; Ringø and Vadstein 1998; Ottesen and 
Olafsen 2000; Makridis et al. 2008). Riquelme et al. (1997) reported a reduction in 
mortality following the bathing of scallop (Argopecten purpuratus) larvae in probiotic 
suspension (Suomalainen et al. 2005). Certainly, it is necessary to optimize the methods 
of delivery to the host, including consideration of dose (Brunt and Austin 2005; Son et 
al. 2009), feeding duration (Aly et al. 2008), and composition of the preparation, 
namely single- or multiple strains (Aly et al. 2008; Hai et al. 2009).        
 
1.4.4.5 Possible mode of action 
The relationship between probiotic bacteria and their hosts is very complex, and the 
mechanisms of action of probiotics are not completely understood. However, the effect 
on reducing disease may be linked to a combination of factors (Figure 1.7):  
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(i) host immunostimulation, i.e. enhancement of humoral and cellular immune 
response (Irianto and Austin 2002b; Nikoskelainen et al. 2003; Panigrahi et al. 
2005; Salinas et al. 2005; Diaz-Rosales et al. 2006), 
(ii) inhibition of or competition with potential pathogens (= production of 
antibiotics, and competition for adhesion sites or nutrient/energy sources) (Gram 
et al. 1999; Verschuere et al. 2000; Irianto and Austin 2002b; Vine et al. 2004b; 
Chabrillón et al. 2005b; Hong et al. 2005; Balcázar et al. 2006a; Brunt et al. 
2007; Decamp et al. 2008), 
(iii) enhancement in feed efficiency, source of nutrients or enzymatic contribution to 
digestion (Tovar et al. 2002; Balcázar et al. 2006a; Tinh et al. 2008; Sáenz de 
Rodrigáñez et al. 2009), 
(iv) improvement of water quality (Verschuere et al. 2000; Taoka et al. 2006a; Lallo 
et al. 2007), and  
(v) improvement in the microbial balance (Hill et al. 2009; Picchietti et al. 2009). 
 
 
 
Figure 1.7 Possible mode of action of probiotics in the intestinal tract of a host (source: 
Balcázar et al. 2006b). 
 
1.5 Defense mechanisms of fish   
Fish are poikilothermic aquatic vertebrates, which possess a system of defence 
mechanisms closer to mammals than to any invertebrate, and involve elements of both 
innate and specific immunity (Ellis 1982; Alvarez-Pellitero 2008). The innate 
mechanism of fish provides the first line of immune defence. The specific immune 
mechanisms conferring acquired resistance to disease demand adaptive processes within 
the immune system forms the second line of defence. There are fundamental differences 
between the two systems in terms of receptor types used to recognize pathogens. Innate 
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immune recognition relies on a growing number of pathogen recognizing receptors 
(PRR), with broad specificity, which are conserved pathogen-associated molecular 
patterns (PAMPs), such as polysaccharides, LPS, peptidoglycans, β-glucans, bacterial 
DNA and double stranded viral RNA, and other molecules not normally found on the 
surface of multicellular organisms (see Magnadóttir 2006; Alvarez-Pellitero 2008). The 
PRR can be either soluble (such as mannan-binding lectin or C-reactive proteins) or 
cellular (Mannose receptor or Toll-like receptors, TLRs). For example, C-type lectins 
are well-known for their capacity to identify specific pathogen-associated carbohydrate 
structures (Alvarez-Pellitero 2008). On the contrary, adaptive immune recognition is 
negotiated by antigen (Ag) receptors, with random but narrow specificities (see 
Alvarez-Pellitero 2008). However, there is increasing evidence of inter-dependency of 
the different immune mechanisms into a complex multilevel network (also referred to as 
a combinatorial system), which confronts the dichotomic view between innate and 
specific immune system (Magnadóttir 2006; Whyte 2007; Alvarez-Pellitero 2008). For 
example, there are functional as well as genetic proofs that fish have a network of 
signalling molecules, cytokines and chemokines, that control and co-ordinate the innate 
and specific immune responses (Secombes et al. 1999; Secombes 2002). 
 
1.5.1 Innate immune mechanisms 
The innate (= natural or non-specific) immunity includes all of the defence mechanisms 
that protect an organism against infection, without depending upon prior exposure to 
any pathogens (Bols et al. 2001). It responds to a pathogen in the first few hours after 
infection (Dixon and Stet 2001). Therefore, this arm of the immunity has been regarded 
as an essential component in combating disease events. Key innate immune components 
include the scales, epithelial tissue lines, gill, mucus, the constituents of the blood, 
phagocytic cells, and proteins mediating the responses, such as complement, which 
initiates inflammation, or cytokines that control the cellular components (Dixon and Stet 
2001; Reynaud et al. 2008). 
 
1.5.1.1 Physical and chemical barriers  
The epidermis defines the physical separation between the internal and external 
environment of fish. Thus, the scales, mucus layer on the skin and mucus membranes 
lining the viscera hollow of the respiratory tract, genito-urinary tract, gills and digestive 
system act as the first defence against infection (see Bols et al. 2001; Magnadóttir 2006; 
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Reynaud et al. 2008). The mucus, which is composed of water and gel-forming 
macromolecules including mucins and other glycoproteins, is a well known biological 
barrier to the entry of pathogens from the environment into the fish (Chen et al. 2008). 
By being continuously produced and sloughed off, mucus prevents the adherence of 
pathogens (Austin and Mcintosh 1988; Subramanian et al. 2007), and simultaneously 
serves as a repository of numerous innate immune factors such as lysozyme, 
immunoglobulins, complement proteins, lectins, C-reactive proteins, proteolytic 
enzymes, flavoenzymes, Apolipoprotein A–I and antimicrobial peptides that are 
constitutively expressed to provide immediate protection from opportunistic pathogens. 
In particular, proteases of fish mucus, for example serine-trypsin, cysteine-cathepsin B 
and L, aspartic-cathepsin D and metallo-proteases, can cleave bacterial proteins, thus 
possess bacteriolytic activity (see Subramanian et al. 2007, 2008).   
 
1.5.1.2 Humoral parameters   
Humoral factors (= noncellular nonspecific defence mechanisms), which are found free 
in the serum or body fluids, are predominantly proteins or glycoproteins, and include 
lysozyme, peroxidases, anti-proteases (= clearance of active proteases from the tissue 
fluids), acute-phase proteins, components of the complement pathways, agglutinins and 
precipitins (opsonins, primarily lectins), transferrin (iron binding protein), cytokines, 
chemokines, natural antibodies and antibacterial peptides, which non-specifically inhibit 
the growth of or directly destroy microbial pathogens (Bols et al. 2001; Magnadóttir 
2006; Whyte 2007; Alvarez-Pellitero 2008; Swain and Nayak 2009). Lysozyme disrupts 
the cell walls of bacteria by splitting glycosidic linkages in the peptidoglycan layers 
(Bols et al. 2001). Functions of acute-phase proteins, which are plasma or serum 
proteins (i.e. C-reactive protein, serum amyloid A, ceruloplasmin, fibrinogen), include 
the regulation of phagocytosis and activation of the classical complement cascade in 
response to tissue damage, infection, or inflammation (Bayne and Gerwick 2001; Bols 
et al. 2001). Complement, including the alternative, lectin and classical pathways, is 
among the main mechanisms implicated in the introduction of the innate response and 
further mounting of an adaptive response (Alvarez-Pellitero 2008). It plays important 
roles in the lysis of pathogens, by opsonization and activation of phagocytes, and in 
inflammation (see Alvarez-Pellitero 2008). However, the two subsets of the innate 
immune mechanisms (the humoral and cellular) do not function in isolation, and co-
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operate in many instances in the discharge of their functions. An example is the 
opsonisation through complement/C-reactive protein/phagocytosis (Ellis 1986). 
 
       
          
 
Figure 1.8 Blood cells of fishes: (A) neutrophil granulocyte (n) with segmented nucleus 
and pale cytoplasm, and monocyte/macrophage (m) with vacuolated cytoplasm, (B) 
eosinophil with characteristic peripheral non-segmented nucleus and granule-rich 
cytoplasm, (C) Lymphocyte with characteristic round nucleus and thin blue basophilic 
cytoplasm (source: Lieschke and Trede 2009), (D) granulocytes, (E) lymphocytes, (F) 
monocytes, and (G) thrombocytes (source: http://www.aqualex.org).  
 
1.5.1.3 The cells of the innate system 
Circulating leukocytes together with the nonspecific cytotoxic cells (NCC) and 
reticuloendothelial system (RES) form the cellular arm of innate immunity in fish 
(Secombes 1996; Bols et al. 2001). A central feature of the cellular element of innate 
immunity is its non-specificity, which allows large populations of cells to be mobilized 
quickly at local and/or systemic sites, after antigenic stimulation (Whyte 2007). 
Phagocytic cells (= granulocytes, monocytes and macrophages, neutrophils; Figure 1.8) 
are specialized for the pursuit, capture, ingestion and intracellular destruction of 
invading microbes, i.e. by phagocytosis. Inducible potent microbiocidal responses, i.e. 
the respiratory burst (superoxide O2−), reactive oxygen species (hydrogen peroxide 
H2O2, hypochlorous acid HOCl, hydroxyl radical OH, singlet oxygen 1O2) and nitric 
oxide (NO) have been demonstrated in fish phagocytes (see Bols et al. 2001; Alvarez-
Pellitero 2008). NCC, which mediate the acute innate cytotoxic responses, provide 
resistance against tumor development, and have been assayed by their capacity to 
spontaneously lyse certain fish and mammalian tumor cells, some virus-infected  fish  
A B C 
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cell lines, and specific protozoan parasites (see Bols et al. 2001). The RES, which are 
made up of endothelial cells and macrophages lining the blood vessels, as well as 
sinusoids and ellipsoids of the spleen and sinusoids of the kidney and liver, take up and 
degrade microbes (see Bols et al. 2001). Nevertheless, cellular immunity develops from 
an enhanced ability of a particular cell/tissue to counter infection (Cruickshank 1965).   
 
1.5.2 Specific immune mechanisms 
In contrast, the specific immune response targets pathogen-specific features, and turns 
out once the pathogen is present for a defined amount of time in a form and quantity 
sufficient to stimulate a response by the host (Dixon and Stet 2001). It normally takes 
many days to develop (Dixon and Stet 2001) because of restrictions put on the specific 
immune response by their poikilothermic character plus the directories of limited 
antibodies, affinity maturation and memory and relatively slow proliferation of 
lymphocytes (Magnadóttir 2006). Temperate species, such as salmonids, require at least 
4–6 weeks while cod takes 10–12 weeks to show specific immune responses (see 
Subramanian et al. 2008). For these reasons, this type of immunity is known as acquired 
or adaptive immunity (Dixon and Stet 2001). Consequently, fish are likely to rely highly 
on their innate immune mechanisms for protection against invading pathogens. 
However, lymphocytes, which recognise antigen–MHC (major histocompatibility 
complex) molecules through surface receptors, are the key effector cells of adaptive 
immunity contributing to a more specific and efficient response against infections 
(Reynaud et al. 2008; Lieschke and Trede 2009). These cells are able to separate into T-
or B-lymphocytes, and usually occur in the peripheral organs (spleen and kidney) and in 
the circulatory and other tissues monitoring the body for non-self antigens or pathogens 
(Trede and Zon 1998). The cell-mediated response relies on the presence of accessory 
cells (= any phagocytes, or professional antigen presenting cells, such as the dendritic 
cells of mammals) to present antigen to T-cells, which is the mainstay of adaptive 
cellular immunity (Lieschke and Trede 2009; Swain and Nayak 2009). In addition, there 
can be various types of humoral activity referring to responses mediated by antibody 
where B-cells are at the centre (Lieschke and Trede 2009). For example, antibodies can 
induce responses that are inflammatory, lytic, phagocytic or allergic (see Dixon and Stet 
2001). An important molecule in the humoral immunity is immunoglobulin (Ig). An 
overview of fish immune systems is given in Table 1.7.  
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Table 1.7 Components and specializations of fish immune systems (as demonstrated by 
zebrafish); source: Lieschke and Trede (2009). 
 Innate immunity Adaptive immunity 
 
Phylogeny Many mechanisms shared with all 
animals; some mechanisms are 
also shared with plants 
Jawless fish have a form of  
lymphocyte and divergent type of 
rearranging immune receptor 
 
Jawed fish mark the appearance of 
the thymus and recombinase-
activating genes (RAGs) 
   
Anatomical 
features 
Surface barrier with mucus coating 
containing secreted protective 
antibacterial molecules 
 
Cells and soluble factors 
distributed in endothelium-lined 
circulation 
No lymph nodes or germinal 
centers 
 
Lymphatic circulation 
 
Secondary lymphoid organs: 
paired thymic organ, anterior and 
posterior kidney, spleen, gut-
associated lymphoid tissue 
   
Key cell types Macrophages 
 
Granulocytes: neutrophil, 
eosinophil, basophil 
 
Natural killer cell equivalent 
(diverse genomic library of novel 
immune type receptors, NITRs) 
 
Thrombocytes (work with 
coagulation pathways to maintain 
host integrity) 
B-lymphocytes (re-arranging B-
cell receptor) 
 
T-lymphocytes (re-arranging T-
cell receptor) 
 
Detailed lymphocyte subtypes not 
yet characterized 
 
Antigen-presenting cells 
   
Cellular 
immunity 
Phagocytosis (predominantly 
macrophages) 
 
Microbiocidal/static biochemical 
pathways (e.g. peroxide, nitric 
oxide production) 
 
Hematopoietic growth factors 
regulate leukocyte precursor 
proliferation, leukocyte function 
Compared to tetrapods, conserved 
T-cell receptor structure 
 
Specificity diversification by 
RAG-dependent 
 
V(D)J recombination 
 
Characteristic cytotoxic T-cell 
responses demonstrable, e.g. 
mixed lymphocyte reaction, graft 
rejection, antiviral response 
   
Humoral 
immunity 
Complement – classical, 
alternative and mannose-lectin 
pathways; highly evolved diversity 
 
Coagulation pathways 
 
Natural antibodies 
 
Induced cytokines, e.g. 
interleukin-1, tumor necrosis 
factors, interferons, chemokines 
 
Ligand and receptor families 
characterised by highly evolved 
diversity 
Compared to tetrapods, less 
conserved B-cell receptor structure 
 
Immunoglobulin classes (μζδ 
isotypes) 
 
Specificity diversification by 
RAG-dependent V(D)J 
recombination; somatic 
hypermutation contributes to a 
lesser extent 
 
No class switching 
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Activation and 
key signaling 
pathways 
Pathogen-associated molecular 
patterns (PAMPs) interact with 
pattern recognition receptors 
(PPRs), e.g. Toll-like receptors 
(TLRs), lectins, peptidoglycan 
recognition proteins, cytokine 
receptors 
Immune receptor engagement with 
antigen 
   
Immunological 
memory 
Fixed repertoire, entrenched in the 
genome 
Adapts to environmental history of 
the individual; mechanisms for 
adaptation entrenched in genome 
   
Cellular 
ontogeny 
Phagocytes are present and 
functional from early segmentation 
 
Haematopoiesis has primitive and 
definitive phases, at distinct 
locations during development 
 
Adult haematopoiesis in the 
kidney interstitium (not bone 
marrow) 
Lymphocytes appear first during 
late organogenesis 
 
T-lymphocytes precede B 
lymphocytes 
 
T-lymphopoiesis resides in the 
thymus throughout life 
 
B-lymphopoiesis resides in adult 
kidney interstitium (embryonic 
location not certain) 
   
Comparison 
with mammals 
Appears highly evolved and richly 
diversified 
Appears less highly evolved and 
possibly less flexible 
 
1.6 Aims and objectives 
The aim of this study was to develop probiotics to protect rainbow trout from vibriosis.  
 
The specific aims were, as follows: 
i) to identify candidate probionts from the intestine of fish useful as control agents 
against V. anguillarum and V. ordalii diseases 
ii) to assess in vivo the effectiveness of the putative probiotics administered to 
rainbow trout in controlling experimental vibriosis  
iii) to establish effective dose(s) rate, feeding duration and composition (= single- or 
multi strain/species) of probiotics for preventing Vibrio infection 
iv) to examine the duration of protecton after cessation of feeding with dietary 
probiotic          
v) to study the efficacy of the cell components of probiotics to confer protection  
vi) to determine the possible mode of action(s) of probiotics on the host, i.e. on the 
immunological, growth and enzymatic performances of the host. 
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2.1 Fish stocks 
Rainbow trout (Oncorhynchus mykiss, Walbaum) and Atlantic salmon (Salmo salar) of 
10–15 g average weight were obtained from a commercial fish farm in Scotland. The 
fish were maintained in continuously aerated free-flowing dechlorinated freshwater at 
~12°C, and fed with commercial pelleted diet (Skretting, Glasgow, Great Britain) at 
~2% of body weight daily. The fish had neither been vaccinated nor exposed to fish 
diseases, and the health of the fish (= changes in physical appearance and internal 
organs followed by swabs from body surface, kidney and liver for bacteriology) was 
randomly checked initially upon receipt and then at 2–4 week intervals (after Austin and 
Austin 1989).  
 
2.2 Fish pathogens 
The pathogens, Vibrio anguillarum and V. ordalii, which were originally recovered 
from diseased salmonids in Tasmania and Norway, respectively (see Austin et al. 1995), 
were obtained from the fish pathogen collection of the School of Life Sciences, Heriot-
Watt University. The cultures were routinely grown on tryptone soya agar (TSA; Oxoid, 
Basingstoke, Great Britain) plates and in tryptone soya broth (TSB; Oxoid) 
supplemented with 1% (w/v) sodium chloride (NaCl; BDH, Poole, Great Britain) 
referred to as TNA and TNB, respectively, with incubation at 26°C for 18 h. Stock 
cultures were stored in TNB containing sterile (121°C for 15 min) 20% (v/v) glycerol 
(Sigma-Aldrich, Basingstoke, Great Britain) at −70°C. For the preparation of 
challenges, loopfuls of pure cultures from TNA plates were grown in 10 mL of TNB at 
26°C for 18 h. Then, cells were harvested by centrifugation (2,500 × g, 15 min, 4°C) in 
a Mark IV refrigerated centrifuge (Baird and Tatlock, London, Great Britain), washed 
twice in saline and redissolved in fresh saline to achieve the required number of cells 
mL−1 as determined using a haemocytometer slide (Improved Neubauer Type; Merck, 
Lutterworth, Great Britain) on a Kyowa light microscope (Tokyo, Japan). 
 
2.3 LD50 dose of the pathogen 
A lethal dose for 50% of the population (LD50) was calculated by the Probit method of 
Wardlaw (1985) for pathogens V. anguillarum and V. ordalii, which were used in the 
challenge model. Thus, groups of 5 rainbow trout were injected intraperitoneally (i.p.) 
and intramuscularly (i.m.) with 0.1 mL fish−1 of pathogen suspensions in saline ranging 
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from 102, 103, 104, 105, and 106 cells mL−1, prepared as above, and mortalities recorded 
over a period of 7 days.   
 
2.4 The development of probiotics 
An approach to isolate candidate probionts could be to look among the intestinal 
microbiota of healthy animals while supposing that this is the natural place of the 
“good” micro-organism (Gullian et al. 2004). Thus, the gut microbiota of healthy 
rainbow trout and salmon were studied for the development of probiotics (after Irianto 
and Austin 2002a; Brunt and Austin 2005).   
 
2.4.1 Isolation of putative probionts 
Fish were killed by an overdose of anesthetic (MS-222; Sigma-Aldrich). The surface of 
the fish was sterilised using 70% ethanol (BDH), and the peritoneal cavity was opened 
aseptically with a sterile scalpel. The intestine between the pyloric caecae and 
approximately 1 cm anterior to the anus was excised, the intestinal content was removed 
by gentle squeezing with a sterile forceps and collected into 10 mL of 0.9% (w/v) sterile 
saline. Ten-fold dilutions were prepared up to 10−6 in fresh saline, and 0.1 mL of each 
dilution was spread onto duplicate plates of TNA. All the plates were incubated 
aerobically at ambient temperature (~20°C) for a week. Then, colonies were picked 
randomly, purified by streaking and re-streaking onto fresh TNA plates. 
 
2.4.2 Pathogen inhibition assay 
The antimicrobial properties of the isolates, either by overgrowing or interrupting the 
growth of V. anguillarum and V. ordalii were tested in order to screen for the potentially 
beneficial cultures.   
 
2.4.2.1 The cross-streaking method  
The antagonistic activity by a random group of 100 colonies was assessed by the cross-
streaking method (= bacteriocin-like inhibitory substance) according to Robertson et al. 
(2000). Briefly, a pure colony of the pathogen(s) was picked with a sterile wire loop and 
inoculated in parallel streaks onto fresh TNA plates. Then, test isolate(s), picked as 
before, were streaked perpendicularly across the inocula of the pathogen(s). All plates 
Chapter 2 – Materials and methods 
37 
were incubated at room temperature for up to 7 days whereupon interruption or 
overgrowth of the pathogen was recorded as evidence of antagonism. 
 
2.4.3 Safety of isolates in fish 
Isolates, which demonstrated antagonistic activity against V. anguillarum and V. ordalii 
were retained and evaluated further for the lack of harm in rainbow trout. Thus, the 
isolates were grown in TNB at 26°C for 18 h, cells were harvested by centrifugation 
(2,500 × g, 15 min, 4°C), washed twice in saline and resuspended in fresh saline to 
~108 cells mL−1 as determined by use of a haemocytometer slide and light microscopy. 
Then, volumes of 0.1 mL fish−1 were injected i.p. and i.m. into groups of 10 rainbow 
trout. Controls were injected with 0.1 mL of saline. The groups of control and treated 
fish were observed daily for 2 weeks. Challenge experiments were maintained in static, 
aerated dechlorinated freshwater at ~18°C with ~50% water exchange daily.  
 
2.4.4 Experimental diets 
A pure culture of putative probiotic from overnight growth on a TNA plate was 
inoculated into 10 mL of TNB with incubation at 26°C for 18 h. The culture was 
centrifuged (2,500 × g, 15 min, 4°C), the cell pellet washed twice, resuspended in 
saline, and the concentration adjusted to ~5 × 107 cells mL−1, as above. Then, 50 g 
quantities of commercial rainbow trout feed were mixed with the bacterial suspension in 
a glass bottle to achieve a dose of ~5 × 107 cells g−1, which was determined as an 
effective feeding dose by Brunt and Austin (2005) and Kim and Austin (2006a). The 
modified feed was stored in screw-top glass bottles at room temperature. A control diet 
contained an appropriate volume of saline instead of the bacterial suspension. The 
viability of bacteria in the feed was monitored by the total viable count (Nikoskelainen 
et al. 2003). Briefly, 1 g of feed was homogenized in 9 mL of saline using a sterile 
disposable homogenizer (VWR, Poole, Great Britain), and 10-fold dilutions prepared to 
10−6 in fresh saline, before 0.1 mL volumes were spread over TNA plates. Colony 
counts were determined after incubation at room temperature for one week. 
 
2.4.5 Palatability of bacteria-supplemented feed  
Putative probiotic bacteria with no harmful effects were orally administered to fish as 
dietary supplement to determine palatability. For this, separate groups of 10 rainbow 
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trout were fed to satiation twice a day for 1 week with the experimental (dose = ~5 × 
107 cells g−1) and control diets. The overall feeding response was observed, i.e. the 
number of uneaten pellets and feeding behavior was recorded. Then, the fish were killed 
with an overdose of MS-222.  
 
2.4.6 In vivo evaluation of putative probiotics  
Initially, separate groups of 20 rainbow trout were fed to satiation for 14 days with the 
experimental diet supplemented with putative probiotics at a concentration of ~5 × 
107 cells g−1 or control diet. Then, fish were challenged i.p. with 0.1 mL fish−1 of 
V. anguillarum or V. ordalii suspensions containing 3 × 105 and 5 × 104 cells mL−1, 
respectively. These cell numbers led to the death of >80% of the fish populations as 
determined before (Section 2.3).The groups of control and treated fish were observed 
daily for 2 weeks, and the relative percent survival (RPS1) was calculated after Amend 
(1981). Challenge experiments were maintained as before (see Section 2.4.3). From this 
preliminary work, two isolates, i.e. SM1 and SM2 which were recovered from the gut of 
rainbow trout, were determined to be potentially beneficial, and were evaluated further 
using groups of 60 rainbow trout. The fish were fed with SM1 and SM2 supplemented 
diets containing ~108 and ~107 cells g−1 of feed, respectively, or with control diets three 
times daily for 14 days, and subdivided into groups of 25, before challenge, as above. 
The cell numbers of probiotics used in feed were verified as effective feeding dose (see 
Section 2.6). Additional sub-groups of 10 fish were used for immunological assays 
involving blood, serum or head kidney (HK) macrophages.    
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2.4.7 Characterization of the bacterial isolates    
2.4.7.1 Micro-morphology  
Overnight cultures on TNA plates were used to study micro-morphology. Thus, a cell 
suspension in saline was spread on a sterile slide with a sterile loop (= smear) and 
subsequently stained by Hucker’s modification of the Gram-stain (Hucker and Conn 
1923), and examined at ×1000 magnification on a Kyowa light microscope. Also, 
colonies on the plates were examined visually to determine morphology and colour. The 
cell shape and colour, cell arrangement and staining reactions were noted. 
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2.4.7.2 Motility  
Motility test was assessed microscopically from wet preparations. Thus, isolates were 
grown for 4 h at 26°C in TNB on a shaker. Then, 5 μL of the liquid culture was placed 
on a sterile microscope slide, a coverslip placed on top, with observation on a Kyowa 
light microscope, at a magnification of ×400, as before. Water movement and Brownian 
motion were taken into consideration when observing motility. 
 
In a parallel experiment, motility was recorded by the development of diffuse growth 
extending outward from a stab mark made in semi-solid growth medium (after Karlsen 
et al. 2008). Thus, bacteria were cultured in semi-solid TNB containing 0.25% 
bacteriological agar (Agar no. 1; Oxoid). The bacterial cells from overnight cultures 
were inoculated, using a sterile needle, into the medium, which was incubated at 26°C, 
and motility monitored for 7 days by measuring the diameter of swimming zones. 
 
2.4.7.3 Oxidase and catalase production 
A piece of Whatman filter paper (No. 1) was moistened with 1% N,N,N’,N’-tetramethyl-
p-phenylenediamine dihydrochloride (Sigma-Aldrich), which was streaked by touching 
a single colony grown overnight on TNA plates. A positive reaction for oxidase was 
recorded visually by the development of a purple colour within 30 seconds. Catalase 
production was indicative of rapid evolution of bubbles due to molecular oxygen being 
released when a drop of 5% H2O2 solution was added to a bacterial colony on a glass 
slide.    
 
2.4.7.4 Optimum temperature and salinities for growth  
In order to determine the salinity and temperature tolerances of the isolates, 190 μL 
volumes of medium containing different concentrations of NaCl [= TSB supplemented 
with 0, 2, 4, 6, 8, 10, 15 and 20% (w/v) NaCl] were inoculated with 10 μL of overnight 
bacterial suspensions [= ~109 cfu mL−1 in saline] in microtitre plates (Nalge Nunc), and 
incubated at 4, 15, 26, 37 and 45°C for up to 48 h. At 12, 24, 36 and 48 h, growth was 
measured at OD620 in a microplate absorbance reader using appropriate blank (= 
bacterial growth at 0 h) after thoroughly mixing the cultures. 
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2.4.7.5 pH growth tolerance  
The pH (2–11) growth tolerance of the isolates was tested by growing in suitably 
modified TNB. Cultures (10 mL) at pH 2 to 11, with increments of pH 1 [adjusted with 
(v/v) 0.1 N NaOH or 0.1 N HCl] were grown at 26°C on a shaker (4 × g). The cultures 
were sampled after 12, 24, 36 and 48 h, and growth was determined as described in 
Section 2.4.7.4.  
 
2.4.7.6 API 20E and API 20NE rapid identification systems  
Isolates were examined using substrate utilization tests of API 20E for the identification 
of Enterobacteriaceae and other Gram-negative bacilli/rods, and API 20NE for non-
fastidious and non-enteric Gram-negative rods following the manufacturer’s instructions 
(Bio-Mérieux, Basingstoke, Great Britain). Thus, an overnight TNA culture was used to 
prepare the bacterial inocula in sterile saline. The inoculum was distributed into test 
strips, which were incubated at room temperature and read at 24 and 48 h. Results were 
read as positive or negative, scored against the reading table in the instruction sheet (= 
interpretive color chart), and the numerical profiles entered into the manufacturers’ 
computer-based identification system to obtain the species identification.    
 
2.4.7.7 Enzymatic profile  
To identify the enzymatic profile by API ZYM enzyme substrate test (Bio-Mérieux), 
colonies (= a loopful) from TNA plates were suspended in sterile saline, inoculated onto 
the test strips and incubated for 4 h at 37°C, as recommended by the manufacturer. 
ZYM A and B reagents were added, and the substrate reactions were allowed to react 
for 5 min before recording in comparison with the manufacturer’s guide. 
 
2.4.7.8 Resistance to pepsin and pancreatin 
Essentially the modified methods of Hosseini et al (2009) were used. Thus, cells from 
overnight TSB cultures were collected by centrifugation (2,500 × g, 30 min, 4°C), 
washed and resuspended in PBS (~109 cfu mL−1). Then, 10 μL of this suspension was 
inoculated into 190 μL of TSB (pH 8.0) containing 0 and 1 mg mL−1 of pancreatin 
(Sigma-Aldrich), or into TNB (pH 2.0 and 3.0) supplemented with 0 and 3 mg mL−1 of 
pepsin (Sigma-Aldrich), respectively, in microtitre plates (Nalge Nunc). Resistance of 
the isolates to each of the enzymes was assessed by determining the bacterial growth at 
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OD620 after incubation at 37°C for 3, 4 and 5 h (pepsin) or at 37°C for 4, 5 and 6 h 
(pancreatin). Growth at 0 h was used as the blank. 
  
2.4.7.9 Production of siderophores 
Micro-organisms produce siderophores, which are recognized as efficient mechanisms 
for iron acquisition from the host or iron-limited environments. The chrome azurol S 
(CAS) assay (Schwyn and Neilands 1987) was used to determine siderophores as 
described by Brunt et al. (2007). In short, 60.5 mg CAS (Sigma-Aldrich) was dissolved 
in 50 mL de-ionized water, and mixed with 10 mL iron (III) solution [1 mM 
FeCl3.6H2O (Sigma-Aldrich) in 10 mL of 10 mM HCl (BDH)] in a volumetric flask 
with stirring. This Fe-CAS solution was added slowly to 72.9 mg 
hexadecyltrimethylammonium bromide (HDTMA; Sigma-Aldrich) dissolved in 40 mL 
water. The resultant dark blue liquid was autoclaved (121°C, 15 min−1), and mixed with 
an autoclaved mixture of 15 g bacteriological agar and 30.24 g piperazine-1,4-bis (2-
ethanesulphonic acid) (PIPES; Sigma-Aldrich) dissolved in 750 mL of water with 12 g 
of a solution of 50% (w/v) NaOH to bring the pH to 6.8. After cooling at 60°C, the 
HDTMA-Fe-CAS blue complex and agar with PIPES buffer were mixed slowly by 
pouring along the glass wall and agitated with enough care to avoid foaming. Then, 
overnight TNB cultures of SM1 and SM2 were spotted (100 μL) onto CAS agar plates 
and incubated (26oC for 72 h). The CSA assay detects colour change of Fe-CAS 
complex from blue to orange after chelation of the bound iron by siderophores (Schwyn 
and Neilands 1987).  
 
2.4.7.10 Sensitivity to antibiotics  
Antibiograms were performed on TNA plates seeded with 200 μL (~109 cells mL−1) of 
the test bacteria cultured in TNB. Thereafter, antibiotic sensitivity discs (M5 Mastring; 
Mast Diagnostics, Bootle, Great Britain) were aseptically placed onto the freshly 
prepared lawns with incubation at 26oC for 48 h. Sensitivity was indicated by the 
presence of a clear zone (of ≥ 3 mm) of growth around the discs.  
 
2.4.8 Identification of the probiotics 
SM1 and SM2 were identified by 16S rDNA gene sequencing, as follows: 
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2.4.8.1 Isolation of bacterial DNA 
A loopful of bacterial culture from a TSA plate was inoculated into 10 mL of TNB, 
incubated at 26°C for 18 h, and harvested by centrifugation (2,500 × g, 15 min) at 4°C. 
Then, bacterial cells were lysed, and the DNA was extracted using a DNeasy tissue kit 
(Qiagen, Crawley, Great Britain), following the manufacturer’s protocol, i.e. isolation of 
total genomic DNA for animal tissues.  
 
2.4.8.2 Agarose gel electrophoresis 
The isolated DNA was checked for purity, using standard methods (Sambrook et al. 
1989), i.e. the presence of single bands following electrophoresis in agarose gels. 
Briefly, 1% (w/v) agarose (Sigma-Aldrich), was dissolved in 40 mL of 1× Tris-acetate-
ethylenediaminetetraacetate (EDTA) buffer [TAE; 50× TAE buffer = 40 mM (w/v) Tris 
base (Sigma-Aldrich), 20 mM (v/v) glacial acetic acid (Sigma-Aldrich), 1 mM (w/v) 
EDTA (Sigma-Aldrich), pH 8.0] by heating in a microwave oven until complete 
dissolution of the agarose. The solution was allowed to cool to 50°C before the addition 
of 0.4 μL of 10 mg mL−1 (w/v) ethidium bromide (EtBr; Sigma-Aldrich). The gel 
solution was thoroughly mixed and poured into a gel casting tray avoiding bubbles with 
integral comb (14 wells). The gel was allowed to solidify for 20 min before the addition 
of electrophoresis buffer to cover the top of the gel followed by the careful removal of 
the comb to reveal the sample wells. The electrophoresis tank was topped up with 
enough TAE buffer to cover the gel to a depth of ~1 mm. Then 5 μL of sample DNA 
was mixed with 2.5 μL of 6× gel-loading buffer [0.25% (w/v) bromophenol blue 
(Sigma-Aldrich), 0.25% (w/v) xylene cyanol (Sigma-Aldrich), 25% (v/v) glycerol 
(Sigma-Aldrich), 1% (w/v) sodium dodecyl sulphate (SDS; Sigma-Aldrich), 150 mM 
(w/v) EDTA (pH 8.0), dissolved in distilled water and stored at room temperature] on a 
parafilm sheet, before loading the sample solution into the wells. Six μL of marker 
(GeneRuler 1 kbp DNA ladders; MBI Fermentas, Germany) was loaded in one of the 
wells for a competitive molecular weight determination of the DNA. Electrophoresis 
was carried out for 1 h and 15 min at 60 V or until the tracking dye had travelled to the 
bottom of the agarose gel. Following electrophoresis, the DNA banding patterns on the 
agarose gel were immediately observed by an ultraviolet transilluminator (UV Products, 
Cambridge, Great Britain). Photographic records were taken immediately on a gel 
documentation unit (Amersham Biosciences).     
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2.4.8.3 PCR amplification 
Partial sequencing of the 16S rDNA genes (>925 bp) of new isolates was carried out 
essentially as described by Orozova et al. (2009), after the 16S rDNA gene was 
amplified by PCR with oligonucleotide primers 27f (5′-
AGAGTTTGATCMTGGCTCAG-3′) and 1492r (5′-
TACGGYTACCTTGTTACGACTT-3′). These are effective for most Gram-positive 
bacteria (Lane 1991). The amplification mixture (50 μL) was prepared in a sterile 0.2 
mL PCR tube (Greiner, Stonehouse, Great Britain) with 30.7 μL of sterile Milli-Q water 
(Milli-Q purification system, Millipore, Watford, Great Britain), 10.0 μL of Taq-dNTPs 
buffer mix [i.e. 100 μL 10× PCR buffer (Biomix; Bioline, London, Great Britain); 2 μL 
each of 100 mM dATP, dTTP, dGTP and dCTP (Sigma-Aldrich); 92 μL Milli-Q water], 
2.0 μL of 50 mM magnesium chloride (MgCl2; Bioline), 2.5 μL (5 pmol μL−1) of each 
primers 27f and 1492r (MWG Biotech, Ebersberg, Germany) and 2.0 μL of DNA 
template, and centrifuged for a few seconds. A control contained 2 μL of sterile Milli-Q 
water instead of DNA. PCR amplification was carried out on a Bio-Rad iCycler (version 
3.021; Hercules). Template DNA was initially denatured at 95°C for 5 min and the 
machine paused for the addition of 0.3 μL Taq polymerase (BIOTAQ, Bioline), 
followed by 30 cycles of denaturation at 95°C for 1 min, annealing at 56°C for 1 min, 
extension at 72°C for 1 min and an extra extension step at 72°C for 10 min, and a 
completion holding temperature of 4°C. The integrity of the PCR products was assessed 
by the development of single bands following gel electrophoresis as previously 
described, whilst ensuring that the control sample gave no banding patterns as a result 
of contamination.  
 
2.4.8.4 Sequencing of PCR products  
Prior to sequencing, the 16S rDNA fragment obtained from the PCR was subjected to 
polyethylene glycol precipitation (Embley 1991). Purified PCR products (2−10 μL 
depending on the brightness of the band) in duplicate microfuge tubes were dried in the 
vacuum-drier for 30 min and sent for DNA sequence analysis to MWG Biotech with 
sequencing primers 27f (5′-AGAGTTTGATCMTGGCTCAG-3′) and 685r3 (5′-
TCTRCGCATTYCACCGCTAC-3′) (10 pmol μL−1; MWG Biotech). The derived 
nucleotide sequences were analyzed and aligned with the STADEN package (Staden 
1996). The corrected 16S rDNA gene sequences were compared with those in the 
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GenBank databases (www.ncbi.nlm.nih.gov/blast) by using the BLASTN program 
(Version 2.2.12).  
 
2.5 Survival of probiotics on feed 
The viability of probiotics SM1 and SM2 in the feed was determined by means of the 
total viable counts on TNA plates following storage of the probiotic-supplemented diets 
(~108 cells g−1) either at 4°C or room temperature for 1 month. For this, 1 g amounts of 
feed were homogenized in 9 mL volumes of saline (see Section 2.4.4) and 10-fold 
dilutions prepared to 10−6 in fresh saline, before 0.1 mL volumes were spread over TNA 
plates. Colony counts were determined after incubation at room temperature for 7 days 
(Brunt and Austin 2005). 
 
2.6 Effective feeding dose of the probiotics 
The effective dose of SM1 and SM2 was determined by using feeds containing 105, 106, 
107, 108 and 109 cells g−1 feed. Groups of 20 rainbow trout were fed three times daily for 
14 days and then challenged i.p. with V. anguillarum or V. ordalii and monitored for 
mortalities over 14 days (Brunt and Austin 2005), as before. 
 
2.7 Effective feeding duration of probiotics 
Studies with probiotics to date have employed different feeding durations, for example 
1–8 weeks feeding regimes, leading to improved disease resistance in farmed fish 
(Robertson et al. 2000; Brunt et al. 2007; Aly et al. 2008; Pan et al. 2008; Son et al. 
2009), but the basis for choosing these periods is often unclear. Therefore, optimal 
probiotic feeding duration for sustaining the maximum level of disease protection in 
rainbow trout against Vibrio infections was determined. Thus, groups of rainbow trout 
were fed three times a day for up to 4 weeks with diets supplemented with SM1 (~108 
cells g−1) or control diets. During this feeding regime, sub-groups of 20 fish were 
removed at weekly intervals to challenge i.p. with V. anguillarum, and mortalities were 
recorded daily over 2 weeks and the RPS was calculated, as before. Additional sub-
groups of 10 fish were sampled weekly for immunological assays.    
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2.8 Synergistic effects of probiotics  
The hypothesis about synergistic effects on health, i.e. improvement or prolongation of 
the desirable effects (Timmerman et al. 2004) from using mixtures of probiotic bacteria 
(= either multistrain or multispecies formulations that may complement each other) was 
investigated. Thus, groups of 60 rainbow trout were kept under feeding regimes either 
containing an equi-mixture of SM1 (5 × 107 cells g−1) and SM2 (5 × 107 cells g−1) or 
control diets three times daily for 14 days. Then, fish were challenged i.p. with V. 
anguillarum or V. ordalii, and monitored for mortalities over 14 days, and the RPS was 
calculated. As before, sub-groups of fish were used for immunological assays.   
 
2.9 Long-term beneficial effects of probiotics  
It is argued that the fish immune system lacks memory (see Ortuño et al. 2002), and as 
such the duration of probiotic induced beneficial responses, which are primarily 
mediated by innate immunity (Brunt and Austin 2005; Kim and Austin 2006a; Brunt et 
al. 2007) may inevitably be shorter than that of the specific immune responses. 
Therefore, the duration of disease protection in rainbow trout after feeding with 
probiotics was determined. Groups of rainbow trout were fed three times daily for 2 
weeks with SM1 supplemented or control diets, as before. Then, fish were switched to 
standard commercial diet for up to 5 weeks. During the withdrawal period of dietary 
probiotics, two groups of 20 fish were removed at weekly intervals to challenge with V. 
anguillarum and an additional 10 fish were used for immunology. The groups of control 
and treated fish were observed daily for 2 weeks, and the RPS was calculated. 
 
2.10 Efficacy of the cellular components of probiotics  
The efficacy of sub-cellular components of the probiotics to confer host protection was 
evaluated. Thus, groups of 15 rainbow trout were inoculated i.p. with 0.1 mL volumes 
of 2.0 ± 0.5 mg mL−1 extracellular proteins (ECPs), cell wall proteins (CWPs) and 
whole cell proteins (WCPs) derived from SM1 and SM2, or with phosphate-buffered 
saline (PBS; Sigma-Aldrich) as control. Then, fish were maintained with control diet, 
before challenge with V. anguillarum and sampled for immunology on day 8. As before, 
mortalities were recorded daily over 14 days and the RPS was calculated. 
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Before inoculation into fish, the concentration of total protein present in the cellular 
components, which were dissolved in PBS (see Section 2.11), were measured with 
BioAssay Systems (Hayward, CA, USA) QuantiChrom™ protein assay kit (QCPR-
500). Thus, standard [Bovine serum albumin (BSA)] and samples were diluted in PBS 
according to the manufacturer’s instructions. An aliquot (10 µL) of diluted standard and 
samples were transferred into wells of flat bottom 96-well plates (Nalge Nunc, 
Loughborough, Great Britain). Then, 200 µL of working reagent, which was supplied 
with the kit, was added to each well and mixed gently. The intensity of colour obtained 
was measured at OD620 in a microplate absorbance reader (Sunrise; Tecan, Reading, 
Great Britain). The OD value of a blank was deducted from the OD of standard, and 
plotted against the protein concentrations of standard to produce the standard curve. 
Then, the OD values of the samples were plotted onto the standard curve to obtain the 
protein concentration in the sample. If necessary, the proteins were re-diluted in PBS to 
achieve the required concentration (= 2 mg mL−1) and stored at −20°C for subsequent 
use.   
 
2.11 Preparation of sub-cellular proteins  
2.11.1 Upscaling of probiotic cultures 
A loopful of SM1 or SM2 from a TNA plate was inoculated into 10 mL of TNB and 
incubated overnight at 26°C. Then, cultures were inoculated at a 1:100 dilution in TNB 
and incubated (18 h, 26°C) on a shaker at 4 × g. These cultures were used to prepare the 
sub-cellular proteins.  
 
2.11.2 Collection of extracellular proteins (ECPs) 
ECPs were separated essentially as described by Barbey et al. (2009) with slight 
modifications. Briefly, bacterial cells were removed by centrifuging at 20,000 × g for 
30 min at 4°C (Avanti J-26 XP centrifuge; Beckman Coulter, Brea, CA, USA) and the 
supernatants were filtered through a 0.22 μm porosity filter (Millex-GS; Millipore, 
Cork, Ireland). Then a final concentration of 10% (w/v) trichloroacetic acid (TCA; 
Sigma-Aldrich) was added to the supernatant, mixed well (1 min vortex) and placed in 
an ice bath for 3 h. The mixture was transferred to a 1.5 mL capacity Eppendorf tube, 
the precipitated proteins were harvested by centrifugation (20,000 × g, 30 min) at 4°C 
using a microcentrifuge (Microfuge 22R centrifuge; Beckman Coulter), the pellet was 
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washed four times with 1 mL of cold methanol (BDH), and dried in a ~95°C heat block 
for 5–10 min to drive off the residual methanol. Finally, the pellet was washed twice 
with PBS and redissolved in PBS.   
 
2.11.3 Separation of cell wall proteins (CWPs) 
The modified method of Abbass et al. (2010) was used. Thus, suitably upscaled 
bacterial cultures were centrifuged (2,200 × g, 15 min, 4°C) in a Mark IV refrigerated 
centrifuge (Baird Tatlock), and the cell pellets were resuspended in 0.5 mM NaCl and 
washed twice with 0.05 M Tris-HCl buffer (Sigma-Aldrich), pH 7.8. Then, the cells 
were resuspended to 20 mL with 0.05 M Tris-HCl (pH 7.8) containing protease 
inhibitor, 1 mM phenylmethylsulphonyl fluoride (PMSF; Sigma-Aldrich), and disrupted 
by sonication (6 × 5 min; after each 5 min sonication the sample was incubated for 
4 min in ice) on ice with a sonicator (MSE ultrasonic power unit; MSE, London, Great 
Britain). Cell disruption was checked by microscopy. The sonicated product was 
centrifuged (2,200 × g, 5 min, 4°C) to remove cell debris and the cell-walls were 
separated by centrifugation (20,000 × g, 30 min) of the supernatant at 4°C. The pellet 
was resuspended in 100 mM NaCl, washed twice in PBS and suspended in the same 
buffer.  
 
2.11.4 Preparation of whole cell proteins (WCPs) 
The WCPs were prepared according to Abbass et al. (2010) with slight modification. 
The cells were collected by centrifugation (2,200 × g, 15 min, 4°C), the cell pellets were 
collected and resuspended with 0.5 mM NaCl, washed twice with Milli-Q water, then 
resuspended in Milli-Q water containing 1mM PMSF and frozen at −20°C. Cells in 
suspension were thawed and disrupted by sonication on ice for 6 × 5 min, mixed with 
equal volumes (v/v) of lysis buffer [4 g  SDS, 20 mL  glycerol, 10 mL  β-
mercaptoethanol (Sigma-Aldrich) and 12.5 mL 0.5 M Tris-HCl (pH 6.8) per 100 mL of 
Milli-Q water] and kept on ice for 30 min. The supernatant was collected following 
centrifugation and contains the WCPs. Precipitation of proteins was done following the 
methanol-chloroform method (Wessel and Flugge 1984). Briefly, 0.4 mL  methanol 
(BDH) was added to 0.1 mL lysate, vortexed well, then 0.1 mL  chloroform (BDH) was 
added, and vortexed again before addition of 0.3 mL distilled water. The mixture was 
vortexed and spun for 2 min at 8,950 × g at 4°C. The top aqueous layer was carefully 
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removed and 0.3 mL of methanol added, vortexed and centrifuged (8,950 × g, 5 min, 
4°C) to pellet the proteins. The protein pellet was air dried and suspended in PBS. 
 
2.11.5 Electrophoresis 
One-dimensional denaturing sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE) separation of soluble protein fractions in ECPs, CWPs and 
WCPs extracts was carried out according to Laemmli (1970). Briefly, concentrated 
proteins (~1 mg mL−1) were measured as before (see Section 2.10), mixed 1:1 with 2× 
Laemmli sample buffer [2.5 mL  0.5 M Tris-HCl (pH 6.8), 2 mL  glycerol, 4 mL  10% 
SDS, 0.31 g  dithiothreitol (DTT, Sigma-Aldrich), 0.04%  bromophenol blue; make up 
to 10 mL with distilled water], boiled at ~100°C for 10 min in a heating block, and 
loaded (10–30 μL protein sample well−1) into Tris-HCl-SDS gels with 4% (w/v) 
polyacrylamide  stacking, and 10% (for ECPs and WCPs) or 12% (w/v) polyacrylamide 
separating (= resolving) gels. Also, 10 μL of prestained molecular-mass standards (Bio-
Rad, Hemel Hempstead, Great Britain) were loaded in one lane on all gels. The 
resolving gel solutions (20 mL) contained 70 μL of 10% ammonium peroxodisulphate 
(APS; Sigma-Aldrich) and 15 μL of N,N,N',N'-tetramethylethylenediamine (TEMED; 
Sigma-Aldrich), whereas stacking gels (10 mL) contained 50 μL 10% APS and 10 μL 
TEMED. Electrophoresis was carried out in a Mini Protean II electrophoresis chamber 
(Bio-Rad) for ~1.5 h at 150 V constant voltage, in running buffer [12.0 g  Tris, 57.6 g  
glycine (Sigma-Aldrich), 2.0 g  SDS; made up to 2.0 L with distilled water] at room 
temperature. After the electrophoretic separation, protein bands were visualized by 
staining the gel for 1 h with brilliant blue G solution (Sigma-Aldrich) followed by 
destaining in methanol-acetic acid-water solution (40:10:50) for 3 h. Densitometry of 
gels was performed with the aim of assigning relative molecular masses to the ECPs, 
CWPs and WCPs separated bands. Protein bands were digitally imaged using a Canon 
CanoScan 3000F scanner (Canon, Lake Success, NY, USA).  
 
2.12 Innate immune response 
Immunological assays (5 or 10 fish group−1) were involved with blood, serum or head 
kidney (HK) macrophages. Prior to sampling, fish were anesthetized with 0.01% MS-
222 and individual fish were sampled once to avoid multiple bleeding and/or handling 
stress, which may lead to an influence on the assays. 
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2.12.1 Samples for immunology 
Blood was collected by venepuncture using syringes coated with heparin (Sigma-
Aldrich) and transferred immediately into 9 mL capacity lithium heparin vacuettes 
(Greiner) on ice. For serum, the blood was transferred into vacuettes containing Z 
Serum Clot Activator (Greiner) and allowed to clot at 4°C for 4 h. The sera were 
separated by centrifugation (2,000 × g for 25 min at 4°C) and stored at −70°C until 
required.  
 
Head kidney (HK) macrophages were isolated largely according to the method of 
Secombes (1990). Thus using aseptic techniques, the anterior HK was removed, placed 
into a glass homogenizer (30 mL capacity; VWR-Jencons, East Grinstead, Great 
Britain) containing 5 mL of L-15 medium (Sigma-Aldrich), crushed and passed through 
a 100-μm nylon mesh into a Petri dish. The mesh was rinsed with additional 1 mL 
quantities of L-15 medium. The resulting cell suspension was slowly layered onto a 
51% Percoll cushion [51 mL Percoll (Sigma-Aldrich), 10 mL 10% Hank’s balanced salt 
solution (HBSS; Sigma-Aldrich), 39 mL sterile distilled water] and centrifuged at 400 
× g for 30 min at 4°C. The band of cells lying at the medium/Percoll cushion interface 
was collected with a Pasteur pipette and washed twice with L-15 medium by 
centrifugation at 800 × g for 10 min. The number of cells was adjusted to ~106 cells per 
mL (by microscopy and use of a haemocytometer slide) in fresh L-15 medium 
supplemented with 0.1% (v/v) foetal bovine serum (FBS; Sigma-Aldrich) and 
10 μL mL−1 of heparin (Sigma-Aldrich). Cell viability was determined at ×400 
magnification of preparations containing equal mixtures of the cell suspension and 0.4% 
(w/v) aqueous trypan blue solution (Sigma-Aldrich). Dead cells developed an 
intracellular blue coloration within 5 min. 
 
2.12.2 Cellular immune parameters 
2.12.2.1 Macrophage phagocytosis  
Phagocytic activity of HK macrophages was determined spectrophotometrically 
involving the measurement of stained yeast cells that had been phagocytosed 
(internalization of yeast) by cells (Seeley et al. 1990). Briefly, 1 mL of macrophage 
suspension (~106 cells mL−1) was mixed with 2 mL of Congo red-stained yeast cells 
(yeast cell: macrophage ratio of 30:1) in microfuge tubes. Following incubation at room 
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temperature for 1 h, 1 mL ice-cold HBSS was added and 1 mL of histopaque (density of 
1.077 g mL−1, Sigma-Aldrich) was injected by a syringe into the bottom. The samples 
were centrifuged at 850 × g for 5 min to separate macrophages from free yeast cells. 
Macrophages located at the medium/histopaque interface were harvested with a Pasteur 
pipette and washed twice in HBSS. The cells were then resuspended in 1 mL trypsin-
EDTA solution (5 g L−1 trypsin and 2 g L−1 EDTA, Sigma-Aldrich) and incubated at 
37°C overnight. The OD of the samples was measured at 510 nm with a 
spectrophotometer (Spectronic Genesys 20, Thermo Electron Corporation, Town, 
Country) using trypsin-EDTA as a blank.  
 
Yeast cells (Saccharomyces cerevisiae) were prepared as described previously (Walsh 
and Luer 1998) by staining 1 g dry yeast (NT 116, Anchor Bio-Technologies, Cape 
Town, South Africa) with 3 mL of 0.87% (w/v) Congo red (Sigma-Aldrich) in PBS, 
mixed thoroughly and incubated for 15 min at room temperature. Then 7 mL of PBS 
was added to the mixture, vortexed, and inactivated at 121°C 15 min−1. These cells were 
washed three times in HBSS, the concentration adjusted to ~3 × 107 cells mL−1 and 
stored at 4°C until use. 
 
2.12.2.2 Respiratory burst activity  
Intracellular respiratory burst activity of HK macrophages was detected from the 
reduction of nitroblue tetrazolium (NBT; Sigma-Aldrich) to formazan as a measure of 
superoxide anion (O2−) production (Secombes 1990). Thus, 100 μL of macrophages was 
pipetted into the wells of ‘U’ bottom microtitre plates (Nalge Nunc) and centrifuged at 
700 × g for 20 min. The supernatant was removed, and the wells were washed with L-
15 medium. Then, 100 μL of NBT (1 mg mL−1 in L-15 medium) and 100 μL of phorbol 
12-myristate 13-acetate (Sigma-Aldrich) dissolved at 1 μg mL−1 in dimethyl sulphoxide 
(DMSO; Sigma-Aldrich) was added with incubation for an hour at room temperature. 
The medium was removed, and the cells were fixed with 100% (v/v) methanol for 2–
3 min and again washed twice with 70% (v/v) methanol. The plate was then air dried at 
room temperature before 120 μL of 2 M potassium hydroxide (KOH; Sigma-Aldrich) 
and 140 μL of DMSO were added to each well to dissolve the resulting formazan blue 
crystals. The OD was read in a microplate reader at 620 nm against a KOH/DMSO 
blank.  
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Parallel experiments using whole blood were also carried out to evaluate the respiratory 
burst activity as described previously (Pieters et al. 2008). Thus, 50 μL of blood was 
pipetted into the wells of ‘U’ bottom microtitre plates (Nalge Nunc) and incubated for 
1 h at room temperature to facilitate adhesion of the cells. The supernatant was gently 
removed and the adhered cells were washed three times with PBS. After washing, 50 μL 
of 0.2% (w/v) NBT in PBS was added to the wells and incubated for an hour at room 
temperature. The supernatant was removed, and the cells were fixed with 100% (v/v) 
methanol for 3 min, and then washed three times with 30% (v/v) methanol. The plates 
were air-dried before 60 μL of 2 M KOH and 70 μL DMSO were added to each well to 
dissolve the formazan blue crystals. The OD of the resulting solution was read in a 
microplate reader at 550 nm against a KOH/DMSO blank. 
 
2.12.2.3 Macrophage peroxidase  
The total peroxidase content present inside HK macrophages was measured as described 
previously (Salinas et al. 2008). In brief, ~106 cells mL−1 macrophage suspension were 
lysed with 0.002% cetyl trimethylammonium bromide (CTAB; Sigma-Aldrich) for 
5 min in microfuge tubes. After centrifugation (400 × g, 10 min), 150 μL of the 
supernatants were transferred to a 96-well microtitre plate (Nalge Nunc) containing 
freshly prepared peroxidase substrate, i.e. 25 μL of 10 mM 3,3′,5,5′-
tetramethylbenzidine hydrochloride (TMB; Sigma-Aldrich) and 25 μL of 5 mM H2O2 
(Sigma-Aldrich). The colour-developing reaction was stopped after 2 min by adding 
50 μL of 2 M sulphuric acid (H2SO4; BDH) and the OD was read at 450 nm in a 
microplate absorbance reader. Blank samples without macrophages were also analysed. 
 
2.12.2.4 Bacteriocidal activity  
The bacteriocidal activity of HK macrophages was examined using the method of 
Secombes (1990). Briefly, 100 μL of HK cell suspension (~106 cells mL−1) was added 
to ‘U’ bottom 96-well microtitre plates and centrifuged at 700 × g for 20 min. The 
supernatant was removed, the macrophage monolayer washed off with L-15 and 
resuspended with 100 μL L-15 containing 5% FBS. Overnight cultures of 
V. anguillarum and V. ordalii in TNB were centrifuged, and the cell pellet washed and 
suspended in saline, before adjusting to ~106 cells mL−1 using counts obtained with a 
haemocytometer. Then, 20 μL of the bacterial suspension was added to triplicate wells 
containing macrophages or medium only and centrifuged at 150 × g for 5 min to bring 
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the bacteria into contact with the cells. The plate was incubated at 22°C for 0 and 5 h to 
allow killing activity. At the end of the incubation period, the killing was stopped by 
lysing the macrophages with the addition of 50 μL Tween-20 [0.2% (v/v) in distilled 
water] per well. Then 100 μL of TNB was added and surviving bacteria allowed to grow 
overnight at 22°C. The amount of bacteria existing in the wells was determined by 
addition of 10 μL 5 mg mL−1 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT; Sigma-Aldrich), shaking the plate and reading the OD at 620 nm 
15 min later. The data were converted to a killing index (KI): KI = OD Time5h/OD 
Time0h. The lower the index, the more bacteria had been killed. 
 
2.12.2.5 Number of erythrocytes and leucocytes  
Unclotted blood was used to determine the number of erythrocytes and leucocytes using 
flow cytometry after Newaj-Fyzul et al. (2007). Thus, a staining solution 3,3'-
dihexyloxacarbocyanine [DiOC6(3); Sigma-Aldrich] was prepared in absolute ethanol 
to 500 μg mL−1 and held in the dark. This stock solution was diluted tenfold in HBSS 
immediately prior to use. Then, 5 μL of freshly obtained blood was added to triplicate 
test tubes, each containing 790 μL of HBSS, 5 μL of DiOC6(3) dye solution and 5 μL of 
heparin. These were mixed gently and incubated at room temperature for 2 min. Blood 
cells were analysed with a flow cytometer (Cyflow SL; Partec, Münster, Germany). 
Forward scatter (FSC), side scatter (SSC) and green fluorescence (FL-1) of each cell 
was measured. All data were acquired using the Flomax (Partec) software package and 
analysed with WINMDI 2.8 (Windows Multiple Document Interface for Flow 
Cytometry: J. Trotter).  
 
2.12.2.6 Leukocrit value  
In a parallel experiment, responses for white blood cells were studied by measurement 
of the leukocrit value. Thus, blood was drawn into heparinized microhaematocrit tubes 
(1.15 × 1.15 × 75 mm; Hawksley, Lancing, Great Britain) by capillary action, the ends 
of the tubes sealed and centrifuged in a haematocrit centrifuge (MSE, London, Great 
Britain) for 5 min at 12,000 × g. The leukocyte layer, i.e. the whitish buffy coat above 
packed red cells, was measured, and the leukocrit value was defined as the percentage 
of the leukocyte layer height against total blood volume inside the tube. The 
measurements were performed on a microhaematocrit reader (MSE).   
Chapter 2 – Materials and methods 
53 
2.12.3 Humoral immune parameters 
2.12.3.1 Serum lysozyme  
A turbidometric assay using lyophilized Micrococcus lysodeikticus (Sigma-Aldrich) 
was followed to determine the lysozyme activity in serum as described by Ellis (1990). 
Thus, 2 mL of M. lysodeikticus at a concentration of 0.2 mg mL−1 (w/v) in 0.05 M 
sodium phosphate buffer, pH 6.2 (SPB; Sigma-Aldrich) was added to 100 μL of serum 
sample. As a negative control, SPB replaced serum. The decrease in OD was recorded 
at 530 nm after 1 and 5 min at 22°C. A unit of lysozyme activity was defined as the 
amount of serum causing a reduction in absorbance of 0.001 units min−1. 
 
2.12.3.2 Alternative complement activity 
The activity of the serum alternative complement pathway (ACH50) was examined by 
adapting the method of Giclas (1994) and using sheep red blood cells (SRBC; Oxoid) as 
targets. All reagents, cells and sera were kept on ice throughout this protocol unless 
otherwise mentioned. Briefly, SRBC in Alsevier’s solution were centrifuged at 400 × g 
for 10 min, pelleted and washed twice with ethyleneglycoltetraacetic acid (EGTA)-
Mg2+-gelatin/veronal buffer (GVB) [0.01 M EGTA (Sigma-Aldrich) and 0.01 M 
MgCl2.6H2O (Sigma-Aldrich) in gelatin/veronal-buffered saline (0.142 M NaCl, 0.01 M 
sodium 5,5'-diethyl barbiturate and 0.1% gelatin)] and finally resuspended in the same 
buffer to a concentration of ~4 × 108 cells ml−1. Seven serial 2-fold dilutions of test and 
control sera were prepared in ice-cold EGTA-Mg2+-GVB buffer, mixed well after each 
separate dilution step, before 100 μL of each dilution was transferred to duplicate tubes. 
In separate tubes, 100 μL EGTA-Mg2+-GVB buffer and 100 μL of distilled water were 
used as the background lysis and total lysis control. Then, 50 μL of SRBC suspension 
was added to each tube and incubated for 60 min at 21°C with occasional shaking to 
keep the cells in suspension. The haemolytic reaction was stopped by adding 1.2 mL of 
ice-cold 0.15 M NaCl (w/v) to each tube. The mixtures were centrifuged at 1,250 × g 
for 8 min at 4°C to spin down the remaining SRBC. The OD412 of each supernatant was 
measured after zeroing the spectrophotometer with water or EGTA-Mg2+-GVB. The 
degree of haemolysis (y), defined as the fraction of cells lysed, was calculated taking 
OD412 value for a given tube divided by the OD412 of the total lysis tube. On two-cycle 
log-log paper, the reciprocal of the serum dilution on the y axis against y/(1 − y) on the x 
axis was plotted. Values of y in the range of 0.1–0.9 were used for the calculation. The 
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best straight line between the points was drawn and the ACH50 read from the graph as 
the reciprocal of the dilution where y/(1 − y) = 1, corresponds to lysis of 50% of the 
cells (Kabat and Mayer plot: Mayer 1961). 
 
2.12.3.3 Serum antiproteases  
Total antiprotease activity was determined as indicated by the capacity of serum to 
inhibit trypsin activity (Ellis 1990; Magnadóttir et al. 1999). Briefly, 20 μL of serum 
was incubated with 20 μL of standard trypsin solution (1000–2000 BAEE, 5 mg mL−1; 
Sigma-Aldrich T-7409) for 10 min at 22°C in Eppendorf tubes. Then, 200 μL of 0.1 M 
PBS (pH 7.0) and 250 μL of 2% (w/v) azocasein (Sigma-Aldrich) in PBS were added, 
and incubated for 1 h at 22°C. The reaction was stopped by the addition of 500 μL of 
10% (v/v) TCA, incubated for 30 min at 22°C, and then centrifuged at 6000 × g for 
5 min. The supernatants (100 μL) were transferred to a 96-well microtitre plate (Nalge 
Nunc) containing 100 μL well−1 of 1 N sodium hydroxide (NaOH, BDH). The OD was 
read at 450 nm using a plate reader. For a positive (100%) control, buffer replaced the 
serum, and for a negative control, buffer replaced both serum and trypsin. The 
inhibitory ability of antiprotease was expressed in terms of percentage trypsin inhibition 
(Zuo and Woo 1997). 
100
ODTrypsin
ODSampleODTrypsininhibitionTrypsin% ×−=  
 
2.12.3.4 Serum bacterial killing 
The serum bacterial killing was performed according to Villamil et al. (2003), which 
was measured by comparing the growth of V. anguillarum in serum with that observed 
in TNB. Colonies of pathogen from TNA were grown in TNB for 24 h at 26°C. The 
culture was centrifuged at 2,500 × g for 20 min at 4°C, the cell pellet washed twice and 
resuspended in 0.9% (w/v) saline, and the concentration adjusted to ~108 cells mL−1, as 
before. For the assay, 33 μL of serum samples or TNB (control) were placed in wells of 
a 96-well microtitre plate. Then, 100 μL of bacterial suspension was added to each well, 
mixed with micropipette and incubated for 5 h at room temperature. The plate was 
centrifuged (10 min at 200 × g) in a Sigma 4K15 centrifuge (Newport Pagnell, Great 
Britain), the supernatant discharged and 100 μL of 0.5 mg mL−1 MTT was added to the 
wells. After 15 min of incubation in the dark, the plate was read at an OD of 620 nm 
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and the percentage of surviving bacteria was calculated [(OD620 of each sample ÷ OD620 
of control V. anguillarum) × 100].  
 
2.12.3.5 Serum peroxidase   
The total peroxidase content present in serum was calculated according to the reported 
method (Díaz-Rosales et al. 2006). Briefly, 15 μL of serum was diluted with 35 μL of 
Ca2+- and Mg2+-free HBSS (Sigma-Aldrich) in flat-bottomed 96-well microtitre plates 
(Nalge Nunc). Then, freshly prepared peroxidase substrate, i.e. 50 μL of 20 mM TMB 
and 50 μL of 5 mM H2O2 were added. Subsequently, the serum mixture (150 μL) was 
transferred from each well to new 96-well microtitre plates. The colour-developing 
reaction was stopped after 2 min by adding 50 μL of 2 M H2SO4 (BDH) and the OD was 
read at 550 nm in a microplate absorbance reader. Blank samples without serum were 
also recorded. 
 
2.12.3.6 Serum total immunoglobulin (Ig) 
The method of Siwicki and Anderson (1993) as described by Panigrahi et al. (2005) was 
followed to determine the total immunoglobulin level in serum. Thus, 100 μL of serum 
sample (100-fold dilutions in PBS) was mixed with an equal volume of 12% (v/v) 
solution of polyethylene glycol (10,000 MW, PEG; Sigma-Aldrich) and incubated for 2 
h at room temperature that helped in bringing down the Ig molecules. The Ig molecules 
were removed by centrifugation (5,000 × g, 4°C) and the protein content was 
determined as mentioned for total protein determination by the Bradford method 
(Section 2.15.1). This value was subtracted from the total protein level, which 
corresponds to the total Ig content and was expressed in mg mL−1.  
 
2.13 Growth performance of fish 
After the dietary intake of SM1 and SM2 supplemented feeds for 14 days, groups of 25 
fish were used to determine growth performance in terms of percentage weight gain, 
specific growth rate (SGR), feed conversion ratio (FCR), protein efficiency ratio (PER), 
hepato-somatic index (HSI) and spleen mass index (SMI). Uneaten feed pellets were 
collected from the tank bottom 30 min after each feeding and counted to estimate 
feed/protein intake.     
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Weight gain (%) = [(Wt−W0) ÷ W0] × 100 
SGR (% day−1) = [(lnWt− lnW0) ÷ (t−t0)] × 100 
where, W0 is the initial individual weight of fish 
Wt is the individual weight at time t  
t represents time in days 
FCR = Total feed consumed (g) ÷ Total wet weight gain of animal (g)  
Protein intake (PI) = [Feed intake (g) × percent protein in the diet]  
PER = [Total wet weight gain of animal (g) ÷ Total protein intake (g)] 
HSI = [Weight of liver (g) ÷ Weight of whole fish (g)] × 100 
SMI = [Weight of spleen (g) ÷ Weight of whole fish (g)] × 100 
 
2.14 Influence on digestive enzymes 
2.14.1 Crude enzyme sample 
After 14 days feeding with isolates SM1 and SM2, sub-groups of 10 fish were killed 
with an overdose of anesthetic 2 h after their last meal and dissected by keeping on ice 
plate. Then pyloric caeca, stomach and intestine with digesta in each fish were dissected 
immediately, and pooled tissues were homogenized in 20 volumes (v/w) of ice-cold 
PBS using a glass tissue grinder (30 mL capacity; VWR-Jencons) and then subjected to 
an ultrasonic cell disintegrator (Sonicator; MSE). The homogenates were centrifuged 
(10,000 × g, 30 min, 4°C) and the resultant clear supernatants were adjusted (or if 
needed diluted further) to a protein concentration of 1 mg mL−1 (after Bradford’s 
method) and stored at −20°C until used for enzyme assay. Many previous studies used 
empty intestine where the enzymes localized in mucus may be assayed. However, 
samples from digestive organs with digesta may contain a lot of diverted enzymes of the 
stomach, pancreas and intestine, which might be involved in a complex network to 
complete hydrolysis of ingested nutrients. Thus, the activities of the digestive enzymes 
in these samples may hold information more of the useful ones reflecting actual 
physiological conditions (Li et al. 2009).  
 
2.14.2 API ZYM assay 
Sixty five μL of supernatants were inoculated into each well of API enzyme substrate 
(Bio-Mérieux) and incubated for 4 h at 37°C. The reaction was determined from the 
colour development following incubation for 5–10 min after addition of 1 drop each of 
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reagents ZYM A and ZYM B at room temperature. The resulting colours were 
estimated under natural light and scored as 0–5, according to a colour scale supplied by 
the manufacturer (Bio-Mérieux).  
 
2.15 Changes in biochemical parameters 
2.15.1 Serum total protein, albumin and globulin  
The Bradford method was used for total protein assay (after Simonian and Smith 2006). 
For this, 100 μL of serum sample (100-fold dilutions in PBS) was placed into 
Eppendorf tubes, mixed with 1 mL of Bradford reagent (Sigma-Aldrich), vortexed and 
incubated for 2 min at room temperature. The OD was read at 595 nm using a 1 cm path 
length microcuvette (Fischerbrand, Loughborough, Great Britain). Separate tubes 
containing 100 μL of PBS and 1 mL of Bradford reagent served as blanks. Then, the 
OD of the unknown protein sample was plotted on a standard curve to calculate the 
protein concentration. The standard curve was obtained by plotting the OD against 
known protein concentrations ranging from 0.25 to 1.0 mg mL−1 of BSA in PBS. The 
total protein content in serum was also determined as described in Section 2.10 using a 
commercial kit. 
 
Albumin was measured by the bromocresol green binding method using BCP albumin 
assay kit (DIAP-250; BioAssay Systems) according to the manufacturer’s instruction. 
The intensity of colour obtained with the kit was measured at 620 nm, being directly 
proportional to the albumin concentration in the sample. The globulin content was 
calculated by subtracting albumin values from total serum protein.  
 
2.15.2 Serum haemoglobin (Hb), urea, creatinine and glucose   
Commercially available kits were used to determine the quantitative colorimetric 
concentrations of serum hemoglobin (DIHB-250, QuantiChromTM hemoglobin assay; 
BioAssay Systems), urea (DIUR-500, QuantiChromTM  urea assay; BioAssay Systems) 
and creatinine (DICT-500, QuantiChromTM  creatinine assay; BioAssay Systems), 
respectively. The serum glucose concentration was measured enzymatically using the 
Glucose Hexokinase Reagent SetTM method (Pointe Scientific). 
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2.16 Statistics 
Each experiment was replicated three times within the experiment and the complete 
experiment was performed in triplicate, unless otherwise specified. The results were 
presented as mean ± SD (standard deviation of the mean), and were statistically 
analysed by one-way analysis of variance (ANOVA) and Duncan’s comparison of means 
when necessary. Percentage data and ratio values were transformed to square-root 
arcsine values to homogenize variance. All statistical tests were conducted using the 
computerized software Statistical Package for Social Sciences (SPSS; Release 14.0, 
SPSS, Chicago, IL, USA). Differences were considered statistically significant when P 
< 0.05. The data were plotted using the program Microsoft Excel (Microsoft Co., Seattle 
WA).  
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3.1 The development of probiotics 
3.1.1 Isolation and selection of candidate probionts 
The intestinal content of rainbow trout and Atlantic salmon were used as a source of 
potential probiotics, with the recovery of average viable bacterial counts of 5.4 
± 0.8 × 106 from 1.0 g quantities of the intestinal contents on TSA. The majority of the 
colonies were milky white/cream, smooth and round, although a comparatively few 
were yellow and orange in colour. Ninety representatives of the various colony types 
were examined for antagonistic activity against V. anguillarum and V. ordalii by cross 
streaking.  
 
Table 3.1 The inhibitory properties and effects of the bacterial isolates on rainbow 
trout. 
 Inhibitory activity to:  
No. of mortalities or sign of disease 
in fish following i.p./i.m. injection 
Isolate 
reference no.
 V. anguillarum V. ordalii  i.p. (n = 5) i.m. (n = 5) 
SL2  + +/−  4 4 
SL6  + +  0 0 
SL7  + +  0 0 
SL12  + +  0 0 
RT2  + +  0 0 
SM1  + +  0 0 
RT6  + +/−  2 4 
RT7  + +  4 3 
RT8  + +  3 2 
RT12  + +  0 0 
RT16  + +  0 0 
RT20  + +  2 4 
RT25  + +  4 3 
SM2  + +/−  0 0 
RT29  + +  0 0 
SM3  + +  0 0 
SM4  +/− +  4 0 
+ (overgrowth); +/− (slight overgrowth) 
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Initially, 17 out of 90 bacterial isolates (= ~19% of the total) were selected due to their 
inhibitory properties, either by overgrowing or interrupting the growth of pathogens 
(Table 3.1). The putative probionts were then assessed for the lack of pathogenicity in 
rainbow trout following challenge via the i.p. or i.m. routes with 0.1 mL suspensions 
containing ~108 cells fish−1. Subsequently, 10 isolates were recognized to be harmless to 
the fish as there was not any sign of any pathological effects or mortalities after 
injection (Table 3.1). In the next experiments, these cultures were applied to diet at ~5 × 
107 cells g−1 and fed to groups of fish to determine palatability. Overall, the fish 
accepted the modified diets and displayed a better feeding response (= stimulated 
appetite) than the controls. However, in a few cases the fish initially did not eat well, 
although with time the situation improved and the feed was consumed well.       
 
3.1.2 Resolution of LD50 of the pathogen 
The medium lethal doses (LD50) of the two pathogens were determined to be 0.1 mL of 
3 × 105 and 5 × 104 cells mL−1 per fish for V. anguillarum and V. ordalii, respectively. 
The mortalities were monitored for 14 day post-challenge. 
 
Table 3.2 Percent mortality (%) and RPS1 of rainbow trout fed with putative probiotics 
for 14 days following i.p. challenge with V. anguillarum or V. ordalii. 
Fish challenged i.p. with: 
V. anguillarum  V. ordalii 
Bacterial 
culture 
No. of fish 
Mortality (%) RPS  Mortality (%) RPS 
SL6 20 60 25  70 22 
SL7 20  70 13  90 0 
SL12 20 90 0  90 0 
RT2 20 80 0  50 44 
SM1 20 20 75  30 67 
RT12 20 80 0  50 44 
RT16 20 80 0  70 22 
SM2 20 30 63  30 67 
RT29 20 70 13  50 44 
SM3 20 60 25  100 0 
Control 20 80 –  90 – 
1Relative percent survival as described by Amend (1981) 
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3.1.3 In vivo evaluation of putative probiotics 
In preliminary small-scale experiments, groups of fish were fed with ten putative 
probionts in diets (~5 × 107 cells g−1) to satiation for 14 days, and then challenged i.p. 
with V. anguillarum or V. ordalii. From this preliminary work, two cultures, i.e. SM1 
and SM2, which were isolated from rainbow trout, were determined to be potentially 
beneficial against vibriosis showing a RPS value of 63–75% (Table 3.2), and were 
evaluated further. 
 
3.2 Characterization and identification of bacterial isolates     
3.2.1 Morphological characteristics 
SM1 comprised non-motile, Gram-positive cocci which developed yellow raised 
colonies. In comparison, SM2 comprised non-motile, Gram-positive rods which 
developed orange raised colonies (Figure 3.1; Table 3.3).   
 
          
Figure 3.1 Colony morphology of probiotics – SM1 showing the presence of yellow 
colonies (A) and SM2 developed orange colonies (B) on TNA. Motility, which was 
determined by culturing bacteria on semi-solid agar plates following the measurement 
of the diameter of swimming zones. SM1 was non-motile (C); V. anguillarum was 
included as a positive control (D).    
 
Table 3.3 Morphological characteristics of SM1 and SM2.    
Character SM1                           SM2 
Colony colour Yellow Orange 
Cell shape Cocci (round, smooth) Rod (round, smooth) 
Colony size 1–2 mm diameter 1–2 mm diameter 
Texture Viscous Viscous 
Motility – – 
Gram staining reaction + + 
A B C D 
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3.2.2 Biochemical characteristics 
Classical phenotypic tests were performed using the API 20E and 20NE system (Table 
3.4), but neither of the isolates could be identified using the manufacturer’s database. 
However, by using the diagnostic tables in Cowan and Steel (2003), SM1 and SM2 
were tentatively identified as Micrococcus sp. and Corynebacterium sp., respectively.  
 
Table 3.4 Biochemical characteristics of SM1 and SM2.    
Biochemical test SM1 SM2  Biochemical test SM1 SM2 
Oxidase – –  *Catalase ++ + 
API 20E:    API 20NE:   
β-galactosidase + +  Potassium nitrate + – 
Arginine dihydrolase – –  Tryptophan – – 
Lysine decarboxylase – –  Glucose – – 
Ornithine decarboxylase – –  Arginine – – 
Citrate utilization – +  Urea + + 
H2S production – –  Aesculin – – 
Urease production + +  Gelatin + – 
Tryptophan deaminase – –  **pNPG  + + 
Indole production – –  Glucose – – 
Voges-Proskauer reaction – –  Arabinose – + 
Gelatinase production – –  Mannose – + 
Glucose – –  Mannitol – + 
Mannitol – –  N-acetyl-glucosamine – + 
Inositol – –  Maltose + – 
Sorbitol – –  Gluconate – + 
Rhamnose – –  Caprate – – 
Saccharose – –  Adipate + – 
Melibiose – –  Malate + + 
Amygdalin – –  Citrate – + 
Arabinose – –  Phenyl-acetate + + 
*Catalase: ++ (average); + (weak); **p-nitrophenyl-β-D-galactopyranoside 
Chapter 3 – Results 
63 
3.2.3 Physiological characteristics 
SM1 and SM2 were able to grow between 4 and 37°C on TNB. Cell multiplication was 
also seen at 45°C for SM1 but not for SM2. Both isolates grew at pH 2–11 and in 0–
20% (w/v) NaCl (Table 3.5).  
 
Table 3.5 Physiological characteristics of the isolates. 
Character SM1                           SM2 
Growth temperature:   
4°C + + 
15°C + + 
26°C + + 
37°C + + 
45°C + – 
Salinity tolerance:   
0% (w/v) NaCl + + 
2% (w/v) NaCl + + 
4% (w/v) NaCl + + 
6% (w/v) NaCl + + 
8% (w/v) NaCl + + 
10% (w/v) NaCl + + 
15% (w/v) NaCl + + 
20% (w/v) NaCl + + 
pH tolerance:   
2 + + 
3 + + 
4 + + 
5 + + 
6 + + 
7 + + 
8 + + 
9 + + 
10 + + 
11 + + 
Growth was recorded as positive (+), and no growth was recorded as negative (−). 
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Table 3.6 Results of the API-ZYM tests for SM1 and SM2.  
2Enzyme activity of strain:  
Enzyme assayed for: 1Substrate 
SM1 SM2 
Control – – – 
Glycosidases:    
α-galactosidase a 0 5 
β-galactosidase b 1 5 
β-glucoronidase c 0 0 
α-glucosidase d 0 2 
β-glucosidase e 0 0 
N-acetyl-β-glucosaminidase f 0 0 
α-mannosidase g 0 0 
α-fucosidase h 0 0 
Peptide hydrolases:    
Leucine arylamidase  i 2 3 
Valine arylamidase  j 1 1 
Cystine arylamidase  k 1 0 
Trypsin l 0 1 
Chymotrypsin m 0 0 
Ester hydrolases:    
Esterase (C4) n 1 1 
Esterase Lipase (C8) o 2 2 
Lipase (C14) p 0 2 
Phosphohydrolases:    
Alkaline phosphatase q 1 0 
Acid phosphatase r 0 1 
Naphthol-AS-BI-phosphohydrolase s 1 2 
1Substrate: a6-Br-2-naphthyl-αD-galactopyranoside; b2-naphthyl-βD-galactopyranoside; 
cNaphthol-AS-BI-βD-glucuronide; d2-naphthyl-αD-glucopyranoside; e6-Br-2-naphthyl-βD-
glucopyranoside; f1-naphthyl-N-acetyl-βD-glucosamide; g6-Br-2-naphthyl-αD-
mannopyranoside; h2-naphthyl-αL-fucopyranoside; iL-leucyl-2-naphthylamide; jL-valyl-2-
naphthylamide; kL-cystyl-2-naphthylamide; lN-benzoyl-DL-arginine-2-naphthylamide; mN-
glutaryl-phenylalanine-2-naphthylamide; n2-naphthyl butyrate; o2-naphthyl caprylate; p2-
naphthyl myristate; q2-naphthyl phosphate; r2-naphthyl phosphate; sNaphthol-AS-BI-
phosphate. 
2Numbers indicate the relative magnitude of enzyme activity. 
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3.2.4 Enzymatic profile 
Table 3.6 lists the enzymatic activities determined by use of API ZYM. SM1 was 
completely negative for carbohydrase activities, except for β-galactosidase production. 
Moreover, protease activities were weak with no activity for trypsin and chymotrypsin. 
Similarly, ester hydrolases and phosphohydrolases exhibited low activities, while lipase 
and acid phosphatase activities were not detected at all (Table 3.6). In contrast, SM2 
showed more carbohydrase activities, with evidence for strong α-galactosidase and β-
galactosidase production. Moderate activity was noted for α-glucosidase, but SM2 was 
negative for β-glucosidase, N-acetyl-β-glucosaminidase, α-mannosidase and α-
fucosidase. There were also reasonable activities of proteases, ester hydrolases and 
phosphohydrolases. However, cystine arylamidase, chymotrypsin and alkaline 
phosphatase reactions were negative (Table 3.6).  
 
3.2.5 Resistance to pepsin and pancreatin  
As observed by growth at pH 2.0 or 3.0, the addition of pepsin at these pH values did 
not affect the viability of the isolates. Thus, SM1 and SM2 were resistant to pepsin at 
pH 2.0 and 3.0. Moreover, both isolates survived when exposed to pancreatin at pH 8.0 
(Table 3.7).  
 
Table 3.7 Effect of pepsin and pancreatin on the growth of SM1 and SM2. 
Isolate Pepsin (3 mg mL−1) at:  Pancreatin (1 mg mL−1) at: 
 pH 2.0 pH 3.0  pH 8.0 
SM1 + +  + 
SM2 + +  + 
Growth was recorded as positive (+), and no growth was recorded as negative (−). 
 
3.2.6 Sensitivity to antibiotics 
The antimicrobial sensitivity profiles of the isolates are presented in Table 3.8. SM1 
was totally resistant to sulphatriad and moderately sensitive to streptomycin (= 4 mm 
zone of clearing). SM2 was sensitive to ampicillin, chloramphenicol and tetracycline, 
but resistant to penicillin and sulphatriad (Table 3.8).    
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Table 3.8 Antimicrobial sensitivity profiles of SM1 and SM2. 
Bacterial isolates 
Antibiotics 
SM1 SM2 
Ampicillin (10 µg) S S 
Chloramphenicol (25 µg) S S 
Penicillin G (1 IU) S R 
Streptomycin (10 µg) MS MS 
Sulphatriad (200 µg) R R 
Tetracycline (25 µg) S S 
S = sensitive; MS = moderately sensitive (≥ 4−6 mm); R = resistant 
 
3.2.7 Production of siderophores 
Bacterial siderophores are high-affinity Fe(III) chelators for the acquisition of iron 
under iron-limiting conditions, which could limit iron for potential pathogens. 
Siderophore production (= scavenging of iron) by SM1 and SM2 was determined due to 
the change of colour of Chrome Azurol S (CAS) agar. However, neither isolate 
produced siderophore (Figure 3.2).   
 
a) 
 
b)
 
Figure 3.2 The universal CAS assay for testing siderophore production, which detects 
colour change of Fe-CAS complex from blue to orange (see the arrow) after chelation of 
the bound iron by siderophores. SM1 was negative for siderophore production (a), and 
V. anguillarum was included as positive control (b).    
 
3.2.8 16S rDNA gene sequencing 
The two isolates were identified using partial sequencing of the 16S rDNA gene (Figure 
3.3) following comparison in a BLAST search, which revealed a 100% sequence 
homology with Kocuria sp. (Genbank accession number AM990819) for SM1 and 
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Rhodococcus sp. (Genbank accession number AY745831) for SM2, respectively. 
Evidently, the sequencing results for the isolates were relevant with the identification as 
Micrococcus sp. and Corynebacterium sp. obtained by using diagnostic tables in Cowan 
and Steel (2003). Indeed, the genus Kocuria was created from the genus Micrococcus 
(Stackebrandt et al. 1995). Moreover, Corynebacterium, which initially covered several 
taxa due to close relationship in 16S rRNA data sequences (see Goodfellow et al. 1998), 
was recently reclassified into the genera Rhodococcus, Arthrobacter, Clavibacter, and 
Curtobacterium (see Cowan and Steel 2003).  
 
A B C  
 
Figure 3.3 16S rDNA PCR results for the purified DNA products of 
probiotics – Kocuria SM1 (lane B) and Rhodococcus SM2 (lane C). 
Lane A: DNA ladder of 1000 base pairs.  
 
 
Table 3.9 Survival of probiotic in feed maintained at different temperatures. 
Number of viable cells on feed (cfu g−1) 
Day 3   Day 7   Day 14  Probiotic 
4°C *Rt  4°C Rt  4°C Rt 
SM1  4.7 × 107 4.2 × 107  1.2 × 107 8.8 × 106  6.7 × 106 3.5 × 106 
SM2 2.6 × 107 1.5 × 107  0.2 × 107 4.5 × 106  3.6 × 106 1.2 × 106 
*Room temperature 
 
3.3 Survival of probiotics on feed  
The viability of bacteria in the feed was monitored by the total viable count following 
storage of the diet at 4°C and room temperature (Table 3.9). When stored at room 
temperature, cell numbers of SM1 declined to 4.2 × 107 cfu g−1 from an initial 7.8 × 107 
cfu g−1 after 3 days, and to 8.8 × 106 and 3.5 × 106 cfu g−1 after 7 and 14 days, 
respectively. However, storage at 4°C fared better with cell viability reducing to 4.7 × 
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107, 1.2 × 107 and 6.7 × 106 cfu g−1 after 3, 7 and 14 days, respectively. The viability of 
SM2 in feed was similar to SM1 (Table 3.9). Overall, storage at 4°C prolonged the 
survival of cells, although a steady decrease in cell numbers for both cases occurred 
with both probiotics.        
 
Table 3.10 Effect of feeding different concentrations of SM1 and SM2 on the survival 
of rainbow trout after i.p. challenge with V. anguillarum or V. ordalii.  
Mortality (%) after 
challenge with: 
 
Mortality (%) after 
challenge with: 
SM1 in feed 
(cells g−1) 
1VIB1 2VIB2  
SM2 in feed 
(cells g−1) 
1VIB1 2VIB2 
~105 45 25  ~105 55 45 
~106 60 15  ~106 35 25 
~107 10 20  ~107 20 25 
~108 0 10  ~108 40 40 
~109 20 30  ~109 45 65 
Control 90 70  Control 75 80 
1V. anguillarum; 2V. ordalii 
 
3.4 Effective feeding dose of the probiotics   
The effective dose for the probiotics was determined using feed containing 105−109 
cells g−1 feed (Table 3.10). Fish were fed with probiotic-supplement for 14 days 
followed by challenge with the selected pathogens, and the mortality was observed over 
the following 2 weeks period. The result indicated that any dose below or above 107 and 
108 cells g−1 did not lead to good protection. SM1 conferred the best protection at a dose 
of ~108 cells g−1 feed, whereas the appropriate dose was ~107 cells g−1 feed for SM2.  
 
3.5 Control of vibriosis in rainbow trout 
Groups of 60 rainbow trout fed with SM1 and SM2 at doses of ~108 and ~107 cells g−1 
of feed for 14 days followed by challenge with V. anguillarum or V. ordalii conferred 
marked reductions in mortalities when compared to the controls. Effectively, use of 
SM1 led to a significant (P < 0.05) reduction in mortalities, i.e. 15% (RPS = 81%) and 
20% (RPS = 73%) after challenge with V. anguillarum and V. ordalii, respectively, 
compared to the 80 and 74% mortalities among the respective controls (Table 3.11). 
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Also, use of SM2 led to significant (P < 0.05) protection by reducing mortalities to 12% 
(RPS = 85) by V. anguillarum, and 15% (RPS = 80) after challenge with V. ordalii 
(Table 3.11). The survivors among the probiotic-fed groups were devoid of disease 
signs at the end of the experiments. In contrast, the surviving control fish displayed 
signs of disease including sluggish movement, abdominal distension, necrosis, surface 
haemorrhages, exophthalmia and the presence of ascitic fluid in the peritoneal cavity. 
 
Table 3.11 Mortality (%) of rainbow trout fed with SM1 or SM2 supplemented diet for 
14 days followed by i.p. challenge with V. anguillarum or V. ordalii. 
Rainbow trout challenged i.p. with: 
V. anguillarum  V. ordalii Treatment No. of fish 
Mortality (%) RPS  Mortality (%) RPS 
SM1 2 × 25 15 ± 10* 81  20 ± 11* 73 
SM2 2 × 25 12 ± 10* 85  15 ± 5* 80 
Control 2 × 25 80 ± 17 –  74 ± 15 – 
Data represent the average ± SD from a triplicate set of 25 fish.  
Significant difference (P < 0.05) from the control group is indicated by an asterisk.  
 
 Control  Blood from SM1 fed fish 
SSC SSC
 
    FL-1  
 
  FL-1 
 
Figure 3.4 Flow cytometry analysis of DiOC6(3) stained blood cells obtained from 
SM1-fed  and control fish. The graph illustrates the cell populations in whole blood 
sample (R1: erythrocytes and R2: leucocytes). 
R1 
R2 
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3.5.1 Mode of action 
Figure 3.4 shows a typical flow cytometry analysis of whole blood cells from SM1-fed 
and control fish, where ‘R1’ was composed entirely of erythrocytes, and ‘R2’ was 
differential leucocytes according to the intensity of FL-1 and SSC properties (Newaj-
Fyzul et al. 2007). The number of leucocytes increased significantly (P < 0.05) from 
3.7 ± 0.8 × 106 mL−1 in the controls to 5.5 ± 0.8 and 6.5 ± 1.5 × 106 mL−1 in SM1 or 
SM2-fed fish (Table 3.12). Also, the erythrocyte counts for the probiotic treated and 
control fish were significantly (P < 0.05) elevated to 1.2 ± 0.1 and 1.1 ± 0.1 × 108 mL−1 
in the experimental group from 0.8 ± 0.1 × 108 mL−1, in the controls (Table 3.12). 
Moreover, the HK macrophage bacteriocidal activity of SM1 or SM2-fed fish was 
significantly higher (P < 0.05) than the controls with the killing index for 
V. anguillarum and V. ordalii calculated as 0.71 ± 0.02 or 0.73 ± 0.06, and 0.86 ± 0.05 
or 0.81 ± 0.02 in treatment groups, respectively, compared with 0.87 ± 0.05 and 
0.95 ± 0.04 in the corresponding controls (Table 3.12).   
 
Table 3.12 Immunological responses of rainbow trout fed with probiotic-supplemented 
diet for 2 weeks. 
Immunological parameter  SM1 SM2 Control 
Erythrocytes (×108 mL−1)  1.2 ± 0.1* 1.1 ± 0.1* 0.8 ± 0.1 
Leucocytes (×106 mL−1)  5.5 ± 0.8* 6.5 ± 1.5* 3.7 ± 0.8 
1VIB1 0.71 ± 0.02* 0.73 ± 0.06* 0.87 ± 0.05 Bacteriocidal activity 
(killing index)  2VIB2 0.86 ± 0.05* 0.81 ± 0.02* 0.95 ± 0.04 
1V. anguillarum; 2V. ordalii. 
Data represent the average ± SD from a triplicate set of 10 fish.  
Significant difference (P < 0.05) from the control group is indicated by asterisk. 
 
Furthermore, there was a significantly (P < 0.05) higher respiratory burst activity of HK 
macrophages in the experimental (SM1: 0.05 ± 0.01; SM2: 0.04 ± 0.01) compared to the 
control groups (0.02 ± 0.01) (Figure 3.5). The difference between experimental and 
control groups was reinforced by the serum alternative complement activity, which 
increased from 40 ± 8 units mL−1 of natural haemolytic complement activity in the 
controls, to statistically significant (P < 0.05) higher levels, averaging 56 ± 7 and 61 ± 5 
units mL−1 in the experimental group SM1 and SM2, respectively (Figure 3.6).  
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Figure 3.5 The PMA-induced respiratory burst activity of head-kidney macrophages 
from rainbow trout fed with probiotic-supplemented diet for 2 weeks. Data represent the 
average ± SD from a triplicate set of 10 fish. Significant difference (P < 0.05) from the 
control group is indicated by an asterisk. 
 
 
*
*
20
30
40
50
60
70
SM1 SM2 Control
Treatment
A
C
H
 50
 u
ni
ts
 m
L−
1
 
Figure 3.6 Serum alternative complement activity (ACH50) in rainbow trout fed with 
probiotic-supplemented diets for 2 weeks. Data represent the average ± SD from a 
triplicate set of 10 fish. Significant difference (P < 0.05) from the control group is 
indicated by an asterisk. 
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Figure 3.7 Serum lysozyme activity in rainbow trout fed with probiotic-supplemented 
diets for 2 weeks. Data represent the average ± SD from a triplicate set of 10 fish.  
 
Although there was an elevation in serum lysozyme level of probiotic-fed fish, the data 
did not differ statistically (P > 0.05) to the controls. Thus, the lysozyme activity of 
serum was 920 ± 129, 856 ± 100 and 760 ± 115 units mL−1 for SM1, SM2 and control, 
respectively (Figure 3.7). So, the use of probiotics for 14 days led to the stimulation of 
cellular and humoral immune responses in rainbow trout. Certainly, immunostimulation 
has been identified as the dominant mode of action for a range of probiotics, including 
representatives of both Gram-positive and Gram-negative bacterial taxa (Austin and 
Austin 2007) offering host protection against pathogenic infections. 
 
3.6 The most effective feeding duration of probiotics 
When administered between one and four weeks, dietary supplementation of SM1 (~108 
cells g−1 of feed) led to a reduction in mortalities after challenge with V. anguillarum. A 
two-week feeding regime with SM1 led to the maximum reduction in mortalities, i.e. 
16% (RPS = 79%), compared to mortalities of 62% (RPS = 20.5%), 30% (RPS = 67%) 
and 22% (RPS = 69%) for one, three and four weeks feeding regimes, respectively. 
These compared to the 70–90% mortalities of the controls (Table 3.13). Although 
feeding with probiotic for one week did not result in good levels of protection, the 
mortalities were nevertheless significantly lower (P < 0.05) than the controls (Table 
3.13). In general, a two-week feeding regime with SM1 led to the best protection 
against V. anguillarum in rainbow trout. 
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Table 3.13 Mortality (%) of rainbow trout fed with SM1 supplemented or non-
supplemented control diets for up to four weeks followed by challenge with V. 
anguillarum.  
Duration of feeding: 
Treatment 
Mortality/
RPS (%) 7 days 14 days 21 days 28 days 
Control Mortality   78 ± 7 77 ± 14 90 ± 10 70 ± 12 
Mortality   62 ± 8*a 16 ± 10*b 30 ± 13*b 22 ± 15*b SM1 
RPS   20.5 79 67 69 
Data represent the average ± SD from a triplicate set of 20 fish. 
*Different at P < 0.05 from the control group within the same sampling week. 
Means without a common letter in a row differ significantly (P < 0.05) among the 
different probiotic feeding regimes. 
 
3.6.1 Innate immune responses 
There was a significant increase in the phagocytic activity of head kidney macrophages 
of fish fed SM1 at weeks two, three and four (i.e. 0.92 ± 0.06, 0.75 ± 0.03 and 
0.82 ± 0.04; P < 0.05) compared with the levels observed in the controls, 0.60 ± 0.02 to 
0.71 ± 0.04 (Figure 3.8). However, the data for week one (i.e. 0.63 ± 0.04; P > 0.05), 
which also indicated an increased activity, were not significantly different. 
Administration of probiotic for two weeks showed significantly higher (P < 0.05) 
phagocytic activity than all other feeding regimes (Figure 3.8). Furthermore, except for 
one week feeding with SM1 (0.68 ± 0.02; P > 0.05), the peroxidase content of the 
macrophages from experimental groups, i.e. 0.91 ± 0.04, 0.85 ± 0.04 and 0.89 ± 0.01 for 
two, three and four weeks, respectively, was statistically different (P < 0.05) from that 
of control fish, i.e. averaging 0.66 ± 0.02 (Figure 3.9). Moreover, there was significantly 
elevated (P < 0.05) serum total antiprotease activity after two weeks of probiotic 
treatment (Figure 3.10). In contrast, the mean antiproteases for other feeding periods, 
which ranged from 72.4 ± 4.0 to 80.7 ± 2.5, did not differ statistically but still sustained 
high levels as compared to the controls (68.0 ± 2.0 to 74.4 ± 3.5) (Figure 3.10). 
Moreover, the lysozyme activity of serum was between 850 and 1350 units mL−1 for 
controls, and 900–1850 units mL−1 for the fish fed with probiotic. In particular, two 
weeks of probiotic feeding demonstrated significantly increased (P < 0.05) activity in 
comparison with the controls (Figure 3.11).  
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Figure 3.8 Phagocytic activity (OD510 nm) of rainbow trout head kidney macrophage 
from specimens fed SM1 supplemented ( ) or non-supplemented control ( ) diets. Data 
represent the average ± SD from a duplicate set of 10 fish. *Significantly different 
(P < 0.05) from the control group within the same sampling week. Means without a 
common letter differ significantly (P < 0.05) among the different probiotic feeding 
regimes.  
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Figure 3.9 Head kidney macrophage peroxidase content (OD450 nm) in rainbow trout fed 
SM1 supplemented ( ) or non-supplemented control ( ) diets. Data represent the 
average ± SD from a duplicate set of 10 fish. *Significantly different (P < 0.05) from the 
control group within the same sampling week. Means without a common letter differ 
significantly (P < 0.05) among the different probiotic feeding regimes. 
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Figure 3.10 Serum total antiproteases activity in rainbow trout fed SM1 supplemented 
( ) or non-supplemented control ( ) diets. Data represent the average ± SD from a 
triplicate set of 10 fish. *Significantly different (P < 0.05) from the control group within 
the same sampling week. Means without a common letter differ significantly (P < 0.05) 
among the different probiotic feeding regimes.  
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Figure 3.11 Serum lysozyme activity in rainbow trout fed SM1 supplemented ( ) or 
non-supplemented control ( ) diets. Data represent the average ± SD from a triplicate 
set of 10 fish. *Significantly different (P < 0.05) from the control group within the same 
sampling week. Means without a common letter differ significantly (P < 0.05) among 
the different probiotic feeding regimes. 
 
Conversely, the data did not reveal any significant differences for blood respiratory 
burst activity between experimental (0.20 ± 0.02 to 0.23 ± 0.05) and controls 
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(0.16 ± 0.01 to 0.19 ± 0.04), but the levels of respiratory burst following probiotic 
treatments remained enhanced over the controls until the end of the experiment (Figure 
3.12). So, a two-week feeding regime with SM1 was most immunomodulatory leading 
to significant stimulation of macrophage phagocytic activity compared to other 
treatments and controls. Moreover, in comparison with the controls, serum antiprotease 
and lysozyme activities were significantly enhanced at week two. Likewise, there was a 
pronounced effect on macrophage peroxidase at the end of week two.  
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Figure 3.12 Blood respiratory burst activity (OD550 nm) in rainbow trout fed SM1 
supplemented ( ) or non-supplemented control ( ) diets. Data represent the average ± 
SD from a triplicate set of 10 fish.  
 
3.7 Synergistic effects of probiotics 
An equi-mixture of SM1 (5 × 107 cells g−1) and SM2 (5 × 107 cells g−1) conferred 
significant (P < 0.05) protection against vibrio infections when fed to rainbow trout for 
14 days as feed supplement, i.e. a reduction in mortalities to 20–27% (RPS = 68–74%) 
after challenge with V. anguillarum or V. ordalii compared to 78–84% mortalities of the 
controls (Table 3.14). Although, the use of a mixture of probiotic bacteria significantly 
enhanced fish survival compared to the controls, the beneficial effect was not 
statistically different (data not shown) when compared to the application of single 
culture of probiotic  (see Section 3.5).  
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Table 3.14 Mortality (%) of rainbow trout fed an equi-mixture of SM1 and SM2 
supplemented diet for 14 days following by challenge with V. anguillarum or V. ordalii.  
Rainbow trout challenged i.p. with: 
V. anguillarum  V. ordalii Treatment 
Mortality (%) RPS  Mortality (%) RPS 
SM1+SM2 20 ± 16* 74  27 ± 6* 68 
Control 78 ± 13 –  84 ± 14 – 
Data represent the average ± SD from a triplicate set of 25 fish.  
Significant difference (P < 0.05) from the control group is indicated by an asterisk.  
 
3.7.1 Changes in immune parameters 
The data for intracellular respiratory burst activity of HK macrophages, which was 
detected from the reduction of NBT to formazan as a measure of superoxide anion 
(O2−) production, was statistically significant (P < 0.05) with groups fed with mixture 
of probiotics supplemented diets (0.06 ± 0.01) relative to the controls (0.02 ± 0.01) 
(Table 3.15). Moreover, the use of mixed probiotics led to significantly pronounced 
macrophage phagocytosis, i.e. 0.75 ± 0.07 (P < 0.05), compared with the controls, 0.44 
± 0.03 (Table 3.15). Although the serum peroxidase activity and total immunoglobulin 
levels were higher than the controls, the data were not significantly different (P > 0.05). 
The peroxidase activities were 0.38 ± 0.03 and 0.33 ± 0.05, and immunoglobulin levels 
were 28 ± 3.5 mg mL−1 and 26 ± 2.5 mg mL−1 for experimental and control fish, 
respectively (Table 3.15). 
 
Table 3.15 Immunological responses of rainbow trout fed an equi-mixture of SM1 and 
SM2 supplemented diet for 2 weeks. 
Immunological parameter SM1 + SM2 Control 
O2− production (OD620 nm) 0.06 ± 0.01* 0.02 ± 0.01 
Phagocytosis (OD510 nm) 0.75 ± 0.07* 0.44 ± 0.03 
Peroxidase (OD550 nm) 0.38 ± 0.03 0.33 ± 0.05 
Total immunoglobulin (mg mL−1) 28 ± 3.5 26 ± 2.5 
Data represent the average ± SD from a triplicate set of 10 fish.  
Significant difference (P < 0.05) from the control group is indicated by asterisk. 
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3.8 Long-term beneficial effects of probiotics 
Following a 14 day feeding regime with probiotics, rainbow trout were challenged at 
weekly intervals for 5-weeks with the data revealing a significantly (P < 0.05) lower 
mortality for up to four weeks compared with the untreated controls. Thus, the mortality 
rate of fish fed SM1 was reduced to 10 ± 3% (P < 0.05) at one week after probiotic 
feeding compared to mortalities of 27 ± 8 (P < 0.05), 24 ± 15 (P < 0.05) and 28 ± 17% 
(P < 0.05) after two, three and four weeks, respectively. These compared to 73 ± 6 to 92 
± 3% mortalities of the controls (Table 3.16). In contrast, there was no significant 
difference (P > 0.05) in the mortality among fish groups (SM1: 50 ± 15%; control: 78 ± 
25%) after the challenge at five weeks. Use of SM1 resulted in a RPS of 87, 71, 68, 62 
and 36% against V. anguillarum infection after one, two, three, four and five weeks, 
respectively, representing a sign of gradual decrease in survival (Table 3.16). 
 
Table 3.16 Mortality (%) and RPS following i.p. challenge with V. anguillarum in 
groups fed with SM1 or control diets. 
Mortalities (%) after challenge 7-35 days after feeding with 
probiotic for 14-days: Treatment 
Mortality / 
RPS (%) 
7-days 14-days 21-days 28-days 35-days 
Control Mortality  79 ± 9 92 ± 3 76 ± 5 73 ± 6 78 ± 25 
Mortality  10 ± 3a* 27 ± 8ab* 24 ± 15ab* 28 ± 17ab* 50 ± 15b SM1 
RPS 87 71 68 62 36 
Data represent the average ± SD from a triplicate set of 20 fish. 
Significant difference (P < 0.05) from the control group is indicated by an asterisk.  
Means without a common superscript lower-case letter in a row differ significantly 
(P < 0.05) among the probiotic treated groups. 
 
3.8.1 Protective immunity 
At the end of two weeks after feeding with probiotic SM1, the fish showed a 
significantly enhanced respiratory burst activity of blood (0.07 ± 0.01; P < 0.05), 
although the levels after three (0.05 ± 0.01), four (0.05 ± 0.01) and five weeks (0.04 ± 
0.01) did not differ statistically (P > 0.05) compared to the controls (0.04 ± 0.00 to 0.05 
± 0.01) (Table 3.17). Moreover, compared to controls (605 ± 185 units mL−1), probiotic-
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fed fish exhibited significantly improved serum lysozyme activity (872 ± 114 units 
mL−1; P < 0.05) only at two weeks post-feeding. Thereafter, serum lysozyme activity, 
although higher, was not different (P > 0.05) than that of the control (Table 3.17). 
Particularly, there was significantly less activity at week five (497 ± 100 units mL−1; 
P < 0.05) when compared within the probiotic treated samples (Table 3.17). 
Furthermore, the leukocrit content, i.e. white blood cell numbers (% WBC) remained 
statistically non-significant (P > 0.05) among fish groups throughout the experimental 
period, except with fish fed SM1 (5.1 ± 1.1%; P < 0.05) after three weeks (Table 3.17). 
The corresponding serum peroxidase and bacterial killing activities three weeks after 
ending the probiotic feeding regime were significantly higher [i.e. (0.37 ± 0.11; 
P < 0.05) and (percentage of surviving bacteria = 57 ± 4%; P < 0.05), respectively], 
compared with 0.23 ± 0.02 and 82 ± 12% of the controls. However, these immune 
parameters for the other sampling periods remained statistically similar (P > 0.05), 
although higher values were noted for the SM1 group (Figures 3.13, 3.14). These 
observations indicate that, there was a steady maintenance of immune response from the 
induction phase, i.e. there may be an innate memory responsible for long-term 
protection, which was decreased over time.     
 
Table 3.17 Changes in immune parameters of rainbow trout over five weeks after 
feeding with probiotic SM1.  
Weeks after cessation of probiotic 
Character Treatment 
W-2 W-3 W-4 W-5 
1R. burst  SM1 0.07 ± 0.01a* 0.05 ± 0.01b 0.05 ± 0.01b 0.04 ± 0.01b 
 Control 0.05 ± 0.01 0.05 ± 0.00 0.04 ± 0.00 0.04 ± 0.00 
2Lysozyme SM1 872 ± 114a* 755 ± 168ab 695 ± 156b 497 ± 100c 
 Control 605 ± 185 718 ± 133 633 ± 112 450 ± 93 
3Leukocrit SM1 4.2 ± 1.4a 5.1 ± 1.1a* 4.5 ± 2.0a 3.3 ± 1.3a 
 Control 2.3 ± 0.5 2.9 ± 1.8 3.6 ± 0.6 3.1 ± 0.8 
1Respiratory burst (OD550 nm); 2Serum lysozyme (units mL−1); 3Leukocrit (% WBC)  
Data represent the average ± SD from a triplicate set of 10 fish. 
*Data in the same column are significantly different (P < 0.05) from the control.  
Significant differences (P < 0.05) following the probiotic treatment are indicated with 
different superscript lower-case letter.  
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Figure 3.13 Serum peroxidase activity of rainbow trout over five weeks after feeding 
with probiotic SM1 supplemented ( ) or non-supplemented control ( ) diets. Data 
represent the average ± SD from a triplicate set of 10 fish. *Different at P < 0.05 level 
from the control group within the same sampling week. Means without a common letter 
differ significantly (P < 0.05) following the probiotic treatment at different time points. 
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Figure 3.14 Survival percentage (%) of V. anguillarum incubated with rainbow trout 
serum collected over five weeks after feeding with Kocuria SM1 supplemented ( ) or 
non-supplemented control ( ) diets. Data represent the average ± SD from a triplicate 
set of 10 fish. *Different at P < 0.05 level from the control group within the same 
sampling week. Means without a common letter differ significantly (P < 0.05) 
following the probiotic treatment at different time points. 
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3.9 Protective efficacy of cell components of probiotics 
The viable cells of probiotics SM1 and SM2 were highly effective in controlling 
vibriosis in rainbow trout. Here, I investigated the efficacy of sub-cellular components 
of bacterial cultures to determine which part of the cell is responsible for protection 
against vibriosis in rainbow trout. Thus, fish inoculated with extracellular proteins 
(ECPs), cell wall proteins (CWPs) and whole cell proteins (WCPs) of SM1 and SM2, 
respectively, followed by challenge on day 8 with V. anguillarum led to 11–38% 
mortalities compared with 86% mortalities in the controls (Figure 3.15). In particular, 
use of CWPs (SM1: 17%; SM2: 14%) and WCPs (SM1: 13%; SM2: 11%) of the 
probiotics led to significant (P < 0.05) resistance to infection. However, the total 
mortalities for the ECPs did not differ statistically when compared to controls (Figure 
3.15). Overall, these results pointed to the potential of using cellular components of 
probiotics in controlling bacterial fish diseases and may well explain the parts of the 
cells involved in protection. Moreover, SDS-PAGE profiles of WCPs of probiotics 
revealed 23–26 protein bands (range: 17.3 to 209 kDa) in comparison to 11–12 well 
stained bands between 13.1 to 209 kDa in the CWPs. This compares with 6–8 bands 
(range: 22 to 182 kDa) for the ECPs (Figures 3.16, 3.17). Some likely common proteins 
(see arrows on gel image) were also clear between WCPs and CWPs for both probiotics.    
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Figure 3.15 Percent mortality (%) of rainbow trout following i.p. challenge with V. 
anguillarum after inoculation with cellular components of the probiotics SM1 ( ) or 
SM2 ( ) for 7 days, compared with controls ( ). Data represent the average ± SD from 
a triplicate set of 10 fish. *Significantly different (P < 0.05) from the control group. 
Means with a common letter did not differ significantly (P > 0.05) among different 
treatments with cellular proteins of the probiotics.  
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Figure 3.16 Coomassie brilliant blue stained SDS-PAGE analysis of proteins extracted 
from the probiotic SM1. Lanes: (A) protein markers, (B) whole cell proteins (WCPs), 
(C) cell wall proteins (CWPs) and (D) extra cellular proteins (ECPs). Arrows points to 
likely common proteins.  
 
 
 
 
 
 
 
 
 
 
Figure 3.17 Coomassie brilliant blue stained SDS-PAGE analysis of proteins extracted 
from the probiotic SM2. Lanes: (A) protein markers, (B) whole cell proteins (WCPs), 
(C) cell wall proteins (CWPs) and (D) extra cellular proteins (ECPs). Arrows points to 
likely common proteins.  
 
3.9.1 Mode of action 
A significant (P < 0.05) influence in the respiratory burst activity, i.e. production of 
superoxide anion was observed in groups receiving CWPs and WCPs, with the highest 
level 0.045 ± 0.002 in fish inoculated with WCPs of SM2 when compared to the 
controls, 0.039 ± 0.003. Although the difference was non-significant (P > 0.05), the 
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level of induction was maintained at elevated levels with ECPs (Figure 3.18). The 
serum peroxidase activity was significantly different (P < 0.05) from the controls in 
experimental samples except those inoculated with ECPs (Figure 3.19).  
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Figure 3.18 Blood respiratory burst activity in rainbow trout inoculated with cellular 
components of the probiotics SM1 ( ) or SM2 ( ), compared with controls ( ). 
*Significantly different (P < 0.05) from the control group. Means without a common 
letter differ at P < 0.05 among different treatments with cellular proteins of probiotics. 
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Figure 3.19 Serum peroxidase activity of rainbow trout inoculated with cellular 
components of the probiotics SM1 ( ) or SM2 ( ), compared with controls ( ). Data 
represent the average ± SD from a triplicate set of 5 fish. *Significantly different 
(P < 0.05) from the control group. Means without a common letter differ significantly 
(P < 0.05) among different treatments with cellular proteins of probiotics. 
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Figure 3.20 The leukocrit content, i.e. white blood cell numbers (% WBC) in rainbow 
trout inoculated with cellular components of the probiotics SM1 ( ) or SM2 ( ), 
compared with controls ( ). Data represent the average ± SD from a triplicate set of 5 
fish. *Significantly different (P < 0.05) from the control group. Means without a 
common letter differ significantly (P < 0.05) among different treatments with cellular 
proteins of probiotics. 
 
a
a
a
a
a
*
a
*
50
60
70
80
90
100
ECPs CWPs WCPs Control
Treatment
B
ac
te
ri
al
 su
rv
uv
al
 (%
)
 
Figure 3.21 Survival percentage (%) of V. anguillarum incubated with serum of 
rainbow trout inoculated with cellular components of the probiotics SM1 ( ) or SM2 
( ), compared with controls ( ). Data represent the average ± SD from a triplicate set 
of 5 fish. *Significantly different (P < 0.05) from the control group. Means without a 
common letter differ significantly (P < 0.05) among different treatments with cellular 
proteins of probiotics. 
 
Moreover, all groups of fish inoculated with cellular proteins of probiotics had an 
increased (P > 0.05) number of white blood cells between 1.98 ± 0.67% and 2.93 ± 
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0.51%, as examined by measurement of the leukocrit value, compared with the controls 
(1.93 ± 0.51%) (Figure 3.20). However, significantly (P < 0.05) enhanced bacteriocidal 
activity was recorded following inoculation with CWPs and WCPs of SM2 compared 
with the controls. Improved bacterial killing was also noted in the rest of the treated 
groups compared to the controls, but the differences were not significant (Figure 3.21). 
 
Table 3.18 Growth performance, feed utilization and body indices of rainbow trout fed 
with probiotic-supplemented or control diets.  
14 days feeding regime with:  
Character 
SM1 SM2 Control 
1Weight gain (%) 20.3 ± 8.7a 25.2 ± 6.2a 23.3 ± 4.5a 
2SGR (% day−1) 1.4 ± 0.8a 1.9 ± 0.6a 1.6 ± 0.2a 
3FCR 0.29 ± 0.01a 0.27 ± 0.02a 0.29 ± 0.01a 
4PER 1.5 ± 0.5a 2.3 ± 0.7a 1.6 ± 0.3a 
5HSI (%) 1.3 ± 0.1a 1.5 ± 0.0a 1.4 ± 0.2a 
6SMI (%) 0.19 ± 0.05a 0.17 ± 0.06a 0.18 ± 0.02a 
1[(Final weight – Initial weight) ÷ Initial weight] × 100. 
2[(ln Final weight – ln Initial weight) ÷ Experiment duration (days)] × 100.  
3[Total feed consumed (g) ÷ Total wet weight gain of animal (g)]. 
4[Total wet weight gain of animal (g) ÷ Total protein intake (g)]. 
5[Weight of liver (g) ÷ Weight of whole fish (g)] × 100. 
6[Weight of spleen (g) ÷ Weight of whole fish (g)] × 100. 
Data represent the average ± SD from a triplicate set of 25 fish. 
Means without a common superscript lower-case letter in a row differ significantly 
(P < 0.05) among the treatments. 
 
3.10 Growth performance of fish 
Results of the growth performance, specific growth rate (SGR), feed conversion ratio 
(FCR), protein efficiency ratio (PER) and body indices [hepato-somatic index (HSI) and 
spleen mass index (SMI)] measured per treatment are summarized in Table 3.18. Fish 
biomass increased by ~20–25% in all groups after the 14 day feeding regime, with SGR 
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≤ 1.90% and FCR ≥ 0.27. Compared to the control group, SGR was improved from 1.6 
± 0.2 to 1.9 ± 0.6%, and FCR was reduced from 0.29 ± 0.01 to 0.27 ± 0.02 in the group 
SM2. The PER was also enhanced in SM2 supplemented group (2.3 ± 0.7) compared to 
the controls (1.6 ± 0.3). However, no significant differences (P > 0.05) among the 
treatments were observed for any of the parameters, including the body indices.  
 
3.11 Influence on digestive enzymes 
Semiquantitative API ZYM assays resulted in no differences in the activity of ester 
hydrolases or phosphohydrolases of rainbow trout fed with probiotics or control diets 
(Table 3.19). Moreover, the activity of proteases was mostly similar between groups, 
except for relatively weak reaction of trypsin and leucine arylamidase with the SM1 and 
controls, respectively (Table 3.19). On the other hand, variable results were observed 
for carbohydrases activities. Notably, α-mannosidase activity was strong with fish fed 
SM1 followed by moderate and fair activity with SM2 and control fish. Higher α-
fucosidase and α-glucosidase activity was recorded for SM1 and control groups. In 
contrast, β-glucoronidase activity was lower after feeding with SM2 (Table 3.19).  
 
3.12 Changes in biochemical indicators 
As part of a general health assessment, modifications of serum biochemistry parameters, 
i.e. total protein, albumin, globulin, haemoglobin (Hb), glucose, urea, and creatinine 
were measured after fish were fed for 14 days with probiotic-supplemented or control 
diets. The total serum protein level differed significantly (P < 0.05) between 
experimental group (SM1: 23.0 ± 4.4 mg mL−1; SM2: 25.0 ± 1.0 mg mL−1) and the 
controls (16.0 ± 1.3 mg mL−1) (Table 3.20). Similarly, there was significantly (P < 0.05) 
increased albumin (7.3 ± 0.2 and 8.2 ± 0.2 mg mL−1 of the SM1 and SM2 treatments 
compared to 6.1 ± 0.1 mg mL−1 of the controls) and globulin content (15.7 ± 0.2 and 
16.8 ± 0.2 mg mL−1 of the SM1 and SM2 treatments compared to 9.9 ± 0.1 mg mL−1 of 
the controls) in the serum of rainbow trout fed the probiotic SM1 or SM2 diets 
compared to the controls (Table 3.20). However, the levels of haemoglobin, and urea 
and creatinine (= marker of kidney function) were not affected by any of the 
experimental diets (Table 3.20). Serum glucose, which is often used as an indicator of 
stress, also remained statistically similar (P > 0.05) between groups (Table 3.20). 
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Table 3.19 Results of API ZYM test 2 h after last meal, carried out on homogenates of 
digestive organs with digesta of juvenile rainbow trout.   
2Enzyme activity of treatment:  
Enzyme assayed for: 1Substrate 
SM1 SM2 Control 
Control – – – – 
Glycosidases:     
α-galactosidase a 0 0 0 
β-galactosidase b 5 5 5 
β-glucoronidase c 4 2 4 
α-glucosidase d 2 2 3 
β-glucosidase e 0 0 0 
N-acetyl-β-glucosaminidase f 5 5 5 
α-mannosidase g 5 3 2 
α-fucosidase h 3 2 2 
Peptide hydrolases:     
Leucine arylamidase  i 5 5 4 
Valine arylamidase  j 5 5 5 
Cystine arylamidase  k 1 1 1 
Trypsin l 3 5 5 
Chymotrypsin m 0 0 0 
Ester hydrolases:     
Esterase (C4) n 2 2 2 
Esterase Lipase (C8) o 2 2 2 
Lipase (C14) p 0 0 0 
Phosphohydrolases:     
Alkaline phosphatase q 5 5 5 
Acid phosphatase r 5 5 5 
Naphthol-AS-BI-phosphohydrolase s 5 5 5 
1Substrate: a6-Br-2-naphthyl-αD-galactopyranoside; b2-naphthyl-βD-galactopyranoside; 
cNaphthol-AS-BI-βD-glucuronide; d2-naphthyl-αD-glucopyranoside; e6-Br-2-naphthyl-βD-
glucopyranoside; f1-naphthyl-N-acetyl-βD-glucosamide; g6-Br-2-naphthyl-αD-
mannopyranoside; h2-naphthyl-αL-fucopyranoside; iL-leucyl-2-naphthylamide; jL-valyl-2-
naphthylamide; kL-cystyl-2-naphthylamide; lN-benzoyl-DL-arginine-2-naphthylamide; mN-
glutaryl-phenylalanine-2-naphthylamide; n2-naphthyl butyrate; o2-naphthyl caprylate; p2-
naphthyl myristate; q2-naphthyl phosphate; r2-naphthyl phosphate; sNaphthol-AS-BI-
phosphate. 
Homogenate concentration was adjusted to 1 mg mL−1 protein in all cases.  
2Numbers indicate the relative magnitude of enzyme activity. 
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Table 3.20 Serum biochemical indicators of rainbow trout fed with probiotic-
supplemented or control diets for 14 days. 
Character  SM1 SM2 Control 
Protein (mg mL−1)  23.0 ± 4.4* 25.0 ± 1.0* 16.0 ± 1.3 
Albumin (mg mL−1)  7.3 ± 0.2* 8.2 ± 0.2* 6.1 ± 0.1 
Globulin (mg mL−1)  15.7 ± 0.2* 16.8 ± 0.2* 9.9 ± 0.1 
Haemoglobin (mg mL−1)  5.0 ± 0.9 5.4 ± 1.5 4.5 ± 1.6 
Urea (mg mL−1)  0.08 ± 0.01 0.10 ± 0.02 0.10 ± 0.01 
Creatinine (mg mL−1)  0.015 ± 0.005 0.019 ± 0.006 0.018 ± 0.006 
Glucose (mg mL−1)  1.09 ± 0.03 1.07 ± 0.05 1.01 ± 0.08 
Data represent the average ± SD from a triplicate set of 10 fish.  
Significant difference (P < 0.05) from the control group is indicated by asterisk.  
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4.1 Discussion  
Outbreaks of infectious bacterial diseases remain a key limitation to the expansion of 
fish and shellfish aquaculture, worldwide (Subasinghe 2005; Austin and Austin 2007). 
Recently, farmed Atlantic salmon, Pacific salmon and rainbow trout in the South of 
Chile have suffered from high mortalities due to vibriosis (Colquhoun et al. 2004; 
Silva-Rubio et al. 2008a,b). Vibriosis, which is attributable to V. anguillarum and V. 
ordalii, is an acute haemorrhagic septicaemia for which current control strategies centre 
on vaccination and chemotherapy (Austin and Austin 2007). However, the use of 
antibiotics may lead to the development and spread of antibiotic-resistant bacteria, 
which may pose a risk to human health (Alcaide et al. 2005; Akinbowale et al. 2006). 
Thus, the value of preventative measures is recognized. As a consequence, the use of 
probiotics, which were initiated during the late 1980s (Dopazo et al. 1988; Kamei et al. 
1988), has garnered attention (Figure 4.1) for disease prevention in aquaculture (Austin 
et al. 1995; Gildberg et al. 1997; Gatesoupe 1999; Verschuere et al. 2000; Spanggaard 
et al. 2001; Irianto and Austin 2002a,b; Balcázar et al. 2006a; Gobeli et al. 2009).  
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Figure 4.1 Interest in probiotics for use in aquaculture. Source: search on ISI Web of 
Knowledge (www.isiknowledge.com) using term “probiotic + aquaculture”.  
 
To date, the use of probiotics has led to control of a range of bacterial pathogens in 
various fish species. For example, supplementation of La. lactis subsp. lactis, Leu. 
mesenteroides and L. sakei dosed at 106 cfu g−1 feed for two weeks significantly 
improved the survival rate by 32.2–34.2% of rainbow trout after challenge with A. 
salmonicida (Balcázar et al. 2007b). Moreover, rainbow trout were protected against A. 
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salmonicida and Y. ruckeri when administered with dietary C. maltaromaticum and C. 
divergens at >107 cells g−1 for two weeks (Kim and Austin 2006a). Similarly, reduction 
of La. garvieae, V. anguillarum, A. hydrophila, A. sobria and Streptococcus sp. 
associated mortalities in rainbow trout, Chinese drum (M. miiuy), Nile tilapia (O. 
niloticus), perch (P. fluviatilis) and grouper (E. coioides) was noticeable by the use of 
probiotics, i.e. A. sobria (Brunt and Austin 2005), C. butyricum (Pan et al. 2008), M. 
luteus (El-Rhman et al. 2009), Ps. chlororaphis (Gobeli et al. 2009) and L. plantarum 
(Son et al. 2009), respectively. Overall, probiotics have been attributed with improved 
nutrition (Balcázar et al. 2006a) and food safety in a more environmentally friendly way 
(Macey and Coyne 2005). Thus, FAO has now indicated the use of probiotics as a 
means of improving the quality of the aquatic environment (Subasinghe et al. 2003). 
Against this background, the aim of the present study was to develop probiotics (Figure 
4.2) for the control of V. anguillarum and V. ordalii infections in rainbow trout. 
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Figure 4.2 Rationale for the development of probiotics, with acknowledgement to 
Verschuere et al. (2000) and Balcázar et al. (2006a).  
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Generally, candidate fish probionts have been obtained from a wide range of sources, 
including healthy adult fish (Gildberg et al. 1997; Gram et al. 1999), rearing water 
(Lauzon et al. 2009), fish larvae (Gatesoupe 1999; Ringø and Vadstein 1998), human 
probiotics L. rhamnosus (Nikoskelainen et al. 2003) and L. plantarum (Picchietti et al. 
2007) or the gut of chickens (Pan et al. 2008) – all of which led to improved health of 
farmed fish species. However, it is argued that isolation of putative probiotics from the 
indigenous microbiota of fish or the rearing environment [= assumed to be the natural 
location of “good” micro-organisms (Gullian et al. 2004)] may have the desirable 
probiotic effect (Verschuere et al. 2000). Thus, in this study I have investigated the 
intestinal microflora of the target host species, i.e. rainbow trout, as a source of potential 
probiotics.  
 
When isolating the putative probiotics, average viable bacterial counts of 5.4 ± 7.6 × 106 
cfu g−1 were obtained on TSA and this agrees with previous results on microbial counts 
in rainbow trout intestine (Kim et al. 2007). Then, representative colonies were tested 
for in vitro antagonism against V. anguillarum and V. ordalii by cross streaking, which 
is a common way for the screening (= elimination of unwanted isolates) and selection of 
putative probiotics (Austin et al. 1995; Verschuere et al. 2000; Irianto and Austin 
2002a; Brunt and Austin 2005). In vitro antagonistic activity is based on the production 
of inhibitory compounds/substances [= antibiotics or antimicrobial peptides (Sugita et 
al. 1998), organic acids or hydrogen peroxide (Ringø and Gatesoupe 1998)] or on 
competition for nutrients [= siderophores (Gram and Melchiorsen 1996; Sugita et al. 
1998)]. Whereas this is an appropriate strategy for beneficial organisms that work by 
competitive exclusion, it is of course of questionable relevance for other modes of 
action, such as stimulation of immunity, which was highlighted in this study.  
Nevertheless, the approach has been successful for the recognition of effective 
probiotics for a range of fish pathogens (e.g. Irianto and Austin 2002a; Brunt and Austin 
2005). Thus by using antagonism as the primary screen, ~19% of the isolates, including 
SM1 and SM2, demonstrated inhibitory properties against the reference pathogens. 
Similarly by using the double-layer method of determining antagonism, Riquelme et al. 
(1997) reported ~2% isolates (= 11 out of total 506 bacteria) to be inhibitory against 
selected pathogens. In addition, extracellular products of five bacteria from a total 106 
isolates recovered from the stomach and intestine of common clownfish (Amphiprion 
percula) were inhibitory against A. hydrophila, A. salmonicida, V. harveyi, V. 
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anguillarum, V. damsela (= Photobacterium damselae), V. alginolyticus and C. 
piscicola (Vine et al. 2004a). This emphasizes that a small ratio of resident microbiota 
of fish or the rearing environment can produce various antagonistic compounds and 
inhibit the growth of pathogens (Robertson et al. 2000; Spanggaard et al. 2001; 
Fjellheim et al. 2007).  In numerous cases, it is these antagonistic bacteria that have 
been demonstrated to be effective probiotics.   
 
However, it is certainly not definite that in vitro antagonism, and the evaluation of other 
selection methods, i.e. growth characteristics (Vine et al. 2004a), and the ability to 
adhere to the mucus layer (Verschuere et al. 2000; Vine et al. 2004a; Chabrillón et al. 
2005a), are necessarily the only suitable characteristics for preselection of probiont 
candidates for use in vivo (Balcázar et al. 2006a). As recorded in this study, some 
strains with desirable in vitro characteristics were pathogenic (Riquelme et al. 1997) or 
were unsuccessful in improving the health of the host (Gram et al. 2001). For example, 
putative probiotics selected on their in vitro antagonistic ability to V. anguillarum were 
unable to confer protection in rainbow trout (Spanggaard et al. 2001). Moreover, Gram 
et al. (2001) demonstrated that results of in vitro pathogen inhibition assays could not 
be used to completely predict an in vivo effect since probiotic Ps. fluorescens with a 
strong antagonism against A. salmonicida did not protect Atlantic salmon from 
furunculosis. Therefore, absence or presence of in vitro antagonism may not be the 
criterion for selection (Riquelme et al. 1997) or for excluding isolates from further 
consideration (Rico-Mora et al. 1998). Nevertheless, in vitro criteria remain necessary 
for selection of putative probiotics (Verschuere et al. 2000; Balcázar et al. 2006a) as the 
approach has the potential to reduce a large collection of isolates to a smaller number, 
thereby saving expenditure and time.  
 
The next step towards the development of fish probiotics requires examination of any 
possible harmful effects of the candidate probionts on the host (Verschuere et al. 2000; 
Irianto and Austin 2002a; Brunt and Austin 2005). Thus, pathogenicity by the selected 
bacterial isolates to the target host should be tested either by injection or by bath (= 
liquid suspension of putative probiotics) challenge (Verschuere et al. 2000). In this 
study, a total 10 isolates, including SM1 and SM2, were recognized to be harmless to 
rainbow trout as there was not any sign of any pathological effects or mortalities after 
challenge via the intraperitoneal (i.p.) or intramuscular (i.m.) routes with the organisms. 
Chapter 4 – Discussion 
93 
This approach followed previous work of Austin et al. (1995), Irianto and Austin 
(2002a) and Brunt and Austin (2005), where fish were challenged i.p. or i.m. with the 
selected probionts, monitored for 7–14 days, and survivors were sacrificed followed by 
examination of disease symptoms after inspecting the kidney, spleen and muscle.  
 
Only those bacterial cultures which did not cause any harmful effects were assessed 
further. In aquaculture, probiotics may be applied either as food supplements [which 
complies with the definition of a probiotic used by FAO and WHO] or as additives to 
water (Moriarty 1998) by (i) bathing the host in a bacterial suspension (Austin et al. 
1995; Gram et al. 1999), (ii) addition of the culture directly to rearing water (Moriarty 
1998; Spanggaard et al. 2001; Gobeli et al. 2009), (iii) supplementation with artificial 
inert diets (Nikoskelainen et al. 2001; Aly et al. 2008; Vendrell et al. 2008), or (iv) via 
bioencapsulation, i.e. enrichment of live food artemia/rotifers (Gatesoupe 1994; Planas 
et al. 2006). It is evident that most studies have administrated the probiotics to fish or 
shellfish (larvi)culture by adding them to the diet or directly into the rearing media; the 
former being more practical than the latter in reality (Hai et al. 2009). However, the 
developmental stage and age of fish and culture environment may be crucial when 
choosing an appropriate delivery method. This project used a commercially available 
pelleted diet into which probiotic cultures were mixed and fed to fish in order to 
determine palatability as well as efficacy. The outcome was that the fish accepted the 
modified diets prepared with SM1 and SM2, and displayed a better feeding response 
than the controls. Moreover, the viability of the putative probiotics in the feed was 
monitored by storing the diet at 4°C and at room temperature. Thus when stored at 4°C 
for 14 days, the cell viability of SM1 and SM2 was prolonged and fared better 
compared to storage at room temperature. This points to the benefit of refrigerating the 
probiotic-containing diet.  However, there was a steady decrease in the viability for both 
probiotics at the two temperatures. In this connection, Aly et al. (2008) demonstrated a 
greater number of viable probiotic cells (i.e. mixtures of B. subtilis and L. acidophilus, 
or B. subtilis or L. acidophilus, alone) and their durability in the feed under refrigeration 
(4°C) compared with storage at room temperature (25°C). Similarly, Irianto and Austin 
(2002a), Newaj-Fyzul et al. (2007) and Capkin and Altinok (2009) demonstrated higher 
numbers of viable cells on the feed when stored at 4°C rather than 20–22°C. 
Interestingly, there was better survival of Gram-positive bacteria than Gram-negative 
isolates (Irianto and Austin 2002a). 
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Table 4.1 List of probiotics effective in controlling bacterial diseases of salmonid fish.  
Disease /  
causative agent 
Probiont Host species Reference 
Streptococcosis: 
S. iniae 
A. sobria, 
Bacillus sp. 
rainbow trout Brunt and Austin (2005), 
Brunt et al. (2007) 
    
Lactococcosis: 
La. garvieae 
A. sobria, Bacillus sp., 
Leu. mesenteroides,  
L. plantarum 
rainbow trout Brunt and Austin (2005), 
Brunt et al. (2007), 
Vendrell et al. (2008) 
    
Furunculosis: 
A. salmonicida 
A. sobria, Bacillus sp., 
A. hydrophila, 
Carnobacterium sp.,  
an unidentified Gram-
positive coccus,  
V. fluvialis, La. lactis, 
Leu. mesenteroides,  
L. sakei, L. rhamnosus,   
1C. inhibens  
rainbow trout 
 
Brunt et al. (2007),  
Irianto and Austin (2002a),  
Irianto and Austin (2003), 
Balcázar et al. (2007b), 
Nikoskelainen et al. (2001), 
Robertson et al. (2000) 
    
 1C. inhibens,  
V. alginolyticus 
Atlantic 
salmon 
Robertson et al. (2000), 
Austin et al. (1995) 
    
 La. lactis,  
Leu. mesenteroides 
brown trout Balcázar et al. (2009) 
    
Vibriosis: 
V. anguillarum 
Ps. fluorescens,  
A. sobria, Bacillus sp., 
V. alginolyticus 
rainbow trout, 
Atlantic 
salmon 
Gram et al. (1999),  
Brunt et al. (2007),  
Austin et al. (1995) 
    
V. ordalii A. sobria, Bacillus sp., 
1C. inhibens, 
V. alginolyticus 
rainbow trout, 
Atlantic 
salmon 
Brunt et al. (2007),  
Robertson et al. (2000), 
Austin et al. (1995) 
    
V. harveyi A. sobria rainbow trout Arijo et al. (2008) 
    
Enteric 
Redmouth 
(ERM):  
Y. ruckeri 
A. sobria, Bacillus sp., 
B. subtilis + B. 
licheniformis,  
1C. inhibens, 
Enterobacter cloacae, B. 
mojavensis  
rainbow trout, 
Atlantic 
salmon 
Brunt et al. (2007),  
Raida et al. (2003), 
Robertson et al. (2000), 
Capkin and Altinok (2009) 
    
Fin rot: 
A. bestiarum 
A. sobria, Brochothrix 
thermosphacta 
rainbow trout Pieters et al. (2008) 
    
White spot: 
Ichthyophthirius 
multifiliis 
A. sobria rainbow trout Pieters et al. (2008) 
A. = Aeromonas, B. = Bacillus, C. = Carnobacterium, L. = Lactobacillus, La. = 
Lactococcus, Leu. = Leuconostoc, Ps. = Pseudomonas, S. = Streptococcus, V. = Vibrio. 
1Carnobacterium strain K1 identified as Carnobacterium inhibens (Jöborn et al. 1999). 
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In vivo studies to determine the effectiveness of potential probiotics for controlling 
disease will inevitably involve experimental challenges of the host (Austin et al. 1995; 
Verschuere et al. 2000). Thus in this study, juvenile rainbow trout administered with 
live cells of SM1 and SM2 supplemented diets for 14 days were followed by challenge 
with V. anguillarum or V. ordalii, with the results revealing a marked reduction in 
mortalities when compared to controls. Certainly, the outcome of this study matches 
previous findings pointing to the greater survival of probiotic-fed fish after experimental 
challenge with a wide range of bacterial fish pathogens (Aly et al. 2008; Vendrell et al. 
2008), and demonstrated that probiotics are not necessarily specific to a single disease. 
Similarly, dietary Bacillus JB-1 and A. sobria GC2 demonstrated effectiveness in 
controlling multiple bacterial diseases, such as V. anguillarum, V. ordalii, La. garvieae, 
A. salmonicida, S. iniae and Y. ruckeri in rainbow trout (Brunt et al. 2007). Moreover, 
Robertson et al. (2000) confirmed efficacy of Carnobacterium sp. at reducing diseases 
caused by A. salmonicida, V. ordalii and Y. ruckeri in salmonids. Improved resistance to 
V. anguillarum in cod (G. morhua) fry was also reported after addition of C. divergens 
(Gildberg and Mikkelsen 1998). The effectiveness of probiotics supplementation against 
infectious bacterial pathogens of salmonids is summarized in Table 4.1. However, it is 
noteworthy that a reduction of mortality for certain host-pathogen combinations may 
not necessarily indicate a universal effect. For example, probiont Ps. fluorescens, which 
was successful in controlling vibriosis in rainbow trout (= vibriosis-rainbow trout 
system), failed to protect Atlantic salmon against furunculosis, i.e. ineffectual with the 
furunculosis-salmon system (Gram et al. 1999, 2001). As an alternative to viable cells, 
Brunt and Austin (2005) and Pan et al. (2008) observed that the addition of formalized, 
sonicated, heat-killed and cell-free supernatant of probiotics conferred less protection in 
rainbow trout and Chinese drum against S. iniae, La. garvieae, A. hydrophila and 
V. anguillarum, which reinforces the benefit of using live cells. Also, Taoka et al. 
(2006b) noted decreased resistance in tilapia (O. niloticus) to E. tarda infection after 
oral administration of dead probiotics when compared to the use of live cells. Therefore, 
the administration of dead/inactivated cells or the supernatant of probiotics does not 
necessarily reduce bacterial infections, indicating that the maximum benefits of 
probiotics are mediated in some cases by live bacterial cells.  
 
Subsequently, isolates (i.e. SM1 and SM2) with favourable characteristics, as 
determined from in vitro or in vivo selection criteria for probiotic bacteria (Figure 4.2), 
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were identified. The identification step remains essential since it can provide useful 
information about the culture requirements and possible virulence gene expression of 
the selected probiont (Vine et al. 2006). Initially, SM1 and SM2 were phenotypically 
characterized using the API 20E and 20NE system, but test results proved inconclusive 
since neither of the isolates could be identified. However, by means of diagnostic tables 
in Cowan and Steel (2003), SM1 and SM2 were tentatively identified as Micrococcus 
sp. (= reclassified to the genus Kocuria; Stackebrandt et al. 1995) and Corynebacterium 
sp. (= reclassified to the genera of Rhodococcus, Arthrobacter, Clavibacter, or 
Curtobacterium; see Cowan and Steel 2003), respectively. This outcome was verified 
by partial sequencing of the 16S rDNA gene and the two isolates were identified as 
Kocuria sp. for SM1 and Rhodococcus sp. for SM2, respectively. Members of the genus 
Kocuria are characterized as Gram-positive, aerobic, coccoid, nonencapsulated, 
nonendospore-forming and nonhalophilic organisms (Kim et al. 2004; Zhou et al. 
2008), with many tolerating high salt concentrations (Stackebrandt et al. 1995; Kim 
et al. 2004). Their habitats include mammalian skin, soil, rhizoplane, freshwater and 
marine sediment (Kim et al. 2004). The organisms are not considered as primary 
pathogens of humans and other mammals (Kocur et al. 1991). Very little is known 
about the presence of Kocuria in fish apart from the report of Kim et al. (2007), who 
observed the occurrence of some Kocuria among the total intestinal bacterial microflora 
of rainbow trout. However, Micrococcus species have been shown to interfere with fish 
pathogens in vitro, such as by the competition for adhesion sites (Chabrillón et al. 
2005b) and the production of antibiotic substances (El-Rhman et al. 2009). Previously, 
it has been reported that an isolate was successful in controlling A. salmonicida 
infections in rainbow trout (see Irianto and Austin 2002b) and thus was regarded as 
possessing the suitable criteria to be considered as a potential probiotic. Non-motile 
Gram-positive actinomycetes of the genus Rhodococcus are common in many 
environmental niches such as soils, rocks, boreholes, groundwater, seawater plants and 
marine/deep-sea sediments (see Larkin et al. 2005; Peng et al. 2008). Occurrence of 
Rhodococcus sp. was also reported in fish, namely tilapia (Zhou et al. 2009) and trout 
(Waché et al. 2006; Arijo et al. 2008). The organisms grow slowly but show persistence 
in the environment, and some are psychrotrophic in nature (Quek et al. 2006). However, 
rhodococci are of significant environmental and biotechnological importance because 
certain species have the ability to degrade a large number of organic compounds (= 
bioremediation), to produce biosurfactants or emulsifiers, to produce exoenzymes and to 
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survive long-term under extremely harsh conditions (Larkin et al. 2005; Das et al. 2008; 
Quatrini et al. 2008; Peng et al. 2008). Moreover, actinomycetes are reported to produce 
antibacterial substances, and the antibiotic product administered to the tiger shrimp 
(Penaeus monodon) post larvae (PL–20) as feed supplement reduced infection due to 
white spot syndrome virus (Kumar et al. 2006). Therefore, there is a potential role in 
aquaculture as probiotics, i.e. association in nutrient cycles (= water quality 
improvement) of aquaculture ponds, competitive exclusion of pathogens and host 
digestion processes.  
 
The dose of probiotics, which is the cell concentration of probiotic (i.e. no. of probiotic 
cells mL−1) available to the aquatic host (Vine et al. 2006) used in this study 
corresponded well with previous work with probiotics (e.g. Nikoskelainen et al. 2003; 
Kim and Austin 2006a). Thus, considering different dose levels (= 105–109 cells g−1 
feed), it was revealed that any dose below or above 107 and 108 cells g−1 for SM1 and 
SM2, respectively, did not result in good levels of protection. Similarly, Newaj-Fyzul et 
al. (2007) demonstrated that doses of B. subtilis lower and higher than 107 cells g−1 of 
feed were less successful at enhancing resistance to Aeromonas infection in rainbow 
trout. Moreover, feeding of rainbow trout with L. rhamnosus-supplemented diets at 109 
cfu g−1 for 51 days led to reduced mortality rates from 52.6% in the control to 18.9% 
when compared to mortality rates of 46.3% for the dose 1012 cfu g−1, following 
challenge with A. salmonicida (Nikoskelainen et al. 2001). Gill and Rutherfurd (2001) 
observed a dose-response effect on the immune function of mice fed L. rhamnosus 
supplemented milk. For example, a dose of 109 cells of L. rhamnosus day−1, which was 
required to significantly enhance the phagocytic capacity of peritoneal cells compared 
to control mice, was increased to 1011 day−1 and this did not further increase peritoneal 
cell phagocytosis. In contrast, a significant incremental enhancement in the phagocytic 
capacity of blood leucocytes was found by increasing the dose from 107 to 1011 cells 
day−1. Therefore, a dose-effect relationship should be carefully determined to avoid 
overdosing with resultant lower efficacy and unnecessary costs, or conversely 
underdosing, which reduces the efficiency of the probiont (Vine et al. 2006). 
 
Equally, consideration of the length of feeding time holds fundamental importance 
while developing probiotics. Studies with probiotics to date have involved the use of 
different feeding durations, for example 1–8 week feeding regimes, leading to improved 
disease resistance in farmed fish (Gildberg et al. 1997; Robertson et al. 2000; Irianto 
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and Austin 2002a; Raida et al. 2003; Aly et al. 2008; Pan et al. 2008; Vendrell et al. 
2008), but the basis for choosing these periods is often unclear. Therefore, in this study, 
fish were fed a diet containing live cells of SM1 for up to four weeks with weekly 
challenges to determine the optimal feeding duration for probiotics maximizing the host 
protection. The results revealed that a two-week feeding regime with SM1 led to higher 
disease protection in rainbow trout against V. anguillarum than any of the lower or 
higher doses. Indeed, supplementation of Bacillus or A. sobria at 2 × 108 cells g−1 feed 
for two weeks conferred protection against V. anguillarum, V. ordalii, La. garvieae, A. 
salmonicida, S. iniae and Y. ruckeri in rainbow trout (Brunt et al. 2007). Furthermore, it 
has been demonstrated in the same fish species that the addition of Leu. mesenteroides 
and L. plantarum at 107 cfu g−1 for 30 days (Vendrell et al. 2008), and a mixture of B. 
subtilis and B. licheniformis at 4 × 104 spores g−1 for 42 days (Raida et al. 2003) 
controlled infections caused by La. garvieae and Y. ruckeri. Also, dietary L. plantarum 
in grouper (Son et al. 2009), C. butyricum in Chinese drum (Pan et al. 2008), and B. 
subtilis, L. acidophilus or a mixture of both in tilapia (Aly et al. 2008) were beneficial 
when used for 28, 30 and 60 days, respectively, reducing mortality following challenge 
with Streptococcus sp., V. anguillarum, A. hydrophila, Ps. fluorescens and S. iniae. 
Conversely, one-week administration of SM1 significantly reduced the fish survival 
after challenge with the pathogen counter to other feeding regimes, which corroborates 
well with some previous findings (e.g. Robertson et al. 2000). Therefore, it is apparent 
that feeding with the probiotics for two or more weeks is effective in controlling fish 
diseases. In conclusion, a two-week feeding regime with SM1 leads to the best defence 
against V. anguillarum in rainbow trout. 
 
The combination of either multistrain or multispecies formulations may improve the 
efficacy of probiotics by triggering synergistic beneficial effects on the health of the 
host, i.e. improvement or prolongation of the desirable effects (Timmerman et al. 2004). 
Although, an equi-mixture of SM1 and SM2 significantly enhanced fish survival against 
V. anguillarum or V. ordalii infections in comparison with the controls, the beneficial 
effect was not statistically different when compared to the application of single cultures 
of probiotic. Similarly, Irianto and Austin (2002a) did not reveal further benefit by 
using an equi-mixture of A. hydrophila, V. fluvialis, Carnobacterium sp. and a Gram-
positive coccus A1-6, over mono species preparations of probiotic in controlling A. 
salmonicida in rainbow trout. These findings disagree with Aly et al. (2008), who noted 
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significantly higher protection in tilapia against several pathogens (= A. hydrophila, Ps. 
fluorescens and S. iniae) when fed mixtures of B. subtilis and L. acidophilus for one 
month compared with the groups that received either B. subtilis or L. acidophilus alone. 
In contrast, tilapia administered with a mixture of M. luteus and Pseudomonas sp. for 90 
days did not resist A. hydrophila infection, reaching mortalities to 80% compared with 
25% mortalities when fed a single culture of M. luteus (El-Rhman et al. 2009). These 
data suggest that the level of host protection due to viable probiotics may differ in 
relation to the fish species, and the type of probiotic strain and their appropriate 
combinations. 
 
It is argued that the fish immune system lacks memory (see Ortuño et al. 2002), and as 
such the duration of probiotic induced beneficial responses, which is primarily mediated 
by innate immunity (Brunt and Austin 2005; Kim and Austin 2006a; Brunt et al. 2007) 
may inevitably be shorter than that of the specific immune responses, e.g. the protective 
immunity conferred from vaccination. Therefore, the duration of disease protection in 
rainbow trout after feeding with probiotics was determined by examining the long term 
beneficial effect of probiotics. For this, following a 14 day feeding regime with 
probiotic SM1, rainbow trout were challenged with V. anguillarum at weekly intervals 
for 5-weeks with the data revealing a significantly lower mortality for up to four weeks 
compared with the untreated controls. These results illustrate a carry-over effect of 
probiotics. This is relevant because in previous work adult rainbow trout orally 
vaccinated with attenuated viral haemorrhagic septicaemia virus (VHSV) strain ATT 
150 were protected significantly upon challenge with the virulent VHSA strain Fi13, six 
weeks after vaccination (Adelmann et al. 2008). Moreover, four weeks after 
immunization, mice and soft-shelled turtle (Trionyx sinensis) orally administered with 
alginate microparticle A. sobria vaccine had significantly higher protective immunity 
against A. sobria (Sun et al. 2007; Yang et al. 2007), and rainbow trout (weight = 22 g) 
showed a RPS value of 50% against lactococcosis when receiving oral immunization 
with La. garvieae cells encapsulated in alginate-acetone capsules (Romalde et al. 2004). 
Analogous results were also reported by Kwon et al. (2007), who observed a higher 
survival of juvenile olive flounder (Paralichthys olivaceus) against E. tarda infection, 
two weeks after dietary supplementation of E. tarda ghosts or formalin-killed E. tarda. 
Clearly this study has highlighted the fact that the beneficial effect of dietary SM1 to the 
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defense mechanisms of rainbow trout extends beyond the withdrawal period of 
probiotic feeding. 
 
Thus far, the administration of dead/inactivated cells or the supernatant of probiotics did 
not necessarily reduce bacterial infections in fish, which reinforced the benefit of using 
live cells (Brunt and Austin 2005;  Taoka et al. 2006b; Pan et al. 2008). In this context, 
the viable cells of two probiotics SM1 and SM2 were highly effective in controlling 
vibriosis in rainbow trout. To move forward with the understanding of probiotics, this 
study investigated the efficacy of sub-cellular components of probiotics to determine 
which part of the cell is responsible in conferring host protection. Thus, the use of cell 
wall proteins (CWPs) and whole cell proteins (WCPs) of SM1 and SM2 led to 
significant resistance to V. anguillarum infection in rainbow trout. Conversely, 
extracellular proteins (ECPs) of both probiotics fared less well. From previous work, 
cell-free supernatants of probiotics offered less protection compared to viable cells 
(Brunt and Austin 2005; Pan et al. 2008). Moreover, immunization with membrane 
vesicle (MVs) rich supernatant of Flavobacterium psychrophilum cells did not protect 
rainbow trout against F. psychrophilum infection (Aoki et al. 2007). Conversely, in a 
recent study, Abbass et al. (2010) observed that subcellular components, i.e. CWPs, 
WCPs, lipopolysaccharides (LPS) and outer membrane proteins (OMPs) of the 
probiotics A. sobria and B. subtilis, when administered to rainbow trout, led to 100% 
survival compared with 10% survival in the controls against a new biogroup of Y. 
ruckeri that has been resistant to conventional vaccines. Moreover, injection with OMPs 
of A. hydrophila was shown to control infection in goldfish caused by pathogenic 
bacteria (Rahman and Kawai 2000). Overall, this study pointed to the potential of using 
cellular components of probiotics in controlling bacterial fish diseases and may well 
explain the parts of the cells involved in protection. 
 
The fundamental question is how dietary probiotics may induce disease resistance in 
rainbow trout. The answer is not conclusive since an array of possible modes of action 
have been suggested, which might have complex interrelationships among themselves. 
It is apparent that the potential effects of probiotics in fish include competitive 
exclusion (i.e. production of inhibitory compounds, competition for chemicals, oxygen 
or available energy, and competition for adhesion sites), inhibition of virulence gene 
expression or disruption of quorum sensing molecules, improvement of water quality, 
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immunostimulation, a source of macro and/or micronutrients, improvement in the 
microbial balance, and enzymatic contribution to digestion (Vershuere et al. 2000; 
Irianto and Austin 2002b; Balcázar et al. 2006a; Gómez and Balcázar 2008; Tinh et al. 
2008; Hill et al. 2009; Picchietti et al. 2009). 
 
In vitro studies showed that Kocuria SM1 and Rhodococcus SM2 were inhibitory 
against V. anguillarum and V. ordalii, indicating both probiotics secrete inhibitory 
compounds. Therefore, it cannot be ruled out that there is the possibility of out-
competing pathogens by antibiosis via the production of low molecular weight 
inhibitors in vivo. Some probiotic micro-organisms were capable of preventing 
proliferation of pathogens on intestinal cells by competing for attachment sites (Mukai 
et al. 2002; Chabrillón et al. 2005a; Gueimonde et al. 2006). In agreement with these 
results, Balcázar et al. (2008) demonstrated that adhesion of the fish pathogens A. 
hydrophila, A. salmonicida, V. anguillarum and Y. ruckeri to intestinal mucus of 
rainbow trout was reduced by lactic acid bacteria La. lactis, L. plantarum and L. 
fermentum, respectively, in in vitro conditions. This anti-adhesion activity may be 
explained by the secretion of antimicrobial substances, such as antibiotics or 
siderophores, by these bacteria (Mukai et al. 2002; Balcázar et al. 2008). However, 
neither SM1 nor SM2 produced siderophores. 
 
Likewise, it has been stated that probiotic bacteria should possess the characteristics of 
gastrointestinal viability, i.e. the capacity of entry and survival during transit through 
the stomach and then persistence in the intestinal tract in order to provide beneficial 
effects for the host (Chou and Weimer 1999; Huang and Adams 2004). Acid 
concentration (pH) in the fish stomach ranges from 2–4, then conditions become 
alkaline (pH 7–9) immediately below the pylorus, dropping a little to a maximum of 8.6 
in the upper intestine, and finally approaching neutrality in the hindgut (Smith 1980). 
This suggests that probiotic cultures upon oral administration have to overcome major 
physiological challenges due to the barrier of extremely low pH of the stomach and the 
antimicrobial action of pepsin (Huang and Adams 2004). In this scenario, in vitro acid 
tolerance ability of the probiotics was tested, and the results indicated that both SM1 
and SM2 were able to grow at pH 2–11. Even the addition of pepsin (3 mg mL−1) at pH 
2 or 3 did not affect the viability of the isolates. Besides, SM1 and SM2 survived well 
when exposed to pancreatin (1 mg mL−1) at pH 8. Although the pH of the small 
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intestine (i.e. 7.0–8.5) is more favourable for bacterial survival, the presence of 
pancreatin or bile salts can have unfavourable effects (see Hosseini et al. 2009). 
However, the two probiotics had the capacity to withstand the effects of pepsin during 
gastric transit, also being resistant to the action of pancreatin in the small intestine. 
Certainly, these results are in agreement with those reported by Balcázar et al. (2008) 
for probiotics La. lactis, L. plantarum and L. fermentum that showed high resistance to 
pH values from 2.5 to 6.5, but lost their viability at pH 1–2, although L. plantarum 
tolerated pH 2 slightly. In contrast, Kim and Austin (2008) observed growth of 
probiotics C. maltaromaticum and C. divergens, derived from rainbow trout intestine, at pH 
5–10. So, depending on the tolerance capacity to stomach acids and bile salts, the 
survivability of probiotic bacteria in the digestive tract is not surprising. For example, 
Kim and Austin (2006a) recovered C. maltaromaticum and C. divergens from the digestive 
tract of rainbow trout after 14 days feeding with diets supplemented with these bacteria. 
Similar observations have been made previously with other probiotic strains (i.e. A. 
hydrophila, V. fluvialis, V. alginolyticus, C. inhibens, B. subtilis) fed to fish (Robertson 
et al. 2000; Irianto and Austin 2002a; Newaj-Fyzul et al. 2007). However, it is argued 
that these probiotic cultures do not show spontaneous primary colonization in the 
digestive tract, instead sustaining a transient state as long as the bacteria are introduced 
via the feed, and then seem to disappear upon switching to regular feed (Robertson et al. 
2000; Newaj-Fyzul et al. 2007).  
 
Another promising side of using dietary probiotics is the potential improvement in feed 
efficiency, which may be reflected through better growth rate of the animal and 
improved feed utilization. In the present study, an improvement of SGR, FCR and PER 
was observed in fish fed with SM2 compared to the control group, although the result 
was statistically indifferent. In contrast, improvements were not recorded when using 
SM1. In this connection, Sáenz de Rodrigáñez et al. (2009) reported significantly higher 
growth and nutrient utilization in juvenile sole (Solea senegalensis weight = 10–15 g) 
after dietary supplementation with probiotics (= Alteromonadaceae family) for 60 days. 
Similar results have been reported in African catfish (Clarias gariepinus) fingerlings 
maintained on diet supplemented with L. acidophilus for 84 days (Al-Dohail et al. 
2009), and in larval sea bass (D. labrax) administered with L. delbrueckii delbrueckii 
via rotifers or Artemia nauplii between days 11 and 70 posthatch (Carnevali et al. 2006) 
than those fed diets without probiotic. Moreover, a significant improvement of FCR, 
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SGR and PER was observed in rainbow trout (weight = ~45 g), previously treated with 
antibiotic, after 70 days feeding on mixed B. subtilis and B. licheniformis supplemented 
diets (Merrifield et al. 2010b). Surprisingly in a similar experiment keeping most of the 
parameters identical, Merrifield et al. (2010a) observed no statistical improvements of 
SGR in rainbow trout (weight = ~70 g) fed with probiotics, although an enhanced SGR 
was noted compared to the controls. It was proposed that, as in terrestrial animals, some 
probiotic strains may be a source of micro- and macroelements in feed (Verschuere et 
al. 2000) and their activity in the digestive tract may stimulate the specific and/or total 
activities of digestive enzymes, such as amylase, protease and lipase activities (Balcázar 
et al. 2006a; see Sáenz de Rodrigáñez et al. 2009) thereby improving the whole 
digestive process, and enhancing the digestibility of feed and the effective utilization of 
nutritive supplies. However, in this study, the overall digestive enzyme activities of 
rainbow trout were not modified after probiotic treatment and the levels were virtually 
analogous to the controls. Interestingly, SM2 demonstrated slightly better extracellular 
enzymatic activities (i.e. carbohydrase, ester hydrolases, phosphohydrolases and 
protease) compared with SM1, but it was not clear whether these enzymes led to better 
growth in fish treated with SM2 in comparison to other treatments.  
 
The organosomatic indices, i.e. hepatosomatic index and splenosomatic index are 
indicators of the health status of fish (see Abd-El-Rhman 2009). Fish spleens are 
macrophage-rich tissues, and a key source of antibody production and immunological 
memory (Hadidi et al. 2008). Thus, rainbow trout with greater spleen weights were 
significantly more resistant to F. psychrophilum (= aetiological agent of bacterial cold-
water disease and rainbow trout fry syndrome) than those of the susceptible fish, 
although the result was pathogen-specific (Hadidi et al. 2008). This suggests a positive 
correlation between fish survival and spleen size when infected with potential diseases. 
However, the hepatosomatic and splenosomatic indices remained unaffected by any 
treatment in the present study. It should be emphasized that the outcome of probiotic 
use is not always reproducible. There may be variability of results noted even after 
using the same probiotic with the same type of fish (see Panigrahi et al. 2004 in 
comparison with Panigrahi et al. 2005, and Merrifield et al. 2010a in comparison with 
Merrifield et al. 2010b).  
 
Irianto and Austin (2002a) provided evidence that probiotics act by stimulating the 
immune response in fish. This particular role of probiotics corroborates well to the 
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present study where innate immune parameters were enhanced in fish treated with SM1 
or SM2 compared to the controls. Certainly, immunostimulation has been identified as 
the dominant mode of action for a range of probiotics, including representatives of both 
Gram-positive and Gram-negative bacterial taxa (Austin and Austin 2007). In 
agreement with previous studies, the use of SM1 or SM2 led to higher leucocyte (Brunt 
and Austin 2005; Newaj-Fyzul et al. 2007) and erythrocyte (Brunt and Austin 2005) 
counts in the blood, although statistical significance in the data was not always reported 
(Brunt et al. 2007). It was observed that the presence of high blood leucocyte numbers 
was accompanied by an enhanced oxidative burst and phagocytic activity in yellowtail 
and rainbow trout (see Gannam and Schrock 2001), which have been associated with 
bacteriocidal activity and functioning as a defensive immune mechanism (Claver and 
Quaglia 2009). The leukocytes usually develop from an enhanced ability of a particular 
cell/tissue to counter infection (Cruickshank 1965), and are recognized as vital immune 
competent cells (e.g. lymphocytes and monocytes) mediating specific (= acquired or 
adaptive immunity) and non-specific immunity in fish (Wang et al. 2006). However, 
erythrocytes in fish can equally act as immune cells, binding and engulfing Candida 
albicans (Passantino et al. 2002). So, probiotics can enhance the number of 
erythrocytes, granulocytes, macrophages and lymphocytes in fish (Irianto and Austin 
2002a; Kumar et al. 2008). 
 
Phagocytic activity is responsible for the generation of inflammatory responses before 
antibody production. Moreover, phagocytic activity results in an additional recruitment 
of immunocompetent cells to the inflammatory site, thus playing a crucial role in 
antibacterial host defenses (Isolauri et al. 2001; Nayak 2010). In agreement with 
previous studies using rainbow trout, feeding with viable probiotics for two weeks or 
more leads to higher macrophage phagocytosis (Brunt and Austin 2005; Panigrahi et al. 
2005; Pieters et al. 2008), which is a mechanism involved in the eventual killing of 
phagocytosed infectious agents and also serves as an innate immune effector 
(Greenberg and Grinstein 2002). A similar beneficial effect had already been observed 
on the phagocytic activity of finfish fed with L. plantarum at 106−10 cfu kg−1 (Son et al. 
2009) yeast Debaryomyces hansenii at 106 cfu g−1 (Reyes-Becerril et al. 2008), C. 
butyricum at 108 cells g−1 (Pan et al. 2008), and L. delbrüeckii subsp. lactis and B. 
subtilis at 107 cfu g−1 or their equi-mixtures (Salinas et al. 2008) for between two and 
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four weeks. Conversely, La. lactis was unsuccessful in enhancing the phagocytic 
activity of head kidney macrophages in turbot (Villamil et al. 2002). 
 
As in other vertebrates after activation, fish phagocytic cells, 
i.e. monocytes/macrophages and neutrophils, are able to generate superoxide anion 
(O2−), which is a measure of respiratory burst activity, hydrogen peroxide (H2O2), nitric 
oxide (NO), peroxynitrite (ONOO−), hypochlorous acid (HOCl) and hydroxyl radical 
(OH−), all of which are highly microbiocidal (Secombes 1996; Ellis 2001; Neumann et 
al. 2001) and can be associated with the extracellular killing of pathogens (Hardie et al. 
1996; Secombes 1996; Itou et al. 1997). Data suggest that increases in the oxidative 
killing mechanism, as observed with blood/macrophage superoxide anion and 
macrophage peroxidase activities in rainbow trout fed SM1, SM2 or their equi-mixture, 
has been correlated with enhanced pathogen killing capacity of phagocytes in fish 
(Jørgensen et al. 1993; Sharp and Secombes 1993) and so improvement in disease 
resistance is likely. The present results are in accordance with those performed in fish 
where respiratory burst (Nikoskelainen et al. 2003; Brunt and Austin 2005; Aly et al. 
2008) or peroxidase (Rodríguez et al. 2003; Reyes-Becerril et al. 2008; Salinas et al. 
2008) activities were enhanced by dietary supplementation with probiotic bacteria and 
yeast for two and four weeks. Moreover, rainbow trout fed with other probiotics, i.e. 
A. sobria (Brunt et al. 2007) and C. divergens (Kim and Austin 2006a), demonstrated 
stimulation of the respiratory burst activity of macrophages after 2 week feeding 
regimes. Similar to these results, fingerlings of rohu (L. rohita) with an average weight 
of 15 ± 2 g demonstrated significantly higher respiratory burst activity compared to the 
controls when fed for 2 weeks with B. subtilis (Kumar et al. 2008). However, the 
corresponding increase in the activity of serum peroxidase, as recorded here, was not 
surprising since phagocytes produce reactive oxygen species (ROS) during respiratory 
burst (Neumann et al. 2001), which is believed to exert oxidative stress to the fish and 
thus requires to be removed (Newaj-Fyzul et al. 2007). Evidently, the peroxidase 
content in the serum of gilthead sea bream and rainbow trout was significantly higher 
when they were fed with Bacillus or a mixture of Lactobacillus and Bacillus (Salinas et 
al. 2008), and B. subtilis (Newaj-Fyzul et al. 2007) supplemented diets. Likewise, 
Enterococcus faecium (1 × 107 cfu mL−1) was reported to elevate the serum peroxidase 
content in tilapia when added to rearing water every 4 days for 40 days (Wang et al. 
2008). Conversely, Reyes-Becerril et al. (2008) did not observe any significant increase 
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in peroxidase activity of gilthead sea bream fed with diets containing live yeast D. 
hansenii, although a higher activity was noted. 
 
The elevated bacterial killing activity of HK macrophages as observed in this study is in 
agreement with another report using rainbow trout, which were fed with a probiotic, B. 
subtilis (Newaj-Fyzul et al. 2007). Moreover in agreement with this study, tilapia 
treated with B. subtilis, L. acidophilus or their mixture led to a significantly higher 
serum bacteriocidal activity against pathogens A. hydrophila, Ps. fluorescens and S. 
iniae, than in the untreated control group (Aly et al. 2008). Similar views were put 
forward by Kumar et al. (2008), who noted a significant increase of serum bacteriocidal 
activity in rohu fed with B. subtilis in comparison to the control group. Furthermore, 
plasma bacteriocidal activity in tilapia was enhanced by commercial probiotics either 
introduced as live or dead cells via the oral route, or as viable cells via rearing water 
(Taoka et al. 2006b). Conversely, the bacteriocidal activity of serum was not modified 
by use of La. lactis in turbot (Villamil et al. 2002). 
 
In teleosts, the complement system plays a role in the adaptive immune response as well 
as being involved in chemotaxis, opsonization, phagocytosis and degradation of 
pathogens (Swain and Nayak 2009). Therefore, the alternative complement activity, 
which is an antibody-independent pathway with higher levels in fish serum compared to 
mammalian serum (Yano 1992), may be directly involved in the lysis of micro-
organisms (Ellis 1999). Here, the differences in complement levels were statistically 
significant when compared with the controls, and support the findings of previous 
studies involving probiotics and a range of fish species (Nikoskelainen et al. 2003; 
Panigrahi et al. 2004; Balcázar et al. 2007a). It is noteworthy that heat inactivated 
probiotics Pdp11 or 51M6 can also stimulate complement components in fish (Choi and 
Yoon 2008).  
 
Protection of a host against the onslaught of pathogens may reflect increased serum 
lysozyme activity. Lysozyme, which is a key humoral innate defence parameter (i.e. 
bacteriocidal enzyme) in invertebrates and vertebrates (Magnadóttir et al. 2005), can 
hydrolyse peptidoglycan in bacterial cell walls, thereby causing lysis of mainly Gram-
positive bacterial species, and in conjunction with complement, even some Gram-
negative taxa (Ellis 1990; Alexander and Ingram 1992). Stimulation of lysozyme 
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activity has been recognized after two, four and six weeks of feeding with C. divergens 
and L. rhamnosus in rainbow trout (Panigrahi et al. 2005; Kim and Austin 2006a), C. 
butyricum in Chinese drum (Pan et al. 2008), S. cerevisiae in sea bream (Rodríguez et 
al. 2003), and L. plantarum in grouper (Son et al. 2009), respectively. Increases in 
serum lysozyme have been recognized for B. subtilis and L. acidophilus in tilapia (Aly 
et al. 2008), and for La. lactis subsp. lactis, Leu. mesenteroides and L. sakei in brown 
trout (Balcázar et al. 2007a) as feed additives. Possibly, such enhanced nonspecific 
factors of the immune system may have provided defence against infection by the 
pathogen. However, some studies failed to detect any specific change in serum 
lysozyme level after dietary supplementation of probiotics, namely L. sakei, La. lactis 
subsp. lactis, Leu. mesenteroides, L. rhamnosus and A. sobria in fish (Panigrahi et al. 
2005; Balcázar et al. 2007a,b; Brunt et al. 2007).  
 
Immunoglobulins, principally immunoglobulin M (IgM), are major components of the 
teleost humoral immune system, and are found both in soluble (= secreted) and 
membrane-bound forms (Cuesta et al. 2004). The soluble form, which occurs in blood 
and other fluids, is secreted from B cells, and is regarded as an immune effector 
molecule (Ross et al. 1998). As noted in this study, elevation of immunoglobulin level 
after dietary supplementation of probiotics has been reported in many fish species 
(Panigrahi et al. 2004; Nayak et al. 2007; Al-Dohail et al. 2009). Moreover, 10–30 days 
administration of viable and non-viable forms of L. rhamnosus elevated plasma 
immunoglobulin levels in rainbow trout (Panigrahi et al. 2005). Even one week 
supplementation of L. rhamnosus at a dose of 2.8 × 108 cfu g−1 feed was found to 
significantly increase the immunoglobulin level in rainbow trout (Nikoskelainen et al. 
2003). Although not statistically significant, Balcázar et al. (2007a) observed an 
increase in immunoglobulin level in brown trout after feeding La. lactis subsp. lactis, L. 
sakei and Leu. mesenteroides supplemented 106 cfu g−1 feed for a period of 2–4 weeks.  
 
The antiprotease activities in serum and other body fluids, principally α1-antiprotease, 
α2-antiplasmin and α2-macroglobulin, are antienzymes and are characterized by their 
capacity to delay or inhibit pathogens that attack through proteolytic enzyme secretion 
(Ellis 2001; Magnadóttir 2006). These activities are generally high, and appear to be 
hardly modulated in fish even by immunization or infection (Magnadóttir 2006). In this 
study, the total antiprotease activity as measured by the mean antitrypsin activity of sera 
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was elevated in the probiotic-fed fish as compared with the controls, with the 
differences being significant at week two. Similarly, it was reported that higher levels of 
total, α1 and α2-antiprotease occurred in the serum of rainbow trout after feeding with 
probiotics (Brunt et al. 2007; Newaj-Fyzul et al. 2007). However, a 10-fold difference 
in α2-macroglobulin activity between rainbow trout and brook trout has been correlated 
with their differing resistance to the pathogenicity of A. salmonicida (Freedman 1991). 
 
Certainly in this study, a two-week feeding regime with SM1 leads to the best defence 
against V. anguillarum in rainbow trout, with protection linked to significant stimulation 
of macrophage phagocytic activity and serum total protein levels as compared to other 
treatments and controls. Moreover, in comparison with the controls, serum antiprotease 
and lysozyme activities were significantly enhanced at week two, but the differences 
became non-significant by weeks three and four of the experiment. Likewise, 
macrophage peroxidase content was pronounced at the end of week two. The facts 
suggest that an elevated immunomodulatory effect after two weeks of probiotic feeding 
was the key determinant in maximizing host resistance to disease. Similarly, maximum 
stimulation of macrophage phagocytosis (Rodríguez et al. 2003; Salinas et al. 2005; 
Son et al. 2009), peroxidase activity (Rodríguez et al. 2003; Salinas et al. 2005), and 
serum lysozyme (Panigrahin et al. 2005) level has been recorded after 10–14 
days dietary supplementation of probiotics in fish involving other feeding regimes. 
Overall, this study reinforced the importance of probiotics in stimulating the innate 
immune response of rainbow trout. This contrasts with the previous accepted notion that 
probiotics act by competitive exclusion, which may include competition for space and 
nutrients in the digestive tract, or the localized production of antibiotics or low 
molecular weight inhibitors (Verschuere et al. 2000; Irianto and Austin 2002b; Balcázar 
et al. 2006a).  
 
Following withdrawal of dietary SM1, this study found the enhancement of several 
innate immune parameters in rainbow trout for up to 5 weeks compared to those of the 
controls, although statistical significance in the data was not always noted at different 
time points in the experimental groups. Of relevance, the administration of La. lactis 
subsp. lactis and Leu. mesenteroides at 106 cfu g−1 into the diet of brown trout has been 
reported to significantly enhance the serum lysozyme activity, including an increase in 
the levels of serum alternative complement activity and plasma total immunoglobulin 
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between 1–2 weeks of post-probiotic feeding (Balcázar et al. 2007a). In a similar study, 
Nikoskelainen et al. (2003) observed stimulation in the respiratory burst and 
complement bacteriocidal activity at 1 week after cessation of feeding of 2.8 × 108 cfu 
g−1 L. rhamnosus to rainbow trout; but there was a significant elevation of the natural 
antibody (= serum immunoglobulin) level in relation to nonstimulated fish at 2 weeks. 
Comparable results were also obtained by Panigrahi et al. (2005), who demonstrated 
non-significant improvement of phagocytosis, lysozyme and total immunoglobulin 
levels in rainbow trout 15 days after withdrawal of viable L. rhamnosus cells from the 
diet. However, in this study, the level of the immune response was decreased over time; 
principally serum lysozyme dropped significantly at the end of the experiment; a 
phenomenon which is in agreement with findings of other workers (Nikoskelainen et al. 
2003; Balcázar et al. 2007a). Certainly, these observations indicate that there may be an 
innate memory (= long-term protection) that depends on the steady maintenance of 
immune response from the induction phase, which might explain the longevity of the 
disease resistance scenario in rainbow trout in the present study. Undoubtedly, the 
proliferation rate and populations of lymphocytes produced may be the key for the 
magnitude and duration of immunity against infections (Eggset et al. 1997) suggesting 
the fundamental importance of persistence of an immune activator in the support of 
longer immunity.  
 
Nevertheless, in this particular study, rainbow trout fed with standard commercial diet, 
after previous priming with dietary SM1, were significantly protected against V. 
anguillarum for 4 weeks and produced immune responses possibly comparable to those 
demonstrated by vaccine. Clearly, fish vaccinology works through stimulation of 
memory cells, including modulation of innate defense mechanisms (Kozinska and Guz 
2004; Robertson et al. 2005) and usually provides long-term protection against specific 
pathogens (Eggset et al. 1997). Various recent publications reported that probiotics, like 
vaccines, led to the induction of a variety of cytokines (= cellular immunity) such as 
interleukin (IL)-1β, IL-8, tumor necrosis factor (TNF)-α and transforming growth factor 
(TGF)-β (Kim and Austin 2006b; Panigrahi et al. 2007), and lead to an increase in the 
memory T cell population (Picchietti et al. 2009) in naïve fish or fish exposed 
previously to probiotic-supplemented diet. Cytokines are stimulators and effectors of all 
immune and inflammatory responses (Kelso 1998), and may be involved in the 
continued existence of memory cells with the help of interferon α (type I interferon) and 
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IL-15 (see Zanetti and Croft 2001). Therefore, it may be hypothesized that the mode of 
action of probiotics is perhaps comparable to oral vaccines (Irianto and Austin 2002b) 
chiefly due to stimulation of cellular immunity (Irianto and Austin 2002a). However, 
immunological memory is a functional event and is supposed to be a property of the 
overall immune system, but not solely through memory cells, i.e. B (= humoral 
immunity) and T (= cellular immunity) cells (Zanetti and Croft 2001). The possibility of 
stimulation of the cytokine genes involved in the immune response after probiotic 
feeding remains a matter of further investigation.   
 
Cell components of micro-organisms have been reported to activate the immune system 
of many animals, including fish. For example, LPS, a component of the outer cell 
membrane of Gram-negative bacteria, possesses immunogenic properties, and a small 
dose can induce the production/activation of antibody, lysozyme, alternative 
complement pathway, B and T lymphocytes, cytokines like IL-2 and -6, pro-
inflammatory cytokines like IL-1β, TNF-α and several other factors from macrophages, 
including phagocytic activity in fish (Nayak et al. 2008; Nya and Austin 2010). OMPs 
of Gram-negative bacteria are also known to be immunodominant antigens, and may 
provoke strong humoral and cellular immune responses in fish (Boesen et al. 1997; 
Arijo et al. 2004). Moreover after inoculation, ECPs may often lead to adequate 
immunity against piscine pathogens, and some authors has suggested the importance of 
including inactivated ECPs in the design of effective vaccines (Collado et al. 2000; 
Zorrilla et al. 2003; LaFrentz et al. 2004). β-glucans, which are polysaccharides from 
the cell walls of yeast and fungi, are also found in plants, algae and some bacteria, and 
have been determined to enhance specific and non-specific immune responses in several 
fish species, i.e. yellow croaker, Asian catfish, carp and zebrafish (Misra et al. 2006; El-
Boshy et al. 2010). Furthermore, nucleotides and RNA have been shown to have 
immunostimulatory effects, and thus enhance fish resistance to pathogens (Li et al. 
2004). Similarly, bacterial DNA is reported to activate antigen-presenting cells (APCs), 
in mice and fish models (see Hong et al. 2006). These data suggest that the non-specific 
defence of vertebrates has evolved towards recognition of conserved microbial 
structures, i.e. yeast/fungal cell wall β-glucan, bacterial LPS and peptidoglycan, 
bacterial DNA and viral double-stranded RNA – all of which have been reported to 
enhance the host resistance against microbial diseases (Robertsen 1999). Therefore, in 
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this study, a protective immune response in rainbow trout after inoculation with 
subcellular components of probiotics was not surprising. 
 
Overall, it is argued that the immunomodulatory effects of probiotics in fish are still 
poorly understood albeit that a number of previous studies have assessed systemic 
immune responses in vivo (Irianto and Austin 2002a; Nikoskelainen et al. 2003; 
Panigrahi et al. 2004, 2005, 2007; Kim and Austin 2006a,b; Brunt et al. 2007; Aly et al. 
2008; Arijo et al. 2008; Pieters et al. 2008). It is suggested that the interactions of 
probiotics and/or their components/products (= antigenic particles) with gut epithelial 
cells, gut immune system [= gut associated lymphoid tissue (GALT)] and 
gastrointestinal microbiota might control the mechanism behind the immunostimulatory 
activity (Tinh et al. 2008; Nayak 2010). For example, the effect of probiotics in 
stimulating the gut immune system is documented in some fish species, with a 
noticeable increase in the number of Ig+ cells and acidophilic granulocytes (Picchietti et 
al. 2007, 2008, 2009; Salinas et al. 2008). Moreover, Picchietti et al. (2009) 
demonstrated local gut immunity of sea bass by an increase in T lymphocytes after 
supplementation of bioencapsulated L. delbrueckii subsp. delbrueckii. In addition, an 
enhanced gut mucosal lysozyme (Kim and Austin 2006b) and phagocytic activity of 
mucosal leucocytes (Balcázar et al. 2006c) by probiotics was also reported. These data 
suggest that the gut of fish is immunocompetent. Certainly, a strong uptake capacity of 
bacterial antigens in the gut of the rainbow trout and cyprinid fish has been documented 
after oral and anal administration, which was subsequently reported to be processed by 
intraepithelial macrophages (see Hart et al. 1988; Nayak 2010). Likewise, particulate 
antigens (namely whole viruses and bacteria) seem to be taken up by the gut of tilapia 
and mirror carp (see Hart et al. 1988). However, it should be noted that, as in mammals, 
fish do not have Peyer’s patches, secretory IgA and antigen-transporting M cells (= 
phagocytic cells) in the gut, but hold numerous diffusely structured lymphoid cells, 
macrophages, granulocytes and mucus IgM representing the gut immune system (see 
Nayak 2010). 
 
While probiotics are deemed to be beneficial, a question may still arise as to whether or 
not they exert stress or physiological problems to the host. Recently, Hernandez et al. 
(2009) observed an enhanced tolerance to stress (= significantly higher recovery rates 
after 1 h of air exposure) of juvenile Porthole livebearer Poeciliopsis gracilis fed with 
Artemia nauplii enriched with L. casei, when compared with groups fed with just the 
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non-enriched nauplii. Similarly, the application of probiotics has been recognized to 
improve tolerance of other fish species to environmental stressors. For example, 
juvenile Japanese flounder fed with commercial preparations of B. subtilis, L. 
acidophilus, C. butryricum and S. cerevisiae were more resistant to heat shock and air 
stress, and found with significantly higher plasma lysozyme activity as a measure of 
stress parameters (Taoka et al. 2006a). Likewise, probiotics have been reported to 
enhance salinity tolerance in tilapia (Taoka et al. 2006b). Moreover, there was a lower 
cortisol (= a hormone directly involved in stress responses that shows higher levels 
under stress conditions) response in probiotic treated fish during pH-induced stress 
(Rollo et al. 2006) and transportation (Gomes et al. 2008). Furthermore, juvenile 
European sea bass fed with L. delbrueckii subsp. delbrueckii possessed lower levels of 
whole-body cortisol compared to controls, which was indicative of better tolerance to 
rearing conditions by fish treated with probiotics (Carnevali et al. 2006). In this study, 
the levels of serum glucose were statistically similar between the different groups. 
However, how the probiotics affect the physiology of stress response in fish or lessen 
the stress stimulus is not clear, but it is believed to be related to improved host health 
which is directly attributable to probiotics (Rollo et al. 2006). A high quantity of total 
serum protein, albumin and globulin, as recorded in this study, is considered likely to be 
associated with a stronger innate immune response in fish (Wiegertjes et al. 1996), and 
may be equally linked to the nutritional status and the integrity of the vascular system 
and liver function (Abdel-Tawwab et al. 2008). This argument is supported in this study 
by the increased survival of the experimental group of rainbow trout after infection with 
pathogenic vibrios. Certainly, enhanced total protein (Nayak et al. 2007; Newaj-Fyzul 
et al. 2007) and higher albumin and globulin levels (Wang et al. 2008) in fish have been 
reported after administering probiotics. The data for serum urea and creatinine showed 
no statistical difference between groups, and suggest that there were no adverse effects 
of dietary probiotics on the kidney function of rainbow trout in the current study.  
 
It is relevant to address the potential structural, i.e. anatomical and morpho-
physiological changes of the fish digestive tract upon feeding probiotics. Ringø et al. 
(2007) did not observe any changes in the gut histology (i.e. an intact mucosal 
epithelium) when the foregut of the Atlantic salmon was exposed in vitro to C. 
divergens (isolated from the foregut of the Artic charr, Salvelinus alpinus) or to 
Ringer’s solution (= control sample). This suggests that non-pathogenic indigenous 
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bacteria do not affect gut cellular integrity (Ringø et al. 2004). Moreover, Sáenz de 
Rodrigáñez et al. (2009) demonstrated that the use of probiotics positively influenced 
the intestinal functionality of juvenile Senegalese sole (Solea senegalensis) with 
evidence of moderate accumulation of lipids within the enterocytes as compared to big 
lipid inclusions (= intracellular damage and loss of cytoplasma) in fish fed control diets. 
The microvilli were also larger and more numerous than the controls. Similarly, Zhang 
et al. (2009) observed that dietary administration of Halomonas sp. improved the 
integrity of the intestinal mucosal layer of shrimp Fenneropenaeus chinensis; for 
example, the intestinal cells or enterocytes were covered by a layer of intestinal mucosa, 
the arrangement of epithelial cells was more compact and regular in the midgut, and the 
intestinal mucosal layer was denser in shrimp treated with probiotic than that of the 
controls. 
 
There is no doubt that probiotics lead to improved health status and enhanced disease 
resistance of aquacultural species, but there appears to be differences in their activities. 
In particular, an improper dose and/or feeding duration may lead to unfavorable results 
(Nikoskelainen et al. 2001; Son et al. 2009; Merrifield et al. 2010c; Nayak 2010). 
Therefore, age, physiological status and genetic makeup of the fish, rearing conditions, 
the probiotic feeding duration and dosage, the type and composition (i.e. mono-species 
or multi-species) of the probiotic, the method of administration and supplementation 
form, and the interactions of probiotic with the gut microflora could be the determinants 
influencing the outcome of probiotic treatment (reviewed by Merrifield et al. 2010c; 
Nayak 2010).  
 
In conclusion, dietary supplementation of Kocuria SM1 and Rhodococcus SM2 
demonstrated effectiveness for the control of vibriosis in rainbow trout. Clearly, there is 
a role for probiotics in fish disease control strategies, and their use may replace some of 
the inhibitory chemicals currently used in fish farms. 
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4.2 Conclusions 
1. The guts of healthy rainbow trout are suitable locations for the selection of 
candidate probionts, though only a small proportion may be antagonistic to 
pathogens.   
2. Probiotics SM1 (Kocuria sp.) and SM2 (Rhodococcus sp.) conferred marked 
reductions in mortalities of rainbow trout after challenge with V. anguillarum 
and V. ordalii, respectively, when compared to the controls. This demonstrates 
that probiotics are not necessarily specific to single diseases.  
3. A two week feeding regime with SM1 dosed at ~108 cells g−1 feed led to the best 
protection. 
4. An equi-mixture of SM1 and SM2 significantly enhanced fish survival against 
V. anguillarum or V. ordalii infections, but the result was not better than the use 
of single cultures of probiotic. 
5. The beneficial effect of dietary SM1 to the defense mechanisms of rainbow trout 
extends beyond (= up to 4 weeks) the withdrawal period of the feeding regime. 
6. The use of cell wall proteins (CWPs) and whole cell proteins (WCPs) of SM1 
and SM2 led to significant resistance against V. anguillarum infection in 
rainbow trout. However, extracellular proteins (ECPs) of both probiotics fared 
less well. This may explain the parts of the cells involved in protection. 
7. Probiotics or their subcellular components stimulated the cellular and humoral 
innate immune parameters in rainbow trout.  
8. Improvement of specific growth rate (SGR), feed conversion ratio (FCR) and 
protein efficiency ratio (PER) was observed in fish fed with SM2 compared to 
the control group, but the results were statistically indifferent. 
9. SM2 demonstrated slightly better extracellular enzymatic activities compared 
with SM1, but it is not clear whether the difference led to better growth in fish 
treated with SM2.  
10. Stress or physiological problems in rainbow trout were not observed after 
administration of dietary probiotics, since the kidney function and the level of 
serum glucose was similar between groups. 
11. The possible mode of action of probiotics is multifactorial, and may include 
competitive exclusion, nutrition, enzymatic contribution to digestion, and 
stimulation of innate immunity. 
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